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Cardiovascular disease (CVD) is the world-leading cause of mortality. The 
pathophysiological process underlying CVD is atherosclerosis, often preceded by 
dysfunction of the endothelium, the inner layer of the artery wall. The endothelium is 
sensitive to hemodynamic stimuli, including shear stress (i.e. friction force of flowing 
blood). Endothelial function, assessed using brachial artery flow-mediated dilation (FMD), 
is a predictor of future CVD risk. In brief, the FMD test consists of ultrasonic assessment 
of the relative change in brachial artery diameter before and after a 5-minute period of 
distal limb (forearm) ischaemia, induced by cuff occlusion. Releasing the cuff leads to a 
transient increase in shear stress through the brachial artery (i.e. shear rate area-under-
the-curve; SRAUC), which in turn stimulates vasodilation. Since the introduction of the 
FMD technique in 1992, efforts have been made to standardise the methodology for the 
performance of the FMD and expert-consensus protocol guidelines were established. 
However, large variability in FMD data is present within the literature, likely due to poor 
adherence to these guidelines. Despite this variation, research has consistently reported 
age- and sex-specific differences in FMD, where FMD is lower in males compared to 
females, and declines with age, even in healthy individuals. Reproductive hormones may 
explain sex-specific differences in FMD, with animal work suggesting that oestrogen 
improves the relationship between shear stress and vasodilation. Furthermore, 
exercise/heating protocols have demonstrated the potency of shear stress as a stimulus 
for improved FMD. The pattern of shear stress is also relevant, given that antegrade and 
retrograde shear stress impose opposite effects on FMD. However, these studies have 
manipulated mean shear stress, whilst it could be argued that fluctuations in blood flow 
and shear stress are more applicable to daily life. Therefore, the aims of this thesis were 
to: (i) update the expert-consensus guidelines for FMD, (ii) estimate age- and sex-
specific reference values for brachial artery FMD in healthy individuals and explore the 
relation with CVD risk factors, (iii) examine age- and sex differences in the relation 
between FMD and its eliciting shear stress stimulus, and (iv) assess the acute effect of 
fluctuations in shear rate on FMD. 
 
Chapter 3 aimed to update the expert-consensus methodological guidelines for the 
performance and analysis of FMD. Importantly, standardised performance of the FMD 
technique facilitates better between-study comparability, therefore reducing variability. 
This effort also importantly contributes to the construction of reference values (Chapter 
4). Brachial artery FMD data (acquired according to protocol guidelines) and participant 
characteristics/medical history from 5,362 individuals (4-84yrs; 2,076 females) were 
pooled into a single database. Healthy individuals (n=1,403 [582 females]) were used to 
generate age-/sex-specific percentile curves from fractional polynomial regression. 
Subsequently, individuals with CVD risk factors, but without overt disease were included 
(un-medicated n=3,167 [1,247 females], and medicated n=792 [247 females]), and 
multiple linear regression tested the relation of CVD risk factors with FMD. Healthy males 
showed a negative, curvilinear relation between FMD and age, whilst females revealed 
a negative linear relation that started higher, but declined at a faster rate than males. 
Age- and sex-specific differences in FMD relate, at least partly, to baseline artery 
diameter. FMD was related to CVD risk factors in un-medicated (e.g. systolic-/diastolic 
blood pressure) and medicated individuals (e.g. diabetes/dyslipidaemia). Sex mediated 
12 
 
some of these effects (P<0.05), with normalisation of FMD in medicated men, but not 
women with dyslipidaemia. 
 
To better understand the impact of sex and age on the relation between shear stress 
and FMD, healthy adults (n=932 [283 women]) were stratified into young adults (18-40 
years, 389 men, 144 women) and older adults (>40 years, 260 men, 139 women). 
Secondly, women were grouped based on hormonal status (pre- [n=173] and post-
menopausal [n=110]). There was evidence of a weak correlation between SRAUC and 
FMD in all groups but older men, although there was variation in strength of outcomes. 
Further exploration using interaction terms (age-sex*SRAUC) in linear regression 
revealed differential relationships with FMD (young women versus young men (β=-5.8-
4, P=0.017) and older women (β=-5.9-4, P=0.049)). The correlation between SRAUC 
and FMD in pre-menopausal women (r2=0.097) was not statistically different to post-
menopausal women (r2=0.025; Fisher: P=0.30). Subgroup analysis using stringent 
inclusion criteria for health markers (n=505) confirmed a stronger FMD-SRAUC 
correlation in young women compared to young men and older women.  
 
Chapter 6 aimed to examine the impact of fluctuations in shear, whilst maintaining mean 
shear levels around baseline. Fifteen healthy males (27.3±5.0 years) underwent bilateral 
brachial artery FMD assessment before and after unilateral exposure to 30 minutes of 
intermittent negative pressure (10seconds -40mmHg, 7seconds 0mmHg) to induce 
fluctuation in shear rate, whilst the contra-lateral arm was exposed to a resting period. 
Negative pressure significantly increased shear rate, followed by a decrease in shear 
rate upon pressure release (both P<0.001). Importantly, across the 30-minute 
intervention, mean shear rate was not different compared to baseline (P=0.458). A linear 
mixed model revealed a significant effect of time for FMD (P=0.029), with exploratory 
post-hoc analysis showing an increase in the intervention arm (∆FMD +2.0%, P=0.008), 
but not in the contra-lateral control arm (∆FMD +0.5%, P=0.664). However, there was no 
effect for arm (P=0.619) or interaction effect (P=0.096).  
 
Taken together, the work contained in this thesis successfully updated the FMD protocol 
guidelines and, for the first time, estimated reference values for brachial artery FMD. 
Firstly, the present findings highlight an important role for sex in determining vascular 
function. Specifically, sex altered the age-related decline in FMD and relation with some 
CVD risk factors and medication (Chapter 4), in addition to the relation between FMD 
and SRAUC (Chapter 5), suggesting improved sensitivity of the endothelium to shear 
stress in women. Secondly, novel data presented in Chapter 6 suggest that fluctuations 
in shear pattern, even in the absence of altered mean shear, represents a stimulus to 
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Cardiovascular disease (CVD) remains the world’s leading cause of morbidity and 
mortality (World Health Organisation, 2017). Atherosclerosis underlies the development 
of most forms of CVD and the vascular endothelium, the inner monolayer of cells of the 
arterial wall, plays a key role. A prime function of the endothelium is to regulate vascular 
tone via the synthesis and release of vasoactive substances (Cahill & Redmond, 2016). 
A major stimulus for this release of paracrine hormones is the frictional force of flowing 
blood, or shear stress, along the endothelium. One vasoactive substance released in 
response to augmented antegrade shear stress (forward; away from the heart) is nitric 
oxide (NO) (Palmer et al., 1988), which diffuses into vascular smooth muscle cells to 
cause relaxation and facilitate vasodilation. Accordingly, the vasodilator response is a 
reflection of an intact, functional endothelium (Ross et al., 1984). Previous studies have 
reported that endothelial dysfunction contributes to the development and progression of 
atherosclerosis (Charakida et al., 2010). 
 
Several techniques have been developed over the past ~25 years to assess endothelial 
function. One frequently used non-invasive method relates to the flow-mediated dilation 
(FMD) approach. Briefly, this technique involves the use of high-resolution 
ultrasonography to measure conduit artery (most commonly the brachial artery) diameter 
in response to a marked elevation in blood flow and consequent shear stress following a 
period of distal limb ischaemia. FMD is reported as the relative change (presented as a 
percentage) in artery diameter from baseline. Previous research has provided evidence 
that the FMD response is endothelium-dependent (Dawson et al., 2010a) and largely 
mediated by NO (Green et al., 2014) in humans. In healthy individuals, one may expect 
marked vasodilation and the conceptual idea is that a low or absent dilation of the artery 
during the FMD test reflects endothelial dysfunction. Moreover, such an impaired dilator 
response, even in asymptomatic individuals, is related to CVD risk (Ras et al., 2013; Xu 
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et al., 2014; Inaba et al., 2010; Matsuzawa et al., 2015). Despite its valid conceptual basis, 
various factors influence the variability of FMD (De Roos et al., 2003; Donald et al., 2008), 
including lifestyle factors, hormonal changes, test protocol methodology and analysis 
method (Green et al., 2011; Thijssen et al., 2011a). Many of these factors are currently 
controlled by adopting expert-consensus guidelines (Thijssen et al., 2011a). The 
importance of this is supported by the fact that adherence to these guidelines is 
associated with a significantly lower variability of the FMD (Greyling et al., 2016a).  
 
Since the introduction of the FMD technique in 1992, ample evidence has demonstrated 
the presence of age- and sex-specific differences in FMD in healthy individuals 
(Celermajer et al., 1994b; Taddei et al., 1996; Taddei et al., 1995; Adams et al., 1996; 
Yao et al., 2014; Hopkins et al., 2015; Gerhard et al., 1996; Juonala et al., 2008). Despite 
the general consensus in the literature regarding age- and sex-specific differences in 
FMD, methodological variations are present between studies which makes direct 
comparison difficult. Accordingly, aim 1 of this thesis was to update the expert-consensus 
guidelines for the performance of the FMD. Secondly, a key limitation preventing the 
widespread use and interpretation of the FMD relates to the absence of reference values. 
Therefore, aim 2 was to construct age- and sex-specific reference values for brachial 
artery FMD in healthy individuals and explore the relation with CVD risk factors. 
 
Although the terminology of the FMD test implies that vasodilation is flow-mediated, 
experimental research has determined that the vasodilator response during reactive 
hyperaemia is mediated by the total post-deflation shear stress stimulus (Pyke & 
Tschakovsky, 2007). This is calculated as the area under the shear rate curve (SRAUC), 
from cuff release to peak diameter. However, SRAUC poorly correlates with the 
magnitude of FMD, and the strength of the relationship is age-dependent (Thijssen et al., 
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2009a). Furthermore, previous work in animals suggests a positive effect of the sex 
hormone oestrogen in relation to the sensitivity to a given shear stress stimulus (Huang 
et al., 1998). This effect may explain the larger FMD observed in females compared to 
males, and also the larger FMD in pre-menopausal women compared to post-menopause. 
Nonetheless, this hypothesis has not been examined in humans. Therefore, aim 3 of this 
thesis was to explore the relationship between FMD and SRAUC across the lifespan in 
healthy men and women, and also compare pre- versus post-menopausal women. 
 
Shear stress plays a pivotal role in the pathophysiology of atherosclerosis, where areas 
of the vascular tree exposed to unidirectional shear stress are protected from 
atherosclerotic lesions (Cecchi et al., 2011). Due to the direct interaction with the 
endothelium, increasing the antegrade (towards the periphery) component of shear 
improves endothelial function (Tinken et al., 2009), whilst increased exposure to 
retrograde shear (backward; towards the heart) leads to a decrease in endothelial 
function (Schreuder et al., 2015; Thijssen et al., 2009c). In contrast to experimental 
conditions where prolonged exposure to unidirectional antegrade or retrograde shear is 
possible, daily living seems more related to fluctuations in antegrade and retrograde 
shear stress in response to variations in blood pressure and bodily movement completing 
everyday tasks. Although little previous work has focused on fluctuations in shear 
(opposed to prolonged unidirectional shear), some studies have demonstrated positive 
clinical effects of fluctuations in shear stress, such as improved wound healing in patients 
with lower limb ischaemia (Sundby et al., 2016a; Sundby et al., 2018b; Sundby et al., 
2018a). These positive outcomes suggest that fluctuations in shear stress impact 
vascular health. However, these studies did not control for overall differences in 
antegrade or retrograde shear. Therefore, it is currently unknown whether fluctuations in 
shear stress per se influence FMD. Therefore, aim 4 of this thesis was to assess the 
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acute effect of fluctuations in shear stress levels, with preservations on mean shear stress, 
on brachial artery FMD in humans in vivo. 
 
1.2 Aims  
The specific aims of this thesis were to: 
1. Update the expert-consensus guidelines for the performance of the FMD 
(Chapter 3). 
2. A) Construct age- and sex-specific reference values for brachial artery FMD in 
healthy individuals obtained with strict adherence to contemporary expert-
consensus guidelines (Chapter 4). 
B) Examine the impact of cardiovascular risk factors on age- and sex-specific 
reference values for brachial artery FMD (Chapter 4). 
3. Explore the impact of sex and female hormonal status on the relationship between 
FMD and SRAUC across the lifespan in healthy individuals (Chapter 5). 
4. Assess the acute effect of fluctuations in shear stress, with preserved mean level 







Chapter 2  
 
 
Literature Review: Age, Sex and 




2.1 Cardiovascular Disease 
Recent statistics show that 31% of global deaths were attributable to CVD (World Health 
Organisation, 2017), emphasising the importance of prevention, early detection and 
subsequent treatment of CVD. The underlying process of CVD is atherosclerosis, an 
inflammatory process affecting the arteries, whereby artery wall thickening occurs due 
to the build-up of substances such as cholesterol with vascular smooth muscle cells to 
ultimately lead to the formation of a plaque (Cahill & Redmond, 2016). If 
undetected/untreated, this process leads to partial blockage or sudden rupture of a 
plaque, which is clinically referred to as a myocardial infarction or stroke. Importantly, an 
impairment of the functionality of the vascular endothelium contributes to the 
development and progression of atherosclerosis (Juonala et al., 2004; Charakida et al., 
2010; Chiu et al., 2009). Endothelial dysfunction has been identified as an early 
biomarker of CVD (Deanfield et al., 2007; Takase et al., 1998) and this can be detected 
at a very early stage of the atherosclerosis timeline, well before thickening of the arterial 
wall or early formation of atherosclerotic plaques (Figure 2.1). 
 




2.1.1 The Vascular Endothelium 
The vascular endothelium is the inner layer of the vessel wall, lining the whole circulatory 
system, and its placement between the blood and artery wall facilitates interaction via 
cellular signalling. The endothelium is responsive to chemical (e.g., hormonal) and 
hemodynamic stimuli (mechanical forces related to flowing blood) and its function 
includes regulating platelet function, vascular smooth muscle cell growth and vascular 
tone (Cahill & Redmond, 2016). The most important hemodynamic stimulus for dilation 
and adaptation is shear stress (frictional force of flowing blood against the endothelium). 
Increased shear stress activates mechanosensors located within the endothelial cells 
(Labrador et al., 2003), which in turn initiates a cascade of signalling pathways (Chien, 
2007). This results in the synthesis and release of the vasodilators (e.g. NO, 
endothelium-derived relaxing factor (EDRF) and prostaglandins) from the endothelium 
(Bloodsworth et al., 2000). Vasodilation occurs to accommodate for the increase in blood 
flow, and a marked dilator response is reflects a healthy endothelium (Ross et al., 1984).  
 
2.1.2 Hemodynamic Laws of Blood Flow 
Blood flow is influenced by multiple physiological factors, including blood pressure, 
vessel radius and length, and blood viscosity. The relationship between these variables 
were examined by Jean Poiseuille by passing water through glass tubes (of varying 
diameters and lengths), with different pressures applied to one end (Poiseuille & 
Herschel, 1940; Pfitzner, 1976). As a result of this work, he developed an equation, now 
known as Poiseuille’s Law (Pfitzner, 1976): 
 
 








The most important factor determining blood flow relates to pressure. In physics, fluid 
flows through a tube from an area of high- to low pressure, with the difference in pressure 
known as the pressure gradient. In the body, pressure originates from contraction of the 
heart as the driving force of blood around the circulatory system. Additionally, the 
pressure gradient is multiplied by the radius4, highlighting the importance of artery 
diameter as a determinant of blood flow. Another mediator of blood flow is viscosity (i.e. 
thickness of the blood). Importantly, viscosity is affected by age, sex, menstrual cycle 
phase and some CVD risk factors (Tremblay, 2019), and is a factor in the calculation of 
shear stress. However, despite the association with variables mentioned above, viscosity 
is largely ignored and assumed to be constant in FMD research (Parkhurst et al., 2012). 
 
2.1.3 Nitric Oxide 
A Nobel prize-winning discovery by Furchgott & Zawadzki (1980) (more by serendipity 
than design) demonstrated in vitro that acetylcholine administration failed to cause 
relaxation in blood vessels with the endothelial cells rubbed off, whilst vasodilation was 
observed when the endothelium was intact. This vasodilation response was mediated by 
the release of vasoactive substances, namely EDRF and NO. This landmark study 
initiated the recognition of the pivotal role of the endothelium in the regulation of vascular 
tone and vasomotor function, but also the importance of NO in vascular health. NO is 
released basally (Vallance et al., 1989) and is synthesised by the enzyme eNOS from 
the amino acid L-arginine (Palmer et al., 1988). NO possesses a myriad of anti-
atherogenic properties to maintain vessel homeostasis, including inhibition of cell growth 
and proliferation, leukocyte and platelet adhesion, regulation of vascular tone and 
antithrombotic properties (Bloodsworth et al., 2000). Traditional CVD risk factors such as 
hypertension, smoking and obesity are associated with attenuated NO levels (Yetik-
Anacak & Catravas, 2006), whilst physical activity or exercise is believed to increase NO 




importance of the NO pathway for the endothelium and for cardiovascular health and 
disease. 
 
2.1.4 Endothelial Function  
Endothelial function refers to the sensitivity and ability of the endothelium to regulate 
vascular tone in response to various stimuli and is essential for vascular health (Green et 
al., 2004). Endothelial dysfunction is associated with greater CVD risk (Deanfield et al., 
2007), even in asymptomatic individuals (Ras et al., 2013; Xu et al., 2014; Inaba et al., 
2010; Matsuzawa et al., 2015). Based on the detrimental role of endothelial dysfunction 
in the atherosclerotic process, studies have attempted to develop and validate non-
invasive methods and biomarkers to assess endothelial function in humans in vivo. 
Celermajer et al. (1992) were the first to develop and utilise the non-invasive technique 
now known as the FMD test. This measurement simply refers to the assessment of a 
conduit artery dilator response to an increase in blood flow which is endothelium-
dependent (Dawson et al., 2010a) and partly mediated by NO (Green et al., 2014). FMD 
is most commonly assessed in the brachial artery due to its feasibility and relatively easy 
access compared to other conduit vessels (e.g. radial or femoral artery), with studies 
emphasising the independent predictive value of this test for future CVD risk (Matsuzawa 




2.2 Flow-Mediated Dilation 
2.2.1 Prognostic Value 
The measurement of endothelial function using FMD has become a popular research 




et al., 2010; Ras et al., 2013; Vita & Keaney, 2002; Thijssen et al., 2011a) and correlation 
to coronary artery endothelial function (Anderson et al., 1995; Takase et al., 1998; 
Broxterman et al., 2019). Several meta-analyses have explored the prognostic value of 
FMD, and revealed that a 1% increase in brachial artery FMD is associated with an 8-
13% reduction in CVD risk in heterogeneous populations (Ras et al., 2013; Inaba et al., 
2010; Matsuzawa et al., 2015). Despite the association between FMD and CVD risk, 
FMD has failed to add to the value of traditional risk factors for net reclassification index 
of risk (Peters et al., 2012) compared to the Framingham Risk Score (Yeboah et al., 
2012).  
 
The FMD technique is widely used in clinical studies, given that endothelial function 
rapidly responds to interventions such as pharmacological substances (Luscher et al., 
2012) and exercise training (Green & Smith, 2017). The relevance of this is that 
individuals can be identified as “non-responders”, or pharmacological agents deemed 
ineffective, and therefore interventions can be altered as required.  For example, FMD 
was the primary outcome in the dal-VESSEL clinical trial (Luscher et al., 2012), 
examining the vascular effects of a cholesterol-lowering drug. The authors found that 
whilst the drug was successful in reducing low-density lipoprotein (LDL) and increasing 
high-density lipoprotein (HDL) cholesterol, FMD was not affected. This evidence 
demonstrated no negative vascular effects of the drug, therefore highlighting its safety 
for future research. Despite this potency, the FMD lacks clinical applicability as normal 






2.2.2 Endothelium-Dependent Dilation 
FMD represents the relative change in conduit artery diameter in response to distal limb 
ischaemia. The current FMD test protocol consists of measurement of one minute of 
baseline artery diameter and blood flow recording using high-resolution ultrasound, 
followed by a 5-minute period of distal limb ischaemia using a pneumatic cuff (inflated to 
a suprasystolic pressure) around the forearm. Following cuff release, artery diameter and 
blood flow are recorded for a further 3 minutes (Thijssen et al., 2011a). Subsequently, 
FMD is calculated as the relative (percentage) change in diameter from baseline to peak 
following cuff release. The underpinning physiology of the FMD test is depicted in Figure 
2.2.  
 
The endothelium-dependency of the vasodilation response to an increase in shear stress 
has been reviewed elsewhere (Green et al., 2017). In brief, studies in both animals 
(Berdeaux et al., 1994; Pohl et al., 1986) and humans (Dawson et al., 2010b) have shown 
an attenuated or even abolished dilation response to increased shear stress with 
endothelial denudation (i.e. removal of the endothelium). Furthermore, given the role NO 
(produced in the endothelial cells) in the FMD (Green et al., 2014), an intact endothelium 
is essential for vascular function and health. 
 
2.2.3 Endothelium-Independent Dilation 
Independent of the functionality of the endothelium and the magnitude of the eliciting 
shear stress stimulus, the ultimate vasodilation response is reliant upon functional 
vascular smooth muscle cells (Komai et al., 2008). For this reason, brachial artery 
diameter is continuously assessed at baseline and in response to an exogenous NO 
donor, glyceryl trinitrate (GTN), administered via sublingual spray or tablet. GTN directly 




endothelium-independent vasodilation. The original FMD paper by Celermajer et al. 
(1992) showed an impaired GTN response in smokers and coronary artery disease 
patients compared to healthy adults, observations which have been supported by others 
(Zhang et al., 2000; Raitakari et al., 2001). This suggests that the impaired FMD in 
smokers and subjects with coronary artery disease could, at least partly, be explained 
through an impaired ability of vascular smooth muscle cells to mediate vasodilation. 
Furthermore, impaired GTN responses are associated with traditional modifiable CVD 
risk factors (Celermajer et al., 1993; Adams et al., 1998; Gokce et al., 2001) as well as 
age (Montero et al., 2015) and sex (Black et al., 2009). Evidence suggests that 
endothelial- and vascular smooth muscle dysfunction occur at different time points along 
the atherosclerosis timeline (Adams et al., 1998; Kawano et al., 2012), whereby 
endothelial dysfunction precedes vascular smooth muscle dysfunction, with the latter 
being prevalent with increasing severity of the disease/risk factor. Given the relationship 
between GTN response, FMD and traditional (modifiable and non-modifiable) CVD risk 
factors, vascular smooth muscle cell function remains an important component 
contributing to conduit artery vasodilator capacity.  
 





Figure 2.2: Schematic representation of the physiology behind the FMD. Step 1: Shear stress stimulus following cuff release is sensed by 
mechano-sensors. Step 2: Shear stress mechanotransduction initiates signalling cascade and subsequent vasodilator production. Step 3: 
Vasodilator diffusion from endothelium into vascular smooth muscle cell. Step 4: Signalling transduction cascade results in reduced calcium 





2.3 Ageing and FMD 
Advancing age is an established risk factor for CVD. Ample experimental evidence 
shows an age-related decline in brachial artery endothelial function across the lifespan 
(Brandes et al., 2005; Seals et al., 2011), even without the presence of CVD risk factors 
(Gerhard et al., 1996; Celermajer et al., 1994b; Taddei et al., 1996; Taddei et al., 1995; 
Tschudi et al., 1996). The first research group to quantify brachial artery FMD changes 
with age were Celermajer et al. (1994b) in over 200 healthy participants. Interestingly, 
the authors observed that FMD was maintained in females until around 50 years, 
coinciding with the onset of menopause, whilst men showed a lower FMD, and an earlier 
decline around 40 years (Figure 2.3).  
 
Figure 2.3: FMD changes with age in men (left) and women (right), from Celermajer et 
al. (1994b). 
 
On a larger scale, a population-based study by Skaug et al. (2013) assessed the age-
related differences in brachial artery FMD in 4739 adults and observed a progressive 
decline in FMD until age 70 and 80 years in men and women, respectively. However, the 
authors measured the peak FMD diameter 60-seconds post cuff deflation, a technical 
error with potentially significant implications for the validity of the conclusion (which is 
further discussed in Chapter 3). Furthermore, whilst participants in this cohort were 
defined as healthy, smokers were included who are established to have impaired FMD 




issues, a trend for decline in FMD with advancing age exists. Various age-specific 
physiological alterations may underlie this relationship. 
 
2.3.1 Mechanisms of Impaired FMD with Ageing 
2.3.1.1 Changes in Artery Structure 
The key structural variations associated with age are related to artery wall thickening (i.e. 
increasing intima-media thickness; IMT) and increased arterial stiffness. Carotid artery 
IMT is considered a surrogate marker of atherosclerosis and predictor of cardiovascular 
events (O'Leary et al., 1999). Importantly, age- and sex-specific reference intervals have 
been established for carotid artery IMT (Engelen et al., 2013), whereby IMT increases 
with healthy ageing. Furthermore, IMT was inversely associated with FMD (Juonala et 
al., 2004; Yao et al., 2014), even in an asymptomatic population (Halcox et al., 2009). 
As described earlier, endothelial dysfunction is detected at a very early stage of the 
atherosclerosis timeline, before thickening of the artery wall becomes evident (Figure 
2.1). This highlights the importance of assessing endothelial function for early detection 
of CVD, prior to observable structural changes. 
 
Arterial stiffness, which can be measured using pulse wave velocity, is a recognised risk 
factor and predictor for CVD morbidity and mortality (Yambe et al., 2004; Vlachopoulos 
et al., 2010). Stiffening of the artery can be a result of changes in the structural and 
cellular properties of the artery wall (Zieman et al., 2005), and is commonly associated 
with ageing (Lakatta & Levy, 2003; Bossuyt et al., 2015; Engelen et al., 2015). Related 
to endothelial function, a stiffer artery (via reduced elasticity) limits the dilatory capacity 
and therefore FMD. Limited evidence is available regarding the inter-relationships 




arteries with older age could mediate the inverse association observed between pulse 
wave velocity and FMD (Heldens et al., 2013). 
 
2.3.1.2 Nitric Oxide Bioavailability 
Given the importance of the NO-pathway in FMD (Green et al., 2011), a reduction in NO 
is considered one of the largest contributors to the age-related impairment of FMD. This 
is partially due to the attenuated ability of endothelial cells to generate NO with age (Al-
Shaer et al., 2006), through a natural age-related decline in eNOS expression and 
activity (Tschudi et al., 1996; Tanabe et al., 2003), even in asymptomatic individuals 
(Toda, 2012). An elegant study by Taddei et al. (2001) demonstrated a progressive 
decline in (acetylcholine-induced) endothelium-dependent vasodilation with age. 
Interestingly, there appeared to be no association between age and (sodium 
nitroprusside-induced) endothelium-independent vasodilation, which implies that the 
decline in the endothelial function is, at least partly, mediated by the progressive 
impairment of the L-arginine-NO pathway.  
 
2.3.1.3 Oxidative Stress 
Oxidative stress is determined by an imbalance in pro- and anti-oxidant enzymes in the 
blood (Lessiani et al., 2016), more specifically the excessive production of reactive 
oxygen species, with an insufficient anti-oxidant defence system (free radical scavenging) 
(Seals et al., 2014). Oxidative stress plays a key role in the atherosclerotic process 
(Witztum, 1994; Kattoor et al., 2017; Summerhill et al., 2018) and is considered to be a 
key determinant contributing to age-related endothelial dysfunction (Finkel & Holbrook, 
2000; Harman, 2003; Donato et al., 2007; Taddei et al., 2001; Donato et al., 2018). With 
increasing age, oxidative stress is associated with pro-inflammatory markers including 




negative impact of oxidative stress on NO bioavailability (Ungvari et al., 2010), and is a 
consequence of the loss of protective properties of NO outlined in Section 2.1.2. 
Specifically, experimental work demonstrated that administration of antioxidant vitamin 
C improved endothelial function in healthy older individuals (over 60 years old), but was 
ineffective in adults under 60 years old (Taddei et al., 2001). Donato et al. (2007) 
investigated the mechanisms associated with oxidative stress, endothelial function and 
ageing. The authors found increased expression of oxidative stress markers in the 
endothelial cells of healthy old men, compared to young men, with no age-related 
differences in anti-oxidant enzyme expression, demonstrating an imbalance between 
pro- versus anti-oxidant enzymes in older individuals. Additionally, these markers were 
inversely related to brachial artery FMD, implying an important role of oxidative stress in 
the age-related decline in endothelial function (Donato et al., 2007). 
 
Further work has demonstrated that the association between oxidative stress and 
endothelial dysfunction is enhanced by the presence of CVD risk factors such as 
hypertension (Taddei et al., 1998; Harvey et al., 2015). Multiple clinical studies in 
hypertensive patients have shown a positive correlation between blood pressure and 
oxidative stress (Mihalj et al., 2016; Rodrigo et al., 2007; Lacy et al., 2000; Redon et al., 
2003; Touyz, 2004). Others have also shown a simultaneous increase in inflammatory 
marker expression (Herrera et al., 2010; El Assar et al., 2013) in asymptomatic older 
individuals (Bottino et al., 2015), further suggesting a potential relationship between 
these processes. Based on the ability of free radicals to scavenge NO (Incalza et al., 
2018), and the key role of the NO-pathway in mediating endothelium-dependent 
vasodilation, age-related increase in oxidative stress could contribute to blunted NO-





2.3.1.4 Hemodynamic Changes: Forces 
2.3.1.4.1 Parallel Force: Shear Stress 
A typical shear pattern at rest is characterised by a large amount of antegrade shear 
during systole, followed by (in most cases) a brief period of retrograde shear during 
diastole (Figure 2.4). Disturbances in laminar blood flow and shear stress are associated 
with the atherosclerotic process, through the upregulation of pro-inflammatory genes and 
increased expression of factors including adhesion molecules and vasoconstrictors 
(Chiu et al., 2009). Older age is associated with elevated levels of retrograde and 
oscillatory shear stress in peripheral conduit arteries (Credeur et al., 2009; Young et al., 
2010; Padilla et al., 2011; Casey et al., 2012), which is related to pro-atherogenic factors 
(Laughlin et al., 2008; Thijssen et al., 2009c; Newcomer et al., 2011; Schreuder et al., 
2015), such as diminished NO bioavailability (Padilla et al., 2011). Proposed factors 
mediating an increase in retrograde and oscillatory shear stress include increased 
stiffness (Padilla et al., 2011), sympathetic nerve activity (Davy et al., 1998; Thijssen et 
al., 2014; Thijssen et al., 2006; Casey et al., 2012) and decreased vascular smooth 
muscle reactivity (Al-Shaer et al., 2006).  
 





2.3.1.4.2 Perpendicular Force: Blood Pressure 
Age-related increases in blood pressure are likely due to structural variances within the 
vasculature (Pinto, 2007), combined with inflammation and oxidative stress (Harvey et 
al., 2015) in the pathophysiology of hypertension. Whilst systolic blood pressure appears 
to be inversely related to brachial artery FMD (Benjamin et al., 2004), the implications of 
hypertension on FMD are discussed in Section 2.5.3.2. Research is limited on the effects 
of ageing on FMD within the normal blood pressure range, which therefore warrants 
further investigation.  
 
2.3.1.5 Ageing and FMD: Summary 
An age-related decline in FMD is considered “normal”, even in asymptomatic individuals. 
This may be mediated by a number of factors, contributing to structural and biochemical 
changes within the vascular wall. Hemodynamic changes, NO bioavailability, and 
subsequent vascular remodelling may be key mediators of endothelial dysfunction with 
age. However, a gap in our current knowledge remains regarding what is normal across 
the lifespan. Furthermore, there is a sex-specific difference in the change in FMD with 
ageing (Figure 2.3; Celermajer et al. (1994b)), and this will be discussed below. 
 
2.4 Sex Differences in FMD 
Sex-related differences in FMD have been reported since the early stages of FMD 
research (Adams et al., 1996; Celermajer et al., 1994b), demonstrating larger FMD in 
females compared to males. These observations have since been supported by multiple 
research groups (Juonala et al., 2008; Yao et al., 2014; Hopkins et al., 2015). The 
physiological differences between males and females are mostly determined by the 




2.4.1 Hormonal Fluctuations and Influences on FMD 
2.4.1.1 Oestrogen and the Menstrual Cycle 
Oestrogen is commonly believed to have cardio-protective effects against CVD, given 
the lower incidence of CVD in pre-menopausal women compared to age-matched men 
(Townsend et al., 2015a). The presence of oestrogen has also been shown to enhance 
endothelial function through the mediation of vasoactive substances, i.e., upregulation 
of vasodilators NO, prostacyclin and angiotensin 1-7, and attenuation of vasoconstrictor 
endothelin-1 (Novella et al., 2019). Underlying mechanisms of these effects include 
increased eNOS expression and activity (Hayashi et al., 1995; Sumi & Ignarro, 2003) 
and decreased oxidative stress (Wassmann et al., 2001; Dantas et al., 2002). Other 
positive vascular effects of oestrogen relate to regulation of inflammation (Bowling et al., 
2014), circulating lipids (Muesing et al., 1996), and inhibition of endothelial cell apoptosis, 
vascular smooth muscle cell migration and proliferation (Weiner et al., 1994). Together, 
these effects contribute to the protection against the development of atherosclerosis and 
CVD (Mendelsohn, 2000).  
 
The female sex hormones fluctuate throughout a normal menstrual cycle and oestrogen 
reaches its highest peak in the late follicular phase with a lower peak in the luteal phase 
(Figure 2.5). Previous studies have shown that FMD reflects fluctuating oestrogen levels 
during the menstrual cycle (Figure 2.6) (Williams et al., 2001; Brandão et al., 2014; 
Hashimoto et al., 1995; Adkisson et al., 2010; English et al., 1998; Kawano et al., 1996).  
More specifically, peaks in oestrogen levels matches with higher levels of FMD within 
individuals. Despite these observations, other groups have failed to show changes in 
FMD across the menstrual cycle (Shenouda et al., 2018; Saxena et al., 2012; 
Rakobowchuk et al., 2013; D'Urzo et al., 2018). This may relate to heterogeneity in 




Figure 2.5: Fluctuating female sex hormone concentrations during the menstrual cycle 
adapted from Haynes et al. (2013). E2 – estradiol (oestrogen); Prog – progesterone. 
 
 
Figure 2.6: Change in brachial artery FMD throughout the stages of the menstrual cycle. 
EF – early follicular; LF – late follicular; EL – early luteal; LL – late luteal. Combined data 






Oestrogen receptors alpha and beta (ORα and ORβ, respectively) are expressed within 
the endothelial and vascular smooth muscle cells (Mendelsohn & Karas, 1999), and play 
an important role in mediating the vascular effects of oestrogen on the endothelium 
(Miller & Duckles, 2008). As such, it has been shown in cell culture, animal and human 
models that oestrogen mediates ORα expression (Ihionkhan et al., 2002; Pinna et al., 
2008; Gavin et al., 2009; Sakaguchi et al., 2003), which in turn regulates eNOS activity 
(Hayashi et al., 1995; Chen et al., 1999). Gavin et al. (2009) measured brachial artery 
FMD, ORα expression, and eNOS expression and activation in healthy post-menopausal 
women, compared to pre-menopausal women during the early- and late follicular phase 
of the menstrual cycle, representing low and high levels of oestrogen, respectively 
(Figure 2.5). In line with previous work, the authors observed a lower ORα expression in 
the early follicular phase and post-menopause, consistent with lower circulating 
oestrogen, in addition to moderate positive correlations between brachial artery FMD 
with ORα expression, and ORα expression with eNOS. This is relevant since the action 
of an oestrogen molecule binding to a receptor activates eNOS, causing upregulated NO 
release (Russell et al., 2000). This action, combined with NO released in response to 
elevated shear stress (i.e. during the FMD test), and therefore greater NO abundance, 
may contribute to the larger FMD observed in pre-menopausal women (and during the 
late follicular phase) compared to post-menopausal women and age-matched men. 
Together these findings demonstrate the important physiological effects of oestrogen on 
vascular endothelial function, which may partially explain the cardio-protection of 
oestrogen in pre-menopausal women compared to men.   
 
2.4.1.2 Testosterone 
The role of testosterone on vascular function in men is poorly studied with conflicting 
results. Small studies in body builders (Ebenbichler et al., 2001; Sader et al., 2001) and 




administration negatively affected FMD, suggesting an inhibitory effect of testosterone 
on endothelial function. Conversely, other studies have shown positive acute effects of 
testosterone on FMD (Ong et al., 2000) and coronary artery vasodilation (Webb et al., 
1999) in coronary heart disease patients. Furthermore, population-based studies have 
found a positive relationship between testosterone and FMD (Empen et al., 2012; 
Akishita et al., 2007), whilst no association was observed for GTN response (Empen et 
al., 2012), suggesting an interaction between testosterone and the endothelium but not 
smooth muscle cell function. Interestingly, this relationship remained after statistically 
controlling for confounding variables including age, smoker status and other CVD risk 
factors, implying an independent relationship. Given the large number of factors 
influencing these previous studies, but also the conflicting results, further research is 
required to isolate the testosterone-FMD relationship. 
 
2.4.2 Puberty 
Puberty is characterised by the influx of sex hormones, representing a biological 
transition from childhood to adulthood (Day et al., 2015). This process generally occurs 
between age 8-13 years in girls, and 9-14 years in boys (Sorensen et al., 2012). Pubertal 
development is assessed clinically by Tanner stage on a scale from 1 (pre-pubertal) to 
5 (post-pubertal) for boys and girls (Tanner & Whitehouse, 1976), including criteria for 
pubertal hair, menarche (onset of menstrual cycle) for girls, and deeper voice/facial hair 
for boys. Importantly, there is large between-individual variation in timing of the onset of 
puberty (Sorensen et al., 2012), with early age of menarche associated with greater CVD 
risk in females (Day et al., 2015). Physiologically, the surge in sex hormones has been 
found to be associated with changes in CVD risk factors, including body composition, 
systolic blood pressure and lipids (Siervogel et al., 2003; Moran et al., 2008; Marlatt et 
al., 2013). Interestingly, Moran et al. (2008) reported sex-specific differences in the rate 




and lean body mass increased with age at a greater rate in males compared to females. 
Additionally, body fat percentage and HDL cholesterol increased with age in females, 
but decreased in males. Research related to endothelial function during puberty is scant, 
with evidence of no difference in FMD between Tanner stages, despite differences in 
baseline artery diameter (Marlatt et al., 2013), implying no effect of pubertal maturation 
on endothelial function. In contrast to these findings, brachial artery FMD declined with 
age in male children and adolescents (age 6-18 years), whilst no pattern was evident in 
females (Hopkins et al., 2015). Nonetheless, the above studies are limited due to the 
lack of data related to hormone levels. Therefore, further research is warranted in 
children and adolescents to establish the true vascular effects of the puberty-related 
surge in sex hormones. 
 
2.4.3 Menopause 
Menopause is defined by the permanent cessation of menses (Bechlioulis et al., 2009), 
resulting in the loss of endogenous oestrogen. This generally occurs in women between 
the age of 45-55 years (Gold, 2011) and is associated with a decline in vascular 
endothelial function (Celermajer et al., 1994b; Taddei et al., 1996; Gavin et al., 2009; 
Moreau et al., 2012a) and accelerated CVD risk (Collins et al., 2007). Statistics from the 
British Heart Foundation show an exponential increase in deaths in women, coinciding 
with the onset of menopause (Townsend et al., 2015c). Celermajer et al. (1994b) 
observed a steep decline in womens’ FMD response around menopausal age (Figure 
2.3), whilst no changes in endothelium-independent dilation (GTN) were observed, 
suggesting that the decline in function was attributed to dysfunction of the endothelial 
cells. In addition, it has recently been reported that levels of retrograde and oscillatory 
shear stress increased across the menopause transition (Somani et al., 2019). These 
observations may be associated with downstream vasoconstriction and increased 




menopausal women (Hart et al., 2012). This proposed mechanism was supported by 
experimental work demonstrating increased retrograde shear rate with concomitant 
increases in muscle sympathetic nerve activity (Padilla et al., 2010). From the above 
evidence, oestrogen deficiency is a likely mediating mechanism behind the (post-
menopausal) age-related decline in FMD in females.  
 
Some post-menopausal women use hormone replacement therapy (HRT) to offset 
menopausal symptoms such as hot flushes. Given the cardio-protective role of oestrogen, 
one may expect HRT to influence endothelial function and subsequent CVD risk. 
Nonetheless, there is inconsistency within the current literature regarding the benefits 
and/or effectiveness of HRT on CVD risk (Bechlioulis et al., 2009). Whilst some research 
groups have demonstrated an improvement in FMD with oestrogen treatment (Moreau 
et al., 2012b; Moreau et al., 2013), various factors including the time between the onset 
of menopause and administration of hormone treatment (Vitale et al., 2008; Lobo, 2017), 
age (Sherwood et al., 2007), hormone (dosage and type) administered and FMD 
methodology likely mitigate the potential beneficial effects of HRT on vascular function. 
Overall, the effect of HRT on endothelial function and future CVD risk remains unclear 
as there appears to be considerable confounding factors, potentially influencing the 
effects of HRT in this population. 
 
2.4.3 Sex Hormones: Summary 
The protective role of oestrogen against the development of CVD appears to be 
modulated by the preservation of NO bioavailability via the L-arginine-NO pathway 
(Blumenthal et al., 2007). Whilst FMD may not be statistically different between males 
and females in the menstrual phase, female FMD was still greater (Hashimoto et al., 




sex-related difference in FMD. In general, females have a ~25% smaller artery diameter 
than males across all age ranges (Adams et al., 1996; Levenson et al., 2001; Hu et al., 
2008; Juonala et al., 2008; Black et al., 2009). Since a smaller baseline diameter is 
associated with a larger FMD, some of the differences between sexes may be explained 
through the baseline artery diameter (Adams et al., 1996). 
 
2.5 Other Influencing Factors on FMD 
2.5.1 Baseline Diameter 
For mathematical reasons, baseline artery diameter has a direct influence on FMD (i.e., 
FMD is calculated by dividing the absolute change in diameter by baseline diameter), 
and is therefore a strong predictor of the magnitude of FMD (Thijssen et al., 2009a). The 
statistical implications of this are discussed in Chapter 3. It is well documented that an 
inverse relationship exists between baseline artery diameter and FMD response in 
heterogeneous populations (Herrington et al., 2001; Thijssen et al., 2008b; Joannides et 
al., 2002; Thijssen et al., 2008a; Schroeder et al., 2000). A potential mediator of this 
relationship relates to the eliciting shear stress stimulus. Due to the inclusion of artery 
diameter within the calculation of shear rate, the total shear rate stimulus during reactive 
hyperaemia is greater in smaller arteries (Silber et al., 2001; Nishiyama et al., 2007; 
Parker et al., 2006b). Whilst differences between large and small vessels cannot be 
simply explained by shear alone (Thijssen et al., 2011b; Jazuli & Pyke, 2011), structural 
wall characteristics, hemodynamic forces and possible differences in hydrostatic 
pressures (e.g. upper versus lower limb arteries (Thijssen et al., 2011b)) may also 




2.5.2 Eliciting Shear Stress Stimulus 
Given the ability of shear stress to directly influence the endothelium, shear stress has 
become the focus of many research groups to understand its role in vascular 
(patho)physiology. The initial studies were performed in animals, which together 
demonstrated that elevation in shear stress leads to an endothelium-dependent dilation 
(Pohl et al., 1986; Berdeaux et al., 1994) and release of EDRF (Rubanyi et al., 1986). 
Many experimental studies have demonstrated a dose-dependent relationship between 
shear stress and vasodilation (Carter et al., 2013; Pyke & Tschakovsky, 2007; Pyke & 
Tschakovsky, 2005; Pyke et al., 2004; Atkinson et al., 2015b; Leeson et al., 1997). 
Specifically related to the FMD, Pyke & Tschakovsky (2007) explored the contribution of 
the post cuff deflation shear stress stimulus to the magnitude of vasodilation. Using cuff 
occlusion and handgrip exercise, the authors independently manipulated the duration of- 
(i.e. AUC) and the peak shear stress stimulus (with no change in AUC) during reactive 
hyperaemia. Interestingly, FMD increased in a step-wise manner with increasing AUC, 
whilst increasing the peak shear stimulus did not affect FMD. These observations 
suggest that the magnitude of conduit artery vasodilation during reactive hyperaemia is 
determined by the total post cuff deflation shear stress stimulus, i.e. SRAUC (Pyke & 
Tschakovsky, 2007). 
 
2.5.3 Cardiovascular Disease Risk Factors 
Traditional CVD risk factors include age, sex, ethnicity, smoking, diabetes, blood 
pressure, body mass index (BMI), cholesterol, family history and physical inactivity. Over 
the past decades, various CVD risk score calculators have been produced using a 
combination of the above risk factors to predict future CVD risk. A frequently-used 
prediction tool is the Framingham risk score. Despite the independent prognostic value 
of FMD for future CVD events (Ras et al., 2013; Inaba et al., 2010; Matsuzawa et al., 




stratification (Peters et al., 2012). Population-based studies have reported an inverse 
relation between FMD and Framingham risk score (Yao et al., 2014; Kwagyan et al., 
2009; Campuzano et al., 2006). Given the multi-factorial nature of CVD, one may 
question the relative importance of individual risk factors on FMD. Engelen et al. (2013) 
established reference values for carotid IMT in a healthy subpopulation and examined 
the relation between carotid IMT and CVD risk factors. Interestingly, systolic blood 
pressure, smoking and diabetes were the strongest determinants of a larger carotid IMT 
compared to healthy individuals of the same age and sex. Evidence for the negative 
effect of CVD risk factors on FMD are discussed below. 
 
2.5.3.1 Metabolic Syndrome and Diabetes Mellitus 
Metabolic syndrome (MetS) is characterised by the presence of a cluster of 
CVD/metabolic risk factors defined by the National Cholesterol Education Program Adult 
Treatment Panel III (ATP-III) guidelines (Reilly & Rader, 2003; Eckel et al., 2005). These 
guidelines classify MetS based on thresholds for waist circumference, blood metabolites 
(cholesterol, glucose and triglycerides) and blood pressure. Previous studies have 
shown these risk factors are all independently associated with decreased endothelium-
dependent vasodilation (Benjamin et al., 2004; Rodriguez et al., 2005; Kuvin et al., 2003; 
Brook et al., 2001). Interestingly, Melikian et al. (2008) observed a stepwise decline in 
FMD with the presence of each additional ATP-III criteria in asymptomatic individuals 
with and without MetS. Also, individuals with MetS demonstrated significantly greater 
levels of inflammatory markers (Melikian et al., 2008), implying the pivotal role of NO as 
the underlying mechanism of this relationship. These results have been confirmed in a 
large population (Skaug et al., 2014), with emerging sex differences in the effect of MetS 
risk factors on FMD. Additionally, endothelium-dependent vasodilation is markedly 
impaired in obese adults with MetS compared with metabolically healthy obese adults 




difference (1%) in FMD. Although not statistically significant, this may be clinically 
meaningful as a 1% increase in FMD is associated with an 8-13% decrease in CVD risk 
(Ras et al., 2013; Inaba et al., 2010; Matsuzawa et al., 2015).  
 
Diabetes mellitus (both Type 1 and 2) is associated with endothelium-dependent 
dysfunction (Avogaro et al., 2006; Calles-Escandon & Cipolla, 2001; Henry et al., 2004; 
Hamilton & Watts, 2013), whilst some have also observed impaired endothelium-
independent function (Williams et al., 1996; Lim et al., 1999; Beckman et al., 2003; 
Furuta et al., 2013). Furthermore, Type 2 patients have a larger degree of endothelial 
dysfunction compared to individuals with Type 1 (Ohsugi et al., 2014), which may be 
driven by the group differences in BMI. Interestingly, Naylor et al. (2011b) observed a 
step-wise increase in FMD between Type 2, (metabolically healthy) obese and lean 
adolescents, respectively. This suggests that endothelial dysfunction in Type 2 diabetes, 
even in youth, is mediated by a metabolic pathway in addition to obesity.  
 
The vascular pathophysiology provoked by cardiometabolic complications occurs at a 
cellular level, which ultimately negates NO bioavailability. Firstly, impairment in the 
insulin signalling pathway leads to declined eNOS and NO production (Hamilton & Watts, 
2013). Additionally, oxidative stress appears to play a role in endothelial dysfunction 
within this population (Capellini et al., 2010; Pitocco et al., 2010; Anderson et al., 2005). 
Observations of elevated adhesion molecule expression (el-Mesallamy et al., 2007), and 
greater platelet aggregation (Anderson et al., 2005) are present in Type 2 patients, 
further implying blunted NO bioactivity and development of atherosclerosis. The 





Findings from the Framingham Heart study showed an inverse relationship between 
systolic blood pressure and brachial artery FMD (Benjamin et al., 2004). Comparative 
studies have demonstrated that hypertensive patients have impaired endothelium-
dependent function compared to normotensive individuals (Ghiadoni et al., 2001; Taddei 
et al., 2001), which was offset by anti-hypertensive treatment (Taddei et al., 2002), 
implying blood pressure-induced endothelial damage in hypertension. This association 
is believed to be primarily mediated by oxidative stress. For example, experimental 
evidence in mice carotid arteries has shown that increased blood pressure is related to 
the production of oxidative stress (Vecchione et al., 2009) whilst in humans anti-oxidant 
therapy improved brachial artery FMD in hypertensive patients (Plantinga et al., 2007). 
Other potential mediating mechanisms include increases in arterial stiffness (Mitchell et 
al., 2005; Plantinga et al., 2007) and larger artery diameter from vascular remodelling 
(Chung et al., 2009), which may be induced by the prolonged exposure to hypertension. 
 
2.5.3.3 Obesity 
Numerous studies have observed a relationship between body size (i.e. BMI) and artery 
diameter (Chung et al., 2009; Thijssen et al., 2011b; Parikh et al., 2009; Benjamin et al., 
2004; Schroeder et al., 2000), which is a confounding variable on FMD. Furthermore, 
visceral adiposity, an independent CVD risk factor (Mahabadi et al., 2009), has also been 
associated with artery diameter and inversely associated with FMD across the lifespan 
(Hashimoto et al., 1998; Brook et al., 2001; Marchesi et al., 2007; Parikh et al., 2009; 
Konrad et al., 2011; Tounian et al., 2001; Watts et al., 2004). Importantly, exercise and/or 
dietary interventions resulting in weight loss, or visceral fat loss without changing weight 
(Watts et al., 2004), have been successful in improving endothelial function (Pierce et 




Obesity-induced endothelial dysfunction is multifactorial, and largely mediated through 
impaired NO synthesis and release (Shankar & Steinberg, 2005). It has previously been 
reported in obesity that endothelial cell adhesion molecules are increased (Escobar-
Morreale et al., 2003), implying a decline in NO function given the protective properties 
described in Section 2.1.2. Increased inflammatory markers (Escobar-Morreale et al., 
2003) may impair NO production (Steinberg et al., 1997) and induce oxidative stress 
(Shankar & Steinberg, 2005). Furthermore, elevated free fatty acids may be related to 
increased levels of endogenous eNOS inhibitor, asymmetric dimethyl-arginine (Lundman 
et al., 2001; Stuhlinger et al., 2002), which is associated with hypercholesterolaemia and 
Type 2 diabetes (Sibal et al., 2010) and inversely associated with endothelial function 
(Juonala et al., 2007).  
 
2.5.3.4 Dyslipidaemia 
Cholesterol levels, comprised of LDL and HDL cholesterol also influence vascular 
function. More specifically, a combination of high LDL and low HDL is associated with 
endothelial dysfunction (Celermajer et al., 1994a; Clarkson et al., 1996; Kuvin et al., 2002; 
Lupattelli et al., 2003; Lupattelli et al., 2002) and subsequent CVD risk (Abbott et al., 
1988; Miller et al., 1977). Interestingly, Mullen et al. (2001) reported a lower brachial 
artery FMD in patients with hypercholesterolaemia compared to healthy controls despite 
exhibiting a similar SRAUC, implying reduced NO bioavailability/endothelial cell 
sensitivity. Furthermore, in a cohort of 1583 subjects, hypercholesterolaemia and obesity 
were associated with a larger artery diameter (Chung et al., 2009), which in turn is 
inversely associated with FMD (Thijssen et al., 2008a).  
 
In vitro evidence suggests that high HDL promotes eNOS expression (Noor et al., 2007; 




similar GTN responses (Higashi et al., 2010). This evidence implies an interaction 
between HDL and the endothelium. Similar to NO, HDL possesses anti-atherosclerotic 
properties including inhibition of inflammation, platelet adhesion, LDL oxidation and 
endothelial cell apoptosis (Ansell et al., 2005). Overall, this implies that HDL plays a 
protective role within the vasculature by promoting NO bioavailability for the maintenance 
of vascular health and function.   
 
2.5.3.6 Smoking 
Cigarette smoking is considered one of the major modifiable risk factors associated with 
endothelial dysfunction and CVD (Lakier, 1992). A detrimental effect of smoking on FMD 
has been well established (Wiesmann et al., 2004; Celermajer et al., 1993; Celermajer 
et al., 1994a; Benjamin et al., 2004; Esen et al., 2004; Yufu et al., 2009; Ozaki et al., 
2010; Amato et al., 2013), with no difference in GTN responses or baseline artery 
diameter. These data imply a direct interaction between smoking by-products and the 
endothelium. The mediating mechanisms behind the adverse vascular effects of chronic 
cigarette smoking are complex; nonetheless, a key contributor relates to NO, partially 
determined by oxidative stress (Mayhan & Sharpe, 1998; Raitakari et al., 2000). Indeed, 
cigarette smoke contains pro-oxidants and free radicals (Church & Pryor, 1985). 
Importantly, the negative effects associated with smoking may be partially reversed post-
cessation. Early FMD research by Celermajer et al. (1993) observed a greater FMD in 
ex-smokers compared to current smokers, which has been supported by others on a 
larger population scale (Johnson et al., 2010). Nonetheless, inconsistent results have 
been observed with anti-oxidant therapy as a strategy to reverse vascular dysfunction 
(Puranik & Celermajer, 2003), further demonstrating the complexity of the association 






Epidemiological research has demonstrated that African Americans have greater CVD 
risk compared to whites (Mensah et al., 2005). Ample evidence reports ethnic differences 
in brachial artery FMD (Perregaux et al., 2000; Loehr et al., 2004; Melikian et al., 2007; 
Yeboah et al., 2008; Shantsila et al., 2011), with Caucasian subjects demonstrating 
greater FMD compared to African Americans, Blacks, African Caribbean and South 
Asians. Conversely, some research groups have reported no difference between ethnic 
groups in FMD response (Gokce et al., 2001; Shantsila et al., 2011; Pusalavidyasagar 
et al., 2016). However, these results must be interpreted with caution due to 
heterogeneity in methodology compared to contemporary FMD research following 
expert-consensus guidelines (Thijssen et al., 2011a). Furthermore, ethnic differences 
related to vascular health are multi-factorial, with differences in diet and lifestyle 
mediating this relationship, discussed elsewhere (Pusalavidyasagar et al., 2016).  
 
Experimental evidence in vivo and in vitro has shown that ethnic differences in 
endothelial function are determined, at least in part, by oxidative stress (Kalinowski et al., 
2004; Feairheller et al., 2011), inflammation (Albert et al., 2004; Brown et al., 2011) and 
subsequent blunted NO bioavailability. This evidence may explain the predisposition of 
African Americans to greater CVD risk. In addition, healthy black Africans have been 
found to have greater plasma asymmetric dimethyl-arginine compared to white 
Europeans (Melikian et al., 2007), which is negatively associated with endothelial 
function (Juonala et al., 2007). Whilst ethnicity appears to play a role in vascular 
dysfunction, existing research thus far possess discrepancies in the FMD methodology 






2.5.3.8 Physical Activity/Exercise 
Current government recommendations state that adults should engage in 150 minutes 
of moderate intensity or 75 minutes of vigorous intensity physical activity per week as a 
minimum to maintain health (World Health Organisation, 2010). The cardiovascular 
health benefits of engaging in physical activity are profound, and there is a curvilinear 
dose-response relationship between physical activity and disease risk (Department of 
Health, 2004). According to a recent report, ~39% of adults in the UK fail to meet these 
guidelines (British Heart Foundation, 2017). It is well documented that physical activity  
and subsequent greater cardiorespiratory fitness are associated with enhanced 
endothelial function (Hagg et al., 2005; Davison et al., 2010; Siasos et al., 2013), 
mediated by the exercise-induced improvement in CVD risk factors and exposure to 
increases in cyclic blood flow and shear stress (Green et al., 2017; Green & Smith, 2017). 
However, the effects of physical activity on traditional risk factors only accounted for 59% 
reduction in CVD risk (Mora et al., 2007), presenting a “risk factor gap” (Green et al., 
2008). Therefore, the inclusion of emerging/novel risk factors including cardiorespiratory 
fitness (DeFina et al., 2013), vascular structure and function (Andersson et al., 2015; 
Green et al., 2003; Siasos et al., 2013; Kozakova et al., 2010) and autonomic function 
(Joyner & Green, 2009) may account for the “gap” in CVD reduction achieved through 
physical activity. 
 
The effects of exercise training on vascular function has recently been reviewed (Green 
et al., 2017; Green & Smith, 2017). Based on a large number of studies, it became 
apparent that exercise training can improve conduit artery endothelium-dependent 
function (Birk et al., 2012; Green et al., 2004; Thijssen et al., 2010) and (in most cases) 
lead to outward structural remodelling (Green et al., 2004; Dinenno et al., 2001; Spence 




transmural pressure, circumferential wall strain and shear stress (Green & Smith, 2017).  
Shear stress as the stimulus for dilation and adaptation will be discussed below. 
 
2.6 Shear Stress 
At the end of the 19th century, it was observed in chick embryos that more branches 
developed in blood vessels where the blood flow velocity was highest (Thoma, 1893). 
Whilst this suggests a role for blood flow (or shear stress) in angiogenesis, only a few 
decades ago, the importance of the endothelium for mediating vascular function and 
remodelling was observed (Pohl et al., 1986; Berdeaux et al., 1994; Langille, 1996). 
Animal research demonstrated that an acute elevation in shear stress results in increased 
production of the enzyme eNOS mRNA, NO and prostacyclin (Malek et al., 1999), whilst 
chronic exposure to elevated shear stress caused outward structural remodelling (Ben 
Driss et al., 1997). Since these observations, the endothelium has been a focus for 
research, given its strategic placement and crucial role in the progression and 
development of atherosclerosis (McLenachan et al., 1991). Shear stress plays a pivotal 
role in the development and progression of CVD (Cecchi et al., 2011) due to the direct 
interaction with the endothelium (i.e. mechanotransduction (Chien, 2007)). It is now 
widely accepted that vascular adaptation, both relevant for acute changes in diameter as 
well as chronic adaptations in remodelling, is dependent upon an intact, functional 
endothelium (Ross et al., 1984; Zeiher et al., 1989). Furthermore, in addition to an intact 
endothelium and structural properties (i.e. wall thickness and stiffness), other factors 
must be considered in determining the magnitude of FMD. These include the amount and 
pattern of shear stress, transduction of the dilatory response to the vascular smooth 
muscle cells, and the response of the vascular smooth muscle cells to dilator signals via 





2.6.1 Stimulus for Adaptation 
Shear stress plays an important role in inducing functional and structural adaptations, 
facilitated by the endothelium. Increasing shear stress through heat exposure mediates 
acute (Tinken et al., 2009; Greyling et al., 2015a) and chronic (Naylor et al., 2011a) 
elevation in vasodilator function. Tinken et al. (2009) demonstrated shear stress-induced 
improvements in brachial artery FMD immediately following acute forearm heating, 
cycling and handgrip exercise. Furthermore, preventing the increase in antegrade shear 
stress during these interventions with low levels of unilateral pneumatic cuff inflation 
abolished this effect. To follow-up on these observations of the acute impact of exercise, 
studies have examined the impact of repeated exposure to these stimuli. For example, 
an 8-week treadmill exercise training protocol resulted in an increase in brachial artery 
FMD at weeks 2, 4 and 6, which subsequently returned to baseline levels at week 8 
(Tinken et al., 2008). Interestingly, these functional adaptations were superseded by 
structural remodelling, which explains the functional return to baseline levels (Figure 2.7). 
This confirms the hypothesis proposed by Laughlin (1995) regarding the time course of 
change in vascular function and structure with exercise training-mediated increases in 
shear stress. To directly examine the role of shear stress in exercise training-induced 
functional adaptations, FMD was assessed at 2-week intervals during an 8-week bilateral 
handgrip exercise with unilateral cuff inflation protocol (Tinken et al., 2010). Similar to 
previous observations, FMD increased at weeks 2, 4 and 6 in the non-cuffed arm and 
returned to baseline levels at week 8 (with no change in the cuffed arm). Therefore, 
reducing the antegrade component of the shear stress pattern with low levels of unilateral 
pneumatic cuff inflation abolished the increased FMD (Tinken et al., 2010), further 
emphasising the importance of shear stress in vascular adaptation to exercise.  
 
The adaptations during handgrip or cycling exercise training may not only be caused by 




outcomes. For this reason, previous work has examined whether repeated increases in 
shear stress mediated through heat exposure can lead to adaptation. The sustained 
increase in antegrade shear stress observed during heating is associated with immediate 
improvement in endothelium-dependent function (Naylor et al., 2011a; Brunt et al., 2016; 
Carter et al., 2014). Importantly, this method to improve vascular health through heat 
emphasises the importance of elevation in mean shear stress to mediate vascular 
adaptations, but also may serve as a simple and novel strategy to improve vascular 
function in clinical populations, i.e. with limited mobility and/or unable to exercise.  
 
Figure 2.7: Brachial artery FMD and dilatory capacity during an 8-week exercise training 
intervention, from Tinken et al. (2008). 
 
2.6.2 Shear Patterns 
Shear stress has two main components; antegrade (shear towards to periphery) and 
retrograde (shear towards the heart). The relevance of the pattern of shear stress has 
been demonstrated in vivo and with the use of ex vivo simulation of blood flow and wall 




specifically, arterial wall thickening is more likely to occur at bifurcations where wall shear 
stress is multi-directional, suggesting that shear pattern may be an influencing factor in 
atherogenesis (Steinman et al., 2002; Peiffer et al., 2013; Davies et al., 2010). 
Furthermore, experimental studies have shown that increasing the antegrade or 
retrograde shear component is associated with enhanced or impaired vasodilator 
function, respectively (Thijssen et al., 2009c; Schreuder et al., 2015; Johnson et al., 
2012). The importance of shear patterns has been explored in vivo using handgrip 
exercise to produce fluctuations in shear stress. Pyke et al. (2008) compared the 
vasodilation response to the same mean shear stress stimulus with different shear 
pattern (i.e. fluctuations around the mean versus stable). Interestingly, the authors found 
no difference in the magnitude of vasodilation, implying that the endothelium is sensitive 
to mean shear stress levels. These observations were supported by a later study of  
handgrip exercise showing no difference in FMD between conditions imposing varying 
magnitude of fluctuations with preserved mean shear stress levels (King et al., 2013). 
However in the above studies, mean shear was markedly different from resting baseline 
levels, and exposure to prolonged periods of continuous elevations in antegrade or 
retrograde shear stress do not happen regularly in daily living. 
 
Recently, a research group in Norway developed and utilised a method of intermittent 
negative pressure (10 seconds negative pressure (-40mmHg), 7 seconds atmospheric 
pressure) to induce fluctuations in blood flow and shear stress with no changes in central 
hemodynamics (Sundby et al., 2016b). This equipment comprises of a custom-made 
boot-shaped plastic vacuum chamber, which is sealed around the knee, connected to a 
pressure control system pre-programmed for the 17-second cycles (Figure 2.8). The 
authors observed a significant increase in blood flow and shear rate during the 
application of negative pressure, whilst flow and shear rate dropped to below baseline 




levels without altering mean shear stress. Interestingly, Sundby and colleagues 
conducted a series of elegant experiments in patient groups with peripheral arterial 
disease and spinal cord injury (Sundby et al., 2018a; Sundby et al., 2016a; Sundby et 
al., 2017; Sundby et al., 2018b), and the findings from these studies demonstrated that 
the fluctuations in blood flow facilitated lower limb wound/ulcer healing. The authors 
speculated that these positive clinical outcomes could be attributed to shear stress-
induced improvements in endothelial function. However, this is currently unknown, 
therefore further research is warranted to explore the mechanisms involved in the use of 
intermittent negative pressure. Insight into this area will both be relevant to understand 
the clinical benefits of fluctuations in shear stress, but also highlight the physiological 
relevance of exposure to fluctuations in shear stress with mean shear stress levels being 
kept relatively stable. 
Figure 2.8: Experimental set-up of the negative pressure system (left), and the 
fluctuations in blood flow observed during intermittent negative pressure (right), from 
Sundby et al. (2016b). 
 
2.7 Summary 
In summary, whilst CVD remains the world’s leading cause of death, most CVDs are 
preventable which highlights the importance of early detection. Given that endothelial 
dysfunction is an early biomarker of CVD and is present before an atherosclerotic plaque 
is visible, the FMD may represent a valuable research tool in predicting and preventing 




FMD protocol guidelines importantly improve reproducibility, an update of the 2011 
guidelines seem warranted to improve technical performance of the FMD. Secondly, 
reference vales for the FMD are yet to be established. Third, the role of shear stress as 
a hemodynamic stimulus for vasodilation is well recognised, but the exact impact of age 
and sex on the relationship between FMD and the eliciting shear stimulus is unclear. 
Finally, the impact of exposure to constant levels of an increase or decrease in shear on 
FMD is well established. However, emerging evidence is suggestive of positive health-






Chapter 3  
 
 
Evolution of the FMD Test 
and Implications for CVD 
Risk Prediction 
 
Based on published review (see appendix for full article): 
 
Thijssen, D.H.J., Bruno, R.M., Van Mil, A., Holder, S.M., Faita, F., 
Greyling, A., Zock, P., Taddei, S., Deanfield, J.E., Luscher, T., 
Green, D.J., & Ghiadoni, L. (2019). Expert consensus and evidence-
based guidelines for the assessment of flow-mediated dilation 






The FMD test was introduced in 1992 when it was first utilised by Celermajer et al. (1992) 
to assess changes in artery diameter in response to increased flow. This first study was 
performed in children and adults at risk of atherosclerosis compared to healthy controls. 
Following a period of rest, blood flow through the brachial artery was restricted with a 
pneumatic tourniquet inflated to a suprasystolic pressure, and releasing this pressure 
induced a reactive hyperaemic response and subsequent vasodilation. Interestingly, the 
authors observed significant differences in brachial artery dilation between healthy 
individuals, smokers and coronary artery disease patients, where the magnitude of 
dilation declined in a dose-dependent manner. Given the nature of the methodology, this 
technique became known as the FMD. Since then, several research groups worldwide 
have adopted this technique to assess conduit artery endothelial function. Over the 
years, however, this technique has been modified to improve reproducibility and 
reliability, with methodological guidelines being introduced by Corretti et al. (2002) and 
updated by Thijssen et al. (2011a). 
 
The current brachial artery FMD test protocol consists of one minute of baseline brachial 
artery diameter and blood flow velocity recording, followed by a 5-minute period of distal 
limb ischaemia, induced by inflating a pneumatic cuff to suprasystolic level (~220mmHg), 
placed distal to the humeral epicondyle. Following cuff release, artery diameter and blood 
flow velocity are recorded for a further 3 minutes (Thijssen et al., 2011a). Subsequently, 
FMD is calculated as the relative (percentage) change in diameter from baseline to peak 
following cuff release. This chapter will review studies within the area of physiology which 
contributed to the development of expert-consensus guidelines (latest guidelines 




3.2 Protocol: Occlusion Cuff Position and Duration 
The effect of cuff position (distal versus proximal to the imaging site) has previously been 
investigated experimentally (Doshi et al., 2001; Betik et al., 2004). Importantly, changes 
in cuff placement can alter the magnitude (Naylor et al., 2005a), duration (Doshi et al., 
2001; Naylor et al., 2005a), nature (Green et al., 2014) and even the clinical relevance 
(Green et al., 2011) of the FMD response. Below, these aspects have been discussed in 
relation to the position of the occlusion cuff.  
 
3.2.1 Distal Versus Proximal Cuff Position 
In the original paper by Celermajer et al. (1992), brachial artery FMD was examined with 
the occlusion cuff placed distal around the forearm, ~1 cm below the elbow crease 
(Figure 3.1). However, some researchers have supported the placement of the occlusion 
cuff proximal to the imaged artery (Doshi et al., 2001). Multiple research groups have 
demonstrated that proximal cuff occlusion causes a larger FMD response compared to 
distal occlusion (Berry et al., 2000; Agewall et al., 2001; Betik et al., 2004; Doshi et al., 
2001), and this is partially due to a greater shear stimulus elicited during reactive 
hyperaemia (Green et al., 2011). From this, it has been argued that adopting the proximal 
cuff method may improve the ability to detect subtle differences between populations or 
within subjects. Nonetheless, a previous analysis found no significant differences in 
prognostic value between studies that adopted distal versus proximal cuff position 
(Green et al., 2011). Furthermore, evidence suggests that the dilatory response following 
cuff release may be mediated by other vasodilators than NO alone. A recent meta-
analysis by Green et al. (2014) investigated the degree to which FMD is mediated by NO. 
Out of the 20 studies included in the meta-analysis, four used proximal cuff placement, 
whilst the remaining research groups adopted the traditional distal cuff method. The 
authors evaluated the potential effects of the difference in cuff position and the 




conduit artery vasodilation was NO-mediated when the occlusion cuff was placed distal 
to the imaging site. However, when studies adopting proximal cuff placement were 
included in the analysis, FMD was only ~32% NO-mediated.  
 
The between-study differences in cuff position makes comparisons in FMD data difficult, 
and this is of clinical importance since several studies specifically aim to study the NO-
pathway given its role in the atherosclerotic process. Thus, strict standardisation of cuff 
occlusion below the artery is now recommended to ensure maximal dependence of the 
FMD response on endothelium-derived NO. 
 
3.2.2 Duration and Magnitude of Cuff Occlusion 
In addition to cuff position, the duration of cuff occlusion is also important and has a direct 
impact on the magnitude of the dilatory response (Leeson et al., 1997; Mullen et al., 2001; 
Naylor et al., 2005a). Leeson et al. (1997) assessed FMD in response to graded cuff 
occlusion duration (30 seconds, 1.5-, 2.5-, 3.5-, 4.5- and 8 minutes). Interestingly, the 
authors observed a stepwise increase in FMD with increasing occlusion duration, whilst 
a plateau was observed between 4.5-8 minutes. Therefore, current guidelines 
recommend adopting the 5-minute cuff occlusion period. Furthermore, the pressure of 
the cuff during occlusion should be at least 50 mmHg above the participant’s systolic 





Figure 3.1: Set-up for the brachial artery FMD protocol, with the occlusion cuff placed 
distal to the imaging site. 
 
3.3 Protocol: Examining the Time Course of Peak Artery Diameter 
Original studies adopting the FMD approach assessed peak diameter using single B-
mode frames at 60 seconds post cuff release (Celermajer et al., 1992; Celermajer et al., 
1994a) and this time frame was doubled in the 2002 guidelines (Corretti et al., 2002). 
However, experimental evidence has shown that this approach (including pre-
determined time windows) can result in an underestimation of true FMD. Black et al. 
(2008) measured FMD in 36 subjects, equally split into young, trained old and sedentary 
old groups. The authors used various time windows to assess peak diameter, including 
the traditional 60 seconds, 50-70-, 70-90-, 0-90- and 0-120 seconds. In all groups, the 
peak diameter at 60 seconds was significantly lower than the true peak FMD. 
Interestingly, the majority of subjects (34 out of 36) reached their peak diameter within 
the first 2 minutes of reactive hyperaemia, with the remaining two belonging to the 
sedentary old group. This emphasises that timing of peak dilation differs between groups, 
and may alter following interventions such as exercise training (Thijssen et al., 2011c; 
Liuni et al., 2010). Therefore, to ensure successful capture of the true peak diameter, 







3.4 Analysis: Identifying Peak Artery Diameter 
Initial FMD studies used manual analysis techniques to examine peak artery diameter, 
where investigators visually inspected a single frame of the B-mode image 60 seconds 
post cuff release and applied calipers along the artery diameter (Celermajer et al., 1994a; 
Celermajer et al., 1992). Later, the 2002 FMD guidelines by Corretti et al. (2002) 
recommended identifying the peak diameter during FMD using ECG-gated analysis. This 
method assesses the artery diameter at the onset of the R wave (end diastole, when the 
artery diameter is smallest) of every cardiac cycle, in order to limit the influence of arterial 
compliance. These manual analysis methods are highly operator-dependent and 
therefore subject to observer error and inaccurate FMD data (Woodman et al., 2001; 
Williamson et al., 2008; Harris et al., 2010; Mancini et al., 2002; Preik et al., 2000). 
Nonetheless, these methods have now been superseded by continuous diameter 
assessment, which calculates an average diameter across the cardiac cycle to determine 
baseline and peak artery diameter (Figure 3.2). Continuous diameter assessment has 
been found to have strong agreement in FMD and GTN data with ECG-gated analysis 
(Gemignani et al., 2008; Kizhakekuttu et al., 2010) and is also more time efficient 
(Kizhakekuttu et al., 2010). Therefore, given the accuracy and availability of continuous 
assessment systems, ECG gating should no longer be mandatory to determine peak 
artery diameter during FMD. The importance of continuous artery diameter assessment 
will be discussed below. 
 
3.4.1 Edge-Detection and Wall-Tracking 
Given how small the total artery diameter change is (0.1-0.4mm) and observer error 
associated with manual analysis methods, automated edge-detection and wall-tracking 
analysis methods demonstrate greater validity and reproducibility compared to manual 
analysis (Woodman et al., 2001; Williamson et al., 2008; Mancini et al., 2002; Preik et 




FMD output between automated versus manual edge-detection, where all parameters of 
endothelium-dependent and -independent FMD, including baseline diameter, total shear 
rate and percentage change were significantly under-estimated by the manual method 
compared to the automated system (Williamson et al., 2008). This complicates the 
comparability of FMD data between studies using different analysis techniques. The 
manual technique carries significantly greater observer bias and intra-observer variation 
(Woodman et al., 2001), and although whilst using edge-detection software, the initial 
selection of the region of interest is operator-dependent based on image quality, all 
subsequent analysis is observer-independent and carried out without investigator bias 
(Green & Reed, 2006). Edge-detection and wall-tracking software uses pixel density and 
frequency distribution algorithm to assess B-mode frames (Figure 3.3), where the artery 
walls and blood flow velocity trace are automatically detected. Furthermore, these 
softwares automatically calculate FMD and SRAUC (from cuff release to peak diameter; 
highlighted in red in Figure 3.2). Therefore, given the current availability of several edge-
detection and wall-tracking analysis systems and its superiority in terms of validity and 
bias, validated, accurate and reproducible edge-detection and wall tracking systems 




Figure 3.2: Screenshot of FMD analysis, including artery diameter (top), peak blood flow 
(middle) and shear rate (bottom). Baseline diameter is calculated as the average 
diameter between the two red bars, and the peak is determined automatically by the 
software (shown by the orange dashed lines; top panel). 
 
Figure 3.3: A) Screenshot of edge detection software (diameter and velocity), B) Region 
of interest selected by the observer on a section of the artery and software tracking the 







3.5 Normalisation for FMD Stimulus 
Based on the importance of the shear stress stimulus during reactive hyperaemia (Pyke 
& Tschakovsky, 2007), as well as the mathematical and physiological effect of baseline 
diameter on the FMD (Thijssen et al., 2008a), it was suggested that these variables 
should be statistically controlled for during subsequent data analysis. Various 
approaches have been put forward by statisticians to independently control for shear rate 
and baseline diameter, and these will be discussed below. 
 
3.5.1 Shear Stress Stimulus 
Given the between- and within-group variability of SRAUC (Padilla et al., 2008; Pyke et 
al., 2004; Ishibashi et al., 2006), it may be unclear whether these differences are 
attributable to biological variability in endothelial function or differences in the magnitude 
of the shear stimulus. This raised the question of how to account for the shear stimulus 
when interpreting FMD. Researchers began normalising FMD responses by dividing the 
FMD by shear rate to produce a ratio (de Groot et al., 2004; Parker et al., 2006a; Padilla 
et al., 2008). However, this type of ‘simple’ ratio normalisation is statistically flawed as it 
fails to meet important statistical assumptions; (i) the relationship between both 
parameters is linear, (ii) the intercept for the regression slope of this relationship is zero, 
(iii) data (including residuals) are normally distributed, (iv) variances are similar between 
groups and (v) the ratio does not lead to spurious correlations with other variables 
(Atkinson et al., 2009). Atkinson et al. (2009) found that all assumptions for the reliable 
use of FMD/shear rate ratios were violated in the comparison of FMD between boys, 
young men and older men. This evidence suggests that ratio normalisation does not 





Further exploration into statistical strategies to correct for the shear stimulus has 
investigated the use of SRAUC as a covariate in an analysis of covariance (Harris & 
Padilla, 2007; Atkinson et al., 2009; Atkinson & Batterham, 2013b). However, these 
results could be misleading if the covariate, i.e., shear rate, is related to the independent- 
and outcome variable (for example, age, sex, baseline diameter and FMD). Further 
investigation is required to determine the potential utility of this method for normalisation 
in the future, though it seems appropriate for repeated FMD measurement, but not for 
cardiovascular risk prediction. 
 
3.5.2 Baseline Diameter 
The mathematical influence of baseline diameter partly contributes to the known inverse 
relationship between baseline diameter and FMD (Thijssen et al., 2008a).  Allometric 
scaling was proposed to adjust for the influence of baseline diameter on FMD (Atkinson 
& Batterham, 2015; Atkinson & Batterham, 2013b). A study by Atkinson (2014) re-
analysed 44 pairs of FMD/shear normalisation data from Pyke et al. (2004) using the 
allometric approach and the new re-analysis revealed that baseline diameter-
dependency could be eliminated. However, whilst allometric scaling may have 
physiological relevance, it is unclear what this adds to the current prognostic value.  
 
3.5.3 Normalisation for FMD Stimulus: Summary 
In summary, no clear statistical strategy is currently in place to account for the eliciting 
shear rate stimulus during FMD. Ratio normalisation appears statistically flawed, whilst 
too many questions remain around validity, feasibility and interpretation of results as an 
index of endothelial function and cardiovascular risk. Guidelines recommend reporting 
the relevant shear rate stimulus, either as the peak and/or AUC. Reporting this data may 




reactive hyperaemia may offer prognostic value, given its association with cardiovascular 
risk in healthy and diseased populations (Mitchell et al., 2004; Philpott et al., 2009; Huang 
et al., 2007; Paine et al., 2016). 
 
3.6 Reproducibility of FMD 
A nationwide multi-centre study assessed the effect of standardised methodology on the 
reproducibility of the FMD (Ghiadoni et al., 2012). The FMD test was conducted on 135 
healthy participants at baseline, one hour later and 30 days later. Importantly, the seven 
centres involved in the study strictly followed expert-consensus guidelines regarding the 
test protocol and edge-detection analysis system (Thijssen et al., 2011a) and the 
sonographers had also received optimal training. Reproducibility is reported as a 
coefficient of variation (calculated as (standard deviation/mean)x100) and current 
guidelines indicate that FMD coefficient of variation should be below 20–30% (Corretti et 
al., 2002). The results of the multi-centre study demonstrated a coefficient of variation of 
11.6-16.1%, which demonstrates that by following the guidelines and with sufficient 
technical training, FMD is highly reproducible. 
 
Recently, a scoring tool was designed to assess the level of guideline adherence for the 
FMD, specifically related to subject preparation, image acquisition and analysis (Greyling 
et al., 2016b). Using this tool, the authors assessed the relationship between adherence 
score and reproducibility of the FMD between studies (Greyling et al., 2016a) and found 
that strict guideline adherence markedly improved the reproducibility of the brachial 
artery FMD. Together, the above research highlights the importance of adhering to 





3.7 Summary and Conclusion 
The FMD has proven valuable in providing a non-invasive assessment for future CVD 
risk, even in asymptomatic individuals (Inaba et al., 2010; Ras et al., 2013; Green et al., 
2014). However, a major limitation of the current available literature is that there is 
varying level of adherence to expert-consensus guidelines, which limits the comparability 
and validity of FMD results between studies and laboratories. Given the importance of 
following these guidelines on reproducibility and reliability, as discussed above, research 
groups are encouraged to perform the FMD in accordance with expert-consensus 
guidelines. The full article and recommendations can be found in the appendix. 
Implementing standardised methodology adds to the prognostic value of the FMD for 
future CVD, but will also contribute to the development of reference values. Importantly, 
the construction of reference values would allow the FMD test to be applicable in a 
clinical setting rather than just used as a research tool. However, to date, no previous 












Chapter 4  
 
 
Age- and Sex-Specific Reference 
Values for Brachial Artery FMD 






Since its introduction, FMD has become a popular research tool used worldwide to 
assess endothelial function. Nonetheless, despite the independent prognostic value of 
FMD (Ras et al., 2013; Xu et al., 2014; Inaba et al., 2010; Matsuzawa et al., 2015), some 
limitations hamper widespread use of the technique. As reviewed in Chapter 2, age- and 
sex-specific differences in FMD have been consistently reported (Seals et al., 2011; 
Hopkins et al., 2015; Adams et al., 1996; Celermajer et al., 1994b; Taddei et al., 1995; 
Yao et al., 2014) with older age and male sex being associated with lower FMD values. 
However, marked differences in FMD values are present between studies, prohibiting 
meaningful comparisons. These differences are largely attributed to variation in FMD 
methodology between studies (e.g. timing, occlusion cuff position, and manual versus 
automated analysis). Therefore, consistent implementation of expert-consensus 
guidelines (Thijssen et al., 2011a; Thijssen et al., 2019b) seems a logical solution to lower 
FMD variability (Greyling et al., 2016a). Moreover, studies have not controlled for age-
related changes in diameter and CVD risk factors, i.e. (patho)physiological indices that 
importantly contribute to the magnitude and variation of the FMD. This highlights the need 
and importance of age- and sex-specific reference values for FMD, collected when 
adhering to protocol guidelines, to facilitate interpretation of FMD outcomes.  
 
For this study, FMD observations from six laboratories that all strictly adhered to protocol 
and analysis guidelines (Corretti et al., 2002; Thijssen et al., 2011a) were pooled into a 
single database. First, using data from 1,403 healthy individuals, age- and sex-specific 
reference intervals for brachial artery FMD across the entire lifespan were established. 
This data also facilitated exploration into the role of age- and sex-specific differences in 
artery diameter on FMD. Secondly, 3,959 individuals with established CVD risk factors 




how these risk factors, as well as medication use, impacted the age- and sex-specific 
FMD reference values.  
 
4.2 Methods 
4.2.1 Participants  
Research groups from the International Working Group on Flow-Mediated Dilation 
identified eligible studies that included assessment of brachial artery FMD. Studies were 
included if all measurements were performed with adherence to the expert-consensus 
guidelines on measuring FMD (Corretti et al., 2002; Thijssen et al., 2011a) and data 
collection adhered to the Declaration of Helsinki. 
 
Individual-level brachial artery FMD data with corresponding participant characteristics 
and medical history from six laboratories were compiled (for the list of contributing 
laboratories and investigators, see appendix). With permission from principal 
investigators, unpublished data was included (32% of total observations). When the 
original studies adopted a methodological design with repeated FMD measurements, the 
first-performed FMD was included. 
 
For the first objective, i.e. age- and sex-specific reference intervals, healthy individuals 
(4-84 years; 821 males and 582 females) were selected following stringent inclusion 
criteria (Mancia et al., 2013) including (when available): (i) systolic blood pressure 
<140mmHg and diastolic blood pressure <90mmHg, (ii) BMI <25kg/m2, (iii) waist 
circumference <102cm for males and <88cm for females, (iv) total cholesterol 
<4.9mmol/L, (v) LDL <3mmol/L, (vi) HDL >1mmol/L for males and >1.2mmol/L for 




no history of metabolic- or CVD/event, and (xi) not taking any medications or hormone-
based contraception/therapy. For the second objective, i.e. impact of CVD risk factors 
(BMI, blood pressure, cholesterol, diabetes, dyslipidaemia and smoking) , the remaining 
participants with one or more risk factor (n=3,959) were stratified into un-medicated 
(males; n=545, females; n=247), and medicated individuals (males; n=1920, females; 
n=1247). The medicated subpopulation were taking blood pressure-, lipid- and/or 
glucose-lowering drugs.  
 
4.2.2 Brachial Artery FMD: Methodological Considerations 
Importantly, only brachial artery FMD data from research groups strictly adhering to 
expert-consensus guidelines (Corretti et al., 2002; Thijssen et al., 2011a) were included 
in the dataset. FMD assessments were performed following standardised participant 
preparation procedures (i.e. fasted state, abstained from exercise, caffeine and alcohol, 
and timing of menstrual cycle). Following 10-15 minutes of supine rest, brachial artery 
diameter was assessed via high-resolution duplex ultrasound using a hand-held probe 
or probe-holder approach. B-mode images were obtained and optimized, and Doppler 
velocity was recorded simultaneously. After at least 1 minute of baseline diameter and 
blood flow velocity measurement, an occlusion cuff, placed distal to the olecranon 
process, was inflated to suprasystolic pressure (i.e. >50mmHg above the participant’s 
systolic blood pressure) for 5 minutes. Recordings were resumed 30 seconds before cuff 
deflation, and FMD was recorded for a further 3 minutes post cuff deflation.  
FMD data were analysed using automated edge-detection and wall-tracking software 
(BloodFlow Analysis [n=3,244] or FMD Studio, Quipu SRL [n=2,118]) which are largely 
operator independent, and also substantially more reproducible than manual approaches 
(Woodman et al., 2001). These software packages track the vessel walls and blood 




(Woodman et al., 2001). An optimal region of interest to be analysed was selected by 
the sonographer, based on consistent image quality, with a clear distinction between the 
artery walls and lumen. Despite the initial region of interest selection being operator-
determined, the remaining analysis was automated and independent of operator bias 
(Woodman et al., 2001). Laboratory-specific details of analysis software and ultrasound 
machines are reported in the appendix. 
 
4.2.3 Statistical Analysis 
Statistical analyses were conducted using IBM SPSS version 25 (SPSS Inc., Chicago, 
IL) unless stated otherwise.  
 
4.2.3.1 Multiple Imputation 
Multiple imputation chained equations were used to impute missing values (Janssen et 
al., 2010) for weight, BMI, systolic-, diastolic- and mean arterial blood pressure, and 
baseline- and peak diameter (all variables had <20% missing data). Five imputed 
datasets were generated, which were used to fit the relevant regression models and 
results reported were obtained from the pooled analyses on all imputed datasets.  
 
4.2.3.2 Definition of Age- and Sex-Related Reference Values 
Calculation of age-specific reference intervals were performed in healthy males (n=821) 
and females (n=582) separately. Initially, to account for differences in analysis software, 
multiple linear regression was performed, including a dummy variable for FMD Studio as 
an independent determinant of FMD outcome. The regression coefficient for the dummy 
variable (β=0.166%) was used as a calibration factor to rescale individual FMD values 
obtained using FMD Studio. Fractional polynomial (FP) regression (Royston & Wright, 




software (Stata Corp., College Station, TX, USA) with the xrigls command. Age-specific 
2.5th, 10th, 25th, 50th, 75th, 90th and 97.5th percentile curves were calculated as meanFMD 
+ Zp x standard deviation (SD), where Zp assumed the values of -1.96, -1.28, -0.67, 0, 
0.67, 1.28, and 1.96, respectively. Age- and sex-specific percentile curves were also 
calculated for baseline brachial artery diameter. Furthermore, Pearson correlation 
coefficient was used to assess the relationship between baseline diameter and FMD. 
Fisher r-to-z transformation was used to compare the correlation coefficient between 
males and females.  
 
4.2.3.3 Relation with CVD Risk Factors 
First, the expected meanFMD and SDFMD for individuals with CVD risk factors were 
calculated based on the equations computed for healthy individuals. Second, age- and 
sex-specific Z-scores were calculated as observedFMD - expectedFMD/SDexpectedFMD. Z-
scores represent the number of SDs above or below the healthy population mean (50th 
percentile) of the same age and sex. 
 
Multiple linear regression determined the relation of CVD risk factors with FMD Z-scores 
in four subpopulations (un-medicated and medicated males and females). Age was 
included in the regression model to account for any residual effects on outcomes. Sub-
analyses were conducted for smoking and cholesterol, since limited available data were 
present for these variables. Interaction terms were added between each risk factor and 








Participant characteristics are presented for all males and females in Tables 4.1 and 4.2, 
respectively.  
 
4.3.1 Age- and Sex-Related Reference Values for Brachial Artery FMD  
The best fitting FPs’ powers (p) for meanFMD and SDFMD were both p=1 for females, which 
represents a linear relation between FMD and age. For males, the meanFMD p=0 and 
SDFMD p=-0.5, indicating a curvilinear relation (Figure 4.1). The equations derived for 
estimated FMD were: 
 
 
5.3.2 Age- and Sex-Related Differences in Baseline Brachial Artery Diameter 
The best fitting FPs’ powers (p) for meanBaselineDiameter and SDBaselineDiameter were p=-2 and 
p=-1 respectively for females, and p=-0.5 and p=-1 respectively for males, indicating a 
curvilinear relation in both sexes (Figure 4.1). The equations derived for estimated 
baseline artery diameter were: 
Females: 
meanFMD (%) = 9.5947 – 0.0631 x age 
SDFMD (%) = 4.5400 – 0.0349 x age 
 
Males: 
meanFMD (%) = 7.9279 - 1.5725 x ln(age/10) 
SDFMD (%) = 1.4008 + 2.3163 x (age/10)-0.5 
 
Females: 
MeanBaselineDiameter (mm) = 3.3764 – 0.6070 x (age/10)-2 
SDBaselineDiameter (mm) = 0.6389 – 0.3195 x (age/10)-1 
 
Males: 
MeanBaselineDiameter (mm) = 5.8692 – 2.9237 x (age/10)-0.5 





Corresponding reference intervals (percentiles) derived from the above equations for 
estimated FMD and baseline artery diameter are presented in Table 4.3. Correlation 
analysis demonstrated weak but statistically significant inverse relationships between 
observed baseline artery diameter and FMD (female r2=0.163, male r2=0.149; both 







Table 4.1: Participant characteristics of the total male population, and healthy, un-medicated and medicated male subpopulations.  
 Total Healthy Un-medicated Medicated 
n 3286 821 1920 545 
Age (years) 42±19 26±15 45±17 58±11 
Body mass index (kg/m2) 26.3±5.2 22.2±3.8 27.2±4.6 29.4±5.0 
Systolic BP (mmHg) 130±17 118±13 133±17 137±16 
Diastolic BP (mmHg) 78±13 70±10 81±12 83±11 
Mean arterial pressure (mmHg) 95±14 86±10 98±14 101±13 
Total cholesterol [mmol/L (n)] 5.1±1.0 (1756) 4.2±0.5 (105) 5.3±1.0 (1252) 4.9±1.1 (399) 
LDL cholesterol [mmol/L (n)] 3.2±0.9 (1562) 2.3±0.5 (87) 3.4±0.9 (1139) 3.0±1.0 (336) 
HDL cholesterol [mmol/L (n)] 1.2±0.4 (1613) 1.4±0.2 (89) 1.2±0.4 (1181) 1.2±0.4 (343) 
Total-to-HDL cholesterol ratio (n) 4.4±1.3 (1612) 3.0±0.5 (89) 4.5±1.3 (1180) 4.3±1.3 (343) 
Triglycerides [mmol/L (n)] 1.6±1.1 (1670) 0.9±0.4 (92) 1.6±1.1 (1221) 1.7±1.1 (357) 
Plasma glucose [mmol/L (n)] 5.5±1.5 (1293) 4.7±0.6 (83) 5.3±1.1 (982) 6.6±2.4 (228) 
Baseline artery diameter (mm) 4.37±0.86 3.90±0.83 4.46±0.82 4.75±0.72 
FMD (%) 5.56±2.91 6.66±3.24 5.45±2.72 4.30±2.42 
Current smoker [n (%)] 127 (3.9) 0 102 (5.3) 25 (4.6) 
Diabetes [n (%)] 288 (8.8) 0 107 (5.6) 181 (33.2) 
Dyslipidaemia [n (%)] 1474 (44.9) 0 1074 (55.9) 400 (73.4) 
BP-lowering medication [n (%)] 499 (15.2) 0 0 499 (91.6) 
Lipid-lowering medication [n (%)] 253 (7.7) 0 0 253 (46.4) 
Glucose-lowering medication [n (%)] 167 (5.1) 0 0 167 (30.6) 
Data are presented as mean±SD. For blood metabolites, n represents the number of available data within the respective subpopulation. For 
categorical data, data are presented as n (percentage of subpopulation). BP – blood pressure; HDL – high-density lipoprotein cholesterol; FMD 









Table 4.2: Participant characteristics of the total female population, and healthy, un-medicated and medicated female subpopulations.  
 Total Healthy Un-medicated Medicated 
n 2076 582 1247 247 
Age (years) 41±18 28±16 44±16 56±12 
Body mass index (kg/m2) 25.7±6.3 21.6±3.5 26.9±6.1 29.5±7.1 
Systolic BP (mmHg) 125±19 113±12 129±18 138±18 
Diastolic BP (mmHg) 76±12 68±10 78±12 81±14 
Mean arterial pressure (mmHg) 92±15 83±10 94±14 98±17 
Total cholesterol [mmol/L (n)] 5.3±1.0 (1150) 4.3±0.4 (119) 5.1±1.0 (839) 5.3±1.0 (192) 
LDL cholesterol [mmol/L (n)] 3.3±0.9 (999) 2.3±0.4 (93) 3.4±0.8 (737) 3.2±1.0 (169) 
HDL cholesterol [mmol/L (n)] 1.5±0.4 (1026) 1.7±0.3 (99) 1.5±0.4 (755) 1.6±0.4 (172) 
Total-to-HDL cholesterol ratio (n) 3.6±1.0 (1025) 2.6±0.4 (98) 3.8±1.0 (755) 3.6±1.0 (172) 
Triglycerides [mmol/L (n)] 1.2±0.9 (1066) 0.8±0.3 (100) 1.2±0.8 (783) 1.5±1.3 (183) 
Plasma glucose [mmol/L (n)] 5.0±0.9 (866) 4.6±0.5 (107) 5.0±0.7 (656) 5.8±1.6 (103) 
Baseline artery diameter (mm) 3.51±0.66 3.25±0.61 3.58±0.64 3.78±0.66 
FMD (%) 6.62±3.47 7.78±3.77 6.36±3.22 5.18±3.13 
Current smoker [n (%)] 97 (4.7) 0 78 (6.3) 19 (7.7) 
Diabetes [n (%)] 119 (5.7) 0 37 (3.0) 82 (33.2) 
Dyslipidaemia [n (%)] 883 (42.5) 0 708 (56.8) 175 (70.9) 
BP-lowering medication [n (%)] 216 (10.4) 0 0 216 (87.4) 
Lipid-lowering medication [n (%)] 73 (3.5) 0 0 73 (29.6) 
Glucose-lowering medication [n (%)] 81 (3.9) 0 0 81 (32.8) 
Data are presented as mean±SD. For blood metabolites, n represents the number of available data within the respective subpopulation. For 
























Figure 4.1: Age-specific percentiles of brachial artery flow-mediated dilation (FMD; percentage change from baseline) and baseline diameter (in 




Table 4.3: Estimated reference intervals [50th percentile (2.5th-97.5th percentile)] for 
brachial artery FMD (%) and baseline diameter (mm) in healthy females and males, 
derived from the predictive equations. 
 Age (years) Females Males 
FMD (%) 5 9.28 (0.72-17.84) 9.02 (-0.15-18.18) 
 10 8.96 (0.75-17.18) 7.93 (0.64-15.21) 
 15 8.65 (0.78-16.52) 7.29 (0.84-13.74) 
 20 8.33 (0.80-15.86) 6.83 (0.88-12.79) 
 25 8.02 (0.83-15.21) 6.49 (0.87-12.10) 
 30 7.70 (0.86-14.55) 6.20 (0.83-11.57) 
 35 7.39 (0.88-13.89) 5.96 (0.79-11.13) 
 40 7.07 (0.91-13.23) 5.74 (0.73-10.76) 
 45 6.76 (0.93-12.58) 5.56 (0.68-10.45) 
 50 6.44 (0.96-11.92) 5.40 (0.62-10.17) 
 55 6.12 (0.99-11.26) 5.24 (0.57-9.93) 
 60 5.81 (1.01-10.60) 5.11 (0.51-9.71) 
 65 5.49 (1.04-9.95) 4.98 (0.46-9.51) 
 70 5.18 (1.07-9.29) 4.87 (0.41-9.33) 
 75 4.86 (1.09-8.63) 4.76 (0.36-9.16) 
 80 4.55 (1.12-7.97) 4.66 (0.31-9.01) 
Baseline artery 10 2.77 (2.14-3.40) 2.95 (2.16-3.73) 
diameter (mm) 15 3.11 (2.27-3.94) 3.48 (2.49-4.47) 
 20 3.22 (2.29-4.16) 3.80 (2.71-4.90) 
 25 3.28 (2.28-4.28) 4.02 (2.86-5.18) 
 30 3.31 (2.27-4.35) 4.18 (2.98-5.38) 
 35 3.33 (2.25-4.40) 4.31 (3.08-5.53) 
 40 3.34 (2.24-4.43) 4.41 (3.16-5.66) 
 45 3.35 (2.23-4.46) 4.49 (3.22-5.76) 
 50 3.35 (2.23-4.48) 4.56 (3.28-5.84) 
 55 3.36 (2.22-4.49) 4.62 (3.33-5.92) 
 60 3.36 (2.21-4.51) 4.68 (3.37-5.98) 
 65 3.36 (2.21-4.52) 4.72 (3.41-6.03) 
 70 3.36 (2.20-4.53) 4.76 (3.45-6.08) 
 75 3.37 (2.20-4.53) 4.80 (3.48-6.12) 
 80 3.37 (2.19-4.54) 4.84 (3.51-6.16) 





























Figure 4.2: Brachial artery FMD and baseline diameter in healthy males (A; n=796) and 
females (B; n=579). Pearson correlation coefficient was used to determine the 





5.3.3 Relation between CVD Risk Factors and FMD Z-Scores 
In the un-medicated subpopulation, lower FMD Z-scores (i.e. lower FMD compared to 
age-/sex-matched healthy reference values) were found for higher systolic blood 
pressure in both males and females (P=0.015 and P<0.001, respectively). Higher 
diastolic blood pressure was significantly associated with higher FMD Z-scores in 
females (P<0.001). Presence of diabetes was significantly associated with lower FMD 
Z-scores in males (P<0.001; Table 4.4). In the medicated subpopulation, presence of 
dyslipidaemia and diabetes were significantly associated with lower FMD Z-scores in 
females (both P=0.01). In males, smoking and diabetes were significantly associated 
with lower FMD Z-scores (P=0.022 and P=0.027, respectively), whilst dyslipidaemia was 
related to higher FMD Z-scores (P=0.029; Table 4.4). These observations are largely 
reinforced when standardised regression coefficients (per SD increase in- or presence 
of CVD risk factor) are presented in Figure 4.3.  
 
5.3.4 Sex Differences in the relation between CVD Risk Factors and FMD Z-Scores 
Using sex as an interaction term in the regression model revealed that systolic- and 
diastolic blood pressure were stronger determinants for FMD in un-medicated females 
than in males (both P=0.019, Figure 4.3). In the medicated subpopulation, no sex 
differences were found for systolic and diastolic blood pressure (Figure 4.3). Whilst 
presence of dyslipidaemia was not significantly affected by sex in the un-medicated 
group, sex altered the effect of dyslipidaemia on FMD Z-score in the medicated group 
(Figure 4.3). More specifically, FMD was supra-normalised in medicated males, whilst 
FMD in females was lower in those with dyslipidaemia compared to healthy age- and 






Table 4.4: Relation of CVD risk factors with brachial artery FMD Z-scores in un-medicated/medicated males and females. 
Sex Risk Factor Un-medicated (n=3167)  Medicated (n=792) 
β 95% CI P value  β 95% CI P value 
Male Systolic BP (10mmHg) -0.049 -0.088; -0.009 0.015  0.017 -0.053; 0.087 0.636 
 Diastolic BP (10mmHg) 0.040 -0.013; 0.093 0.136  0.057 -0.049; 0.162 0.293 
 Body mass index (kg/m2) 0.001 -0.009; 0.011 0.788  -0.014 -0.031; 0.004 0.118 
 Total-to-HDL cholesterol ratio (unit) -0.021 -0.068; 0.027 0.391  0.003 -0.084; 0.091 0.942 
 Current smoker (yes) -0.124 -0.332; 0.084 0.241  -0.454 -0.843; -0.066 0.022 
 Diabetes (yes) -0.500 -0.696; -0.303 <0.001  -0.209 -0.393; -0.024 0.027 
 Dyslipidaemia (yes) 0.020 -0.077; 0.117 0.682  0.206 0.021; 0.392 0.029 
Female Systolic BP (10mmHg) -0.117 -0.173; -0.061 <0.001  -0.023 -0.141; 0.096 0.704 
 Diastolic BP (10mmHg) 0.150 0.069; 0.231 <0.001  0.124 -0.035; 0.283 0.127 
 Body mass index (kg/m2) 0.004 -0.005; 0.014 0.361  0.010 -0.013; 0.033 0.389 
 Total-to-HDL cholesterol ratio (unit) 0.006 -0.073; 0.085 0.879  0.091 -0.096; 0.279 0.339 
 Current smoker (yes) -0.108 -0.344; 0.128 0.368  0.068 -0.474; 0.611 0.805 
 Diabetes (yes) -0.158 -0.492; 0.176 0.354  -0.438 -0.769; -0.107 0.010 
 Dyslipidaemia (yes) -0.075 -0.197; 0.046 0.223  -0.426 -0.752; -0.101 0.010 
The regression coefficient β represents the increase in brachial artery FMD (in SD from the healthy population mean of the same age and sex) 
per unit increase (or presence) in each risk factor. Multivariable regression models including all risk factors and age determined β values. BP – 




Figure 4.3: Point estimates and 95% confidence intervals represent the increase in 
brachial artery FMD Z-score (in SD from the healthy population mean) per SD increase 
(or presence) in risk factor resulting from a multivariable regression model including all 
risk factors and age for males (●) and females (○). (A) un-medicated males (n=1920) 





Following strict adherence to expert-consensus guidelines (Corretti et al., 2002; Thijssen 
et al., 2011a), this study provides age- and sex-specific reference intervals for brachial 
artery FMD, where sex altered the age-related decline in FMD. Healthy males 
demonstrated a negative curvilinear relation between FMD and age, whilst females 
revealed a linear relation, where FMD started higher, but declined at a faster rate with 
age compared to males. Importantly, this work revealed that differences in baseline 
brachial artery diameter, at least partly, contribute to the age- and sex-related differences 
in FMD. This suggests that differences in FMD between healthy individuals may not 
necessarily relate to differences in endothelial function per se. Additionally, this work 
provides insight into how CVD risk factors and (cardiovascular-controlling) medications 
influence FMD. Some CVD risk factors (e.g. blood pressure, diabetes, dyslipidaemia, 
BMI) alter age- and sex-related FMD Z-scores, both in un-medicated and medicated 
individuals. Moreover, sex altered the impact of CVD risk factors and medication. 
Specifically, a larger impact of blood pressure on FMD was evident in un-medicated 
females compared to males, whilst dyslipidaemia was associated with a lower FMD in 
medicated females, but not in males. Taken together, these reference intervals for 
brachial artery FMD importantly contribute to improved interpretation of FMD outcomes, 
but also extend the current knowledge and understanding of factors that influence FMD. 
 
In the past years, reference values have been estimated for other (pre)clinical tests of 
vascular structure (e.g. stiffness (Bossuyt et al., 2015; Engelen et al., 2015) and IMT 
(Engelen et al., 2013) in large arteries, and media/lumen ratio in small arteries (Bruno et 
al., 2018)), which contributed to widespread and valid use of the technique. Importantly, 
in these examples, efforts were made to standardise assessment prior to estimating 
reference intervals. Similarly, this study included data from laboratories that strictly 




2002; Thijssen et al., 2011a). The importance of following these guidelines is supported 
by this dataset, in that no between-software differences in FMD results were found. 
Importantly, data were derived from multiple laboratories, different countries, and 
involved multiple principal investigators and sonographers. This emphasises that 
adhering to expert-consensus guidelines is essential for the future use of FMD, but also 
highlights the relevance and robustness of the age- and sex-specific reference intervals 
presented in this work. 
 
In the healthy population, and in line with most previous work (Adams et al., 1996; 
Celermajer et al., 1994b; Taddei et al., 1995; Seals et al., 2011), an age-related decline 
in FMD in both sexes was observed. Nonetheless, the rate of change differed between 
sexes, with early work reporting a linear decline in both groups that starts around the 4th 
or 5th decade of life (Celermajer et al., 1994b). Previous studies, however, are limited by 
the inclusion of a relatively small age range and/or have included individuals with CVD 
risk factors. Another limitation is largely ignoring the potential role of age- and sex-
specific differences in baseline artery diameter, which is relevant since baseline diameter 
is inversely related to FMD (Thijssen et al., 2008a; Thijssen et al., 2008b; Herrington et 
al., 2001). Differences in baseline artery diameter may partly explain the lower FMD in 
males compared to females, and may also influence the age-related changes in FMD. 
Indeed, the age-related decline in FMD is mirrored by a concomitant increase in baseline 
diameter. Furthermore, in children there was a steeper rate of change in males compared 
to females, which may contribute to the characteristic drop in FMD in males (and not in 
females) during childhood and adolescence.  
 
The higher FMD in females, but also the steeper decline in FMD with age, compared to 




linked to cardio-protective properties (Miller & Duckles, 2008), as discussed in Chapter 
2 (Section 2.4) . Conversely, in contrast with previous research (Moreau et al., 2012a; 
Celermajer et al., 1994b), the characteristic drop in sex hormones associated with 
menopause did not translate to a steeper decline in FMD in this study. However, these 
previous studies are limited by the cross-sectional nature, making it difficult to untangle 
the impact of menopause versus older age. Alternative explanations for the gradual 
decline in FMD with age may relate to factors including changes in artery structure, shear 
stress patterns and oxidative stress (see Chapter 2; Section 2.3). Future work is required 
to better understand the nature and physiological mechanisms underlying this change.  
 
When examining the relation between CVD risk factors and FMD Z-scores, blood 
pressure and diabetes were negatively associated with FMD in un-medicated individuals. 
This is not surprising, given previous work related to endothelial dysfunction with the 
presence of high blood pressure (Ghiadoni et al., 2001) and diabetes (Hamilton & Watts, 
2013), whilst these risk factors also impacted sex- and age-specific reference values for 
carotid IMT (Engelen et al., 2013) and arterial stiffness (Engelen et al., 2015; Bossuyt et 
al., 2015). Moreover, the relation between blood pressure and FMD Z-score disappeared 
in the medicated subgroup, implying that FMD is not different from healthy controls when 
using drugs that target these risk factors. These findings are supported by previous work 
in blood pressure-lowering medication (Taddei et al., 2002), which found these drugs to 
(in)directly improve endothelial function in patients. No significant impact on FMD in un-
medicated individuals was found in other well-established risk factors, including BMI, 
cholesterol and smoking. A potential explanation for these findings may relate to the 
small proportion of available data for smoking and cholesterol variables. Nonetheless, 
the data presented in the current study confirms that elevated blood pressure is an 




It was also found that sex affects the impact of CVD risk factors and medication on FMD. 
In un-medicated individuals, systolic- and diastolic blood pressure were stronger 
determinants of FMD Z-score in females than in males. These findings fit with previous 
observations, in that untreated hypertensive women showed larger endothelial 
dysfunction (Routledge et al., 2012) and a stronger relation between hypertension and 
myocardial infarction incidence compared to men (Anand et al., 2008). Interestingly, sex-
specific differences for the effect of blood pressure on FMD disappeared in the 
medicated group. Additionally, sex differences were reported in the medicated group, 
with females demonstrating significantly lower FMD Z-scores than males in the presence 
of dyslipidaemia. In fact, FMD Z-scores for medicated males with dyslipidaemia were 
supra-normalised (i.e. greater than the healthy population mean of the same age), 
highlighting the success of drugs targeting dyslipidaemia in males. Whilst the underlying 
mechanisms for these sex differences remain unclear, these observations are extremely 
important in contemporary medicine where increased awareness is required that sex 
differently affects the process of atherosclerosis and CVD development, as well as the 
impact of pharmacological treatments.  
 
4.5 Conclusion 
In conclusion, this study estimated age- and sex-specific percentiles for brachial artery 
FMD in a healthy population and explored the relation of CVD risk factors on FMD Z-
scores. Notably, the FMD data included in the present study were obtained with strict 
adherence to protocol guidelines (Corretti et al., 2002; Thijssen et al., 2011a). Despite 
the large number of studies (and contributing authors) included in the analyses, between-
study variability was low, emphasising the importance of strict guideline adherence. More 
importantly, this also highlights the feasibility and use of FMD for (pre)clinical work, when 
guidelines are strictly adhered to. Accordingly, age- and sex-specific reference values 




sex leads to distinct age-related changes in FMD, but also affects the impact of some 
CVD risk factors in un-medicated and medicated individuals. Whilst age, sex and CVD 
risk factors differently affect endothelial function, other physiological factors have been 
shown to play a role in the FMD outcome. In particular, as discussed in Chapter 2 
(Section 2.5.2), the eliciting shear stress stimulus during reactive hyperaemia (i.e. 
SRAUC) determines the magnitude of FMD (Pyke & Tschakovsky, 2007). Nonetheless, 
it remains unclear whether this important stimulus is affected by age- and sex-specific 



















Chapter 5  
 
 
Age and Sex Differences in the 
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CVD remains the leading cause of morbidity and mortality in women, although the 
incidence of CVD in women is lower compared to age-matched men (Townsend et al., 
2015c). However, a rapid increase in CVD-related mortality in women coincides with the 
onset of menopause (Townsend et al., 2015c). These sex-related differences in CVD 
may, at least partly, relate to differences in endothelial function (Green et al., 2016), since 
pre-menopausal women exhibit enhanced endothelial function compared to men 
(Celermajer et al., 1994b; Juonala et al., 2008; Yao et al., 2014; Green et al., 2016). 
 
As outlined in Chapter 2 (Section 2.4), these sex-specific differences in FMD largely 
relates to oestrogen, whereby FMD has shown to fluctuate during a menstrual cycle 
(Hashimoto et al., 1995; Williams et al., 2001; Brandão et al., 2014) and drop following 
menopause (Moreau et al., 2012a; Green et al., 2016). An alternative explanation for sex 
differences in endothelial function relates to observations in animal studies, which 
suggest that oestrogen improves the vascular responsiveness to changes in shear stress, 
mediated by oestrogen receptors (Huang et al., 2000). For example, Huang et al. (1998) 
found that female and ovariectomized rats with oestrogen replacement show significantly 
greater dilation in response to a given shear stress, compared to male and 
ovariectomized rats. A stronger relationship between endothelial function and shear 
stress may therefore contribute to the enhanced endothelial function observed in pre-
menopausal women, compared to post-menopausal women and age-matched men. To 
date, no study has examined this hypothesis in humans.  
 
The purpose of this study was to explore the relationship between FMD and its eliciting 
shear rate stimulus (i.e. SRAUC) between healthy men and women across the lifespan, 




relationship between FMD and SRAUC would be stronger in younger women, compared 
to men, and that this relationship would be attenuated with older age and post-
menopausal status.  
 
5.2 Methods 
5.2.1 Participants  
Taken from the database detailed in Chapter 4, 932 healthy individuals were identified 
and stratified into young adults (18-40 years; 389 men, 144 women) and older adults 
(>40 years; 260 men, 139 women) (Table 1). The cut-off level of 40 years was chosen 
based on the increase in CVD incidence after this age (Roth et al., 2015) and is in line 
with previous research (Thijssen et al., 2009a). Secondly, based on pre-screening of 
menopausal status (post-menopause was defined as at least one year without a 
menstrual cycle/spotting (Moreau et al., 2012a)), sub-analysis was performed between 
pre-menopausal (n=173) and post-menopausal women (n=110). All participants were 
non-smokers, not taking any medication, and free of CVD risk factors and signs or 
symptoms of cardiovascular or metabolic disease. Pre-menopausal women were not on 
any hormone-based contraception and post-menopausal women were not on HRT. All 
participants gave informed consent and all studies were ethically approved by the local 
ethics committees of Liverpool John Moores School of Sport and Exercise Science 
Research Ethics Committee, Radboud University Medical Center or The University of 
Western Australia. All work adhered to the Declaration of Helsinki. 
 
5.2.2 Statistical Analysis 
Statistical analyses were performed using SPSS (Version 24, SPSS, Chicago, Illinois). 
Pearson’s correlation coefficient was used to calculate the correlation between FMD and 




allometrically scaled FMD to correct for baseline artery diameter (Atkinson & Batterham, 
2013a). Fisher r-to-z transformation was used to compare the difference between two 
correlation coefficients in the independent groups (i.e. sex, age, menopause status). 
Linear regression analysis was performed to examine the interaction between age-sex 
group and SRAUC with FMD as the dependent outcome. Other variables (e.g. age, sex, 
BMI, blood pressure) that have been purported to influence shear rate and/or FMD were 
also considered in the model. Two-way analysis of variance (ANOVA) was also used to 
examine the differences between sex and age. Independent t-tests examined the 
differences between pre- and post-menopausal women.  All data were presented as 
mean±SD, unless stated otherwise. Statistical significance was assumed at P<0.05. 
 
5.3 Results 
5.3.1 Impact of Age and Sex  
Older age was associated with lower FMD, and higher body mass, BMI, systolic, diastolic 
and mean blood pressure, alongside higher baseline and peak brachial artery diameters 
(all P<0.05). There was a significant main effect for sex, with women demonstrating a 
lower height, body mass, systolic, diastolic and mean blood pressure, baseline diameter, 
peak diameter, but a higher FMD response and SRAUC (P<0.05; Table 5.1). A significant 
interaction effect between age and sex was observed for height, body mass, BMI, 







Table 5.1: Subject characteristics of participants divided into young men and women (aged 18-40yrs) and older men and women (>40yrs). 
Values are mean ± SD. Comparisons between groups were made using a 2-way ANOVA with sex and age as factors. 




 Young Adults (18-40yrs) Older Adults (>40yrs) ANOVA 
 Women Men Women Men Sex Age Sex*Age 
n 144 389 139 260    
Age (years) 27±6 25±5 56±10 59±10 0.535 <0.001 <0.001 
Stature (m) 1.69±0.08 1.80±0.07 1.63±0.07 1.77±0.06 <0.001 <0.001 0.003 
Body mass (kg) 69.6±14.0 76.3±10.3 69.7±14.0 82.9±14.1 <0.001 <0.001 <0.001 
BMI (kg/m2) 24.6±5.2 23.6±2.8 25.5±4.5 26.1±4.8 0.130 <0.001 0.030 
Systolic blood pressure (mmHg) 113±10 120±11 124±15 127±14 <0.001 <0.001 0.010 
Diastolic blood pressure (mmHg) 68±8 72±14 74±9 77±9 <0.001 <0.001 0.907 
Mean arterial pressure (mmHg) 86±11 87±11 92±10 94±10 <0.001 <0.001 0.524 
Diameter (mm, baseline) 3.3±0.5 4.1±0.6 3.5±0.5 4.4±0.6 <0.001 <0.001 0.218 
Diameter (mm, peak) 3.6±0.5 4.3±0.6 3.7±0.5 4.6±0.6 <0.001 <0.001 0.103 
FMD% 7.9±3.9 6.4±2.7 5.3±3.3 4.8±2.3 <0.001 <0.001 0.021 
SRAUC (s-1, x103) 23.0±12.0 20.4±10.7 21.6±11.0 19.7±9.0 0.003 0.175 0.662 




A significant positive correlation between FMD response and SRAUC was evident in 
young men (r2=0.042, P<0.001; Figure 5.1A). Young women also demonstrated a 
significant correlation between FMD and SRAUC (young women r2=0.112, P<0.001), 
which did not significantly differ compared to young men (Fisher: P=0.15). The 
correlation between FMD and SRAUC was non-significant in older men (r2=0.011, 
P=0.098), whilst older women presented a very weak, but significant correlation 
(r2=0.029, P=0.047, Figure 5.1B). Using allometrically scaled FMD, the presence of a 
correlation in young women (r2=0.108, P<0.001), and a lower correlation in older women 
were confirmed (r2=0.029, P=0.045), although this difference did not reach statistical 
significance (Fisher: P=0.15). Young and older men did not demonstrate a significant 
correlation between the allometrically scaled FMD and SRAUC (r2<0.001 and P=0.662, 
r2<0.001 and P=0.779, respectively). 
 
The impact of age, sex and SRAUC on FMD was further investigated using interaction 
terms in linear regression. This approach revealed evidence of a differential relationship 
between sex and age status and SRAUC on subsequent FMD outcomes. More 
specifically, young women demonstrated a significantly stronger relationship between 
SRAUC and FMD compared to young men (β=-5.8-4, P=0.017) and older women (β=-
5.9-4, P=0.049). Age did not significantly alter the relation between SRAUC and FMD in 
men (β=-2.5-4, P=0.30). 
 
Other variables that might contribute to FMD response were also explored in the linear 
regression model. In addition to age-sex-SRAUC interactions, FMD is influenced by 
systolic blood pressure (β=-0.035, P=0.001), but not diastolic blood pressure (β=0.006, 
P=0.60) or BMI (β=0.033, P=0.26). Given the systolic blood pressure outcome, the 
bivariate correlations were repeated in a subset of n=505 who all fell within strict cut-off 




kg/m2) and, when available, glucose (<5.6 mmol/L) and cholesterol levels (<4.9 mmol/L). 
Young men show evidence of a correlation between FMD response and SRAUC 
(r2=0.020, P=0.024), but this response was significantly stronger in young women 
(r2=0.124, P<0.001, Fisher: P=0.05). Older men and women did not show a correlation 





Figure 5.1: Brachial artery FMD (%) and the eliciting SRAUC stimulus (in s-1) in healthy 
younger (A, total n=533) and older (B, total n=399) adults. Data were presented and 
analysed separately for younger men (open circles, n=389) and women (solid circles, 
n=144), but also for older men (open triangles, n=260) and women (solid triangles, 
n=139). Pearson’s correlation coefficient was used to examine the relation between the 





5.3.2 Impact of Menopausal Status 
Compared to pre-menopausal women, post-menopausal women demonstrated a higher 
BMI and blood pressure, but lower height and FMD (all P<0.05, Table 5.2). Pre-
menopausal women demonstrated a significant correlation between FMD and SRAUC 
(r2=0.097, P<0.001), whilst this correlation was not significant post-menopause (r2=0.025, 
P=0.100, Figure 5.2, Fisher: P=0.19). Using the allometrically scaled FMD, these findings 
were confirmed as the correlation with SRAUC in pre-menopausal women (r2=0.095, 
P<0.001), disappeared post-menopause (r2=0.025, P=0.099, Fisher: P=0.20). Re-
analysis of the correlation coefficients within the subgroup of healthy participants (n=505) 
confirmed the presence of a correlation between FMD and SRAUC in pre-menopausal 
women (r2=0.09, P=0.001), which was absent in post-menopausal women (r2=0.006, 
P=0.73, Fisher: P=0.30).  
 
Table 5.2: Subject characteristics of women divided based on hormonal status. Values 
are mean ± SD. P-value refers to an independent t-test. 
 Pre-menopause Post-menopause P value 
n 173 110  
Age (years) 30±8 59±9 <0.001 
Height (m) 1.68±0.08 1.62±0.07 <0.001 
Body mass (kg) 69.6±13.7 70.0±15.1 0.938 
BMI (kg/m2) 24.7±5.1 26.4±5.0 0.007 
Systolic blood pressure (mmHg) 113±10 126±14 <0.001 
Diastolic blood pressure (mmHg) 69±9 74±9 <0.001 
Mean arterial pressure (mmHg) 82±8 90±10 <0.001 
Baseline diameter (mm) 3.3±0.5 3.6±0.5 <0.001 
Peak diameter (mm) 3.6±0.5 3.8±0.6 0.018 
FMD% 7.8±3.9 4.9±3.1 <0.001 
SRAUC (s-1, x103) 23.0±11.6 21.3±11.4 0.213 
Time to peak (secs) 51±24 68±32 <0.001 






Figure 5.2: Brachial artery FMD (%) and the eliciting SRAUC stimulus (in s-1) in healthy 
pre-menopausal women (solid circles, n=173) and post-menopausal women (open 
circles, n=110). Pearson’s correlation coefficient was used to examine the relation 




The initial analyses were suggestive of sex differences in conduit artery FMD across the 
lifespan. However, given the impact of systolic blood pressure on FMD, analysis was 
repeated on a subset of participants following the American Heart Association guidelines 
for blood pressure (Whelton et al., 2018). This revealed a significantly stronger 
relationship between FMD and SRAUC in young women compared to young men, and 
this was attenuated with advancing age. The sex-related difference and the impact of 
menopausal status on the relationship between FMD and its eliciting shear stress 
stimulus suggests that oestrogen may play a role in mediating the higher FMD in pre-
menopausal women and, consequently, the reduced risk of CVD in comparison to young 





This study in a large population of 932 healthy adults confirms previous work on the 
association between FMD and shear rate, in that a statistically significant correlation is 
present between endothelial function and the magnitude of the shear stress stimulus. 
This correlation remained present after correcting the FMD for individual differences in 
baseline diameter and when performed in a subset of healthy individuals (n=505). Given 
that SRAUC is the eliciting stimulus of the FMD response (Pyke & Tschakovsky, 2007), 
one would expect to observe a moderate-strong correlation between the two variables. 
However, the data presented in the current study shows a somewhat weaker correlation, 
in general, compared to previous work, especially in men (Thijssen et al., 2009a). This 
finding could be attributed to a number of participant characteristics, which may lead to 
a weaker or even absent relation between FMD and SRAUC (e.g. age, CVD risk factors) 
(Mitchell et al., 2004; Thijssen et al., 2009a). Indeed, the sub-analysis performed within 
individuals with no risk factors revealed a slightly higher r-value. In addition, other factors 
that impact upon the FMD response must be acknowledged, such as the response of 
the vascular smooth muscle cells to dilator signals (endothelium-independent dilation 
was not assessed in these studies) and the structural properties of the artery (i.e., wall 
thickness, stiffness and diameter (Koller & Kaley, 1991; Lehoux et al., 2006; Thijssen et 
al., 2008a)). Also, numerous studies have shown that baseline diameter is a stronger 
predictor of the FMD response than SRAUC (Thijssen et al., 2009a; Mitchell et al., 2004; 
Silber et al., 2005; Pyke et al., 2004; Pyke & Tschakovsky, 2007) and the scaling of FMD 
responses to baseline diameter attempted to account for this.  
 
In line with some previous observations, sex-related differences in the relationship 
between FMD and the eliciting SRAUC stimulus were observed. More specifically, young 
healthy women demonstrated a stronger correlation between FMD and SRAUC, 
compared with their male peers, especially in the healthy subgroup. To examine the 




and found that the relationship between FMD and SRAUC was absent in post-
menopausal women. The potential cardio-protective properties of oestrogen have been 
described in Chapter 2 (Section 2.4). These adaptations likely contribute to changes in 
vascular health, especially since some studies have shown that the cyclical oestrogen 
levels across the menstrual cycle are mirrored by fluctuations in arterial stiffness 
(Adkisson et al., 2010; Robb et al., 2009) and endothelial function (Hashimoto et al., 
1995; Williams et al., 2001; Brandão et al., 2014; Adkisson et al., 2010). Some of this 
work used intra-brachial infusions to examine forearm blood flow responses, an 
endothelial assessment independent of shear rate, and confirmed that endothelial 
function per se fluctuates across the menstrual cycle (Williams et al., 2001). Studies that 
utilised FMD found that fluctuations in this variable across the menstrual cycle were 
independent of changes in the shear rate stimulus (Adkisson et al., 2010; Hashimoto et 
al., 1995; Williams et al., 2001; Brandão et al., 2014). This suggests that these larger 
FMD responses are explained, at least partly, by enhanced sensitivity of the endothelium 
to shear rate.   
 
Distinction between levels of oestrogen receptors may contribute to the relationship 
between FMD and the shear rate stimulus in pre-menopausal women. As detailed in 
Chapter 2 (Section 2.4.1.1), the abundance of oestrogen receptors is determined by 
circulating oestrogen (Gavin et al., 2009; Stirone et al., 2003; Pinna et al., 2008; 
Ihionkhan et al., 2002), which is consequently linked to increased NO bioavailability 
(Rubanyi et al., 1997; Pinna et al., 2008). Given the important role of NO in CVD 
protection and vasodilation, it could be suggested that oestrogen receptors mediate the 
relationship between FMD and shear stress, resulting in greater dilator responses to a 
given shear stress stimulus. More research is required to explore the mechanisms 




When exploring the effects of age, the FMD-SRAUC relationship was attenuated with 
advancing age in both men and women, which confirms previous findings (Thijssen et 
al., 2009a). Notably, a weak, but significant correlation in was observed in older women. 
However, this observation may be attributable to the inclusion of 29 (21%) pre-
menopausal women in the older (over 40 years) group. These findings therefore provide 
further evidence that older age impairs the FMD-SRAUC relationship. Various 
components of vascular ageing (outlined in Chapter 2, Section 2.3), including alterations 
in blood vessel structure, shear patterns and attenuated NO bioavailability may 
potentially contribute to the age-related attenuation in the FMD-SRAUC relationship. 
Since these processes are also present in women, one may question the relative 
importance of age versus oestrogen in the loss of the relationship between FMD and 
SRAUC in post-menopausal women. Given the more gradual impact of age on these 
factors compared with the relatively rapid alterations in oestrogen, one may hypothesise 
that the loss of oestrogen may represent a stronger factor than age in explaining the loss 
of the relationship between FMD and SRAUC. Future studies are required to untangle 
the effects of age and sex on this relationship. 
 
A potential lifestyle factor underlying the age- and sex-related differences in the FMD-
SRAUC relationship relates to fitness and/or physical activity levels. It is well established 
that physical activity and subsequent fitness is associated with enhanced endothelial 
function (Hagg et al., 2005; Siasos et al., 2013; Davison et al., 2010) amongst a myriad 
of other health markers, mediated by the activity-induced exposure to increases in 
cyclical shear stress (Thosar et al., 2012). Since studies highlight a trend for declining 
physical activity levels with advancing age (Milanovic et al., 2013; Townsend et al., 
2015b), age-related differences in physical activity may represent a confounding variable 
in the relationship between FMD and SRAUC. Future studies are warranted to better 




5.4.1 Clinical Relevance 
The clinical relevance of these findings relate to the importance of changes in shear 
stress as an important hemodynamic stimulus for acute (Tinken et al., 2009; Greyling et 
al., 2015a) and chronic (Tinken et al., 2010; Naylor et al., 2011a) adaptation in vascular 
function and structure (Green et al., 2017). High levels of shear stress have also been 
linked to the upregulation of anti-atherogenic proteins and down-regulation of pro-
atherogenic substances (Green et al., 2017; Newcomer et al., 2011; Fisslthaler et al., 
2000) to provide further protection against the development/progression of 
atherosclerosis. Accordingly, enhanced sensitivity of the endothelium to increases in 
shear stress (e.g. induced by physical activity) in younger women may contribute to 
relatively lower risk for CVD events in this cohort. In addition, such changes may also 
contribute to impaired ability for remodelling of arteries in response to prolonged periods 
of changes in shear stress in older women. Importantly, shear stress-mediated changes 
in endothelial function, for example by exercise training, lead to clinically important 
improvements in vascular health, with a 1% increase in brachial FMD being associated 
with 8-13% reduction in CVD risk (Ras et al., 2013; Inaba et al., 2010; Matsuzawa et al., 
2015). 
 
5.4.2 Strengths and Limitations  
Firstly, data on oestrogen levels were not available, which makes it difficult to directly 
link these observations to menstrual status and/or oestrogen. Furthermore, it must be 
acknowledged that the timing/duration of menopause may also play a role in mediating 
the FMD-SRAUC relationship. However, vigorous eligibility screening for the respective 
study established menopause status. Furthermore, markers of endothelial 
activation/damage were not available, which may have helped to better understand the 
age-related changes in endothelial function and/or the role of shear stress. Another 




some variation. Nonetheless, all labs strictly followed expert-consensus guidelines 
(Thijssen et al., 2011a) and utilised identical data collection and validated software 
analysis procedures which result in high reproducibility of FMD (Greyling et al., 2016a). 
 
5.5 Conclusion 
In conclusion, a stronger relationship between endothelial function and the eliciting shear 
rate stimulus was found in women, compared to men, with this sex difference being 
attenuated with advancing age in the healthy subgroup. These findings suggest that 
endogenous oestrogen may play a role in mediating the relationship between SRAUC 
and FMD. Therefore, the stronger relationship between endothelial function and shear 
stress (compared to men) may contribute to the cardio-protection of young women and 
subsequent lower prevalence of CVD.  
 
Despite the somewhat weak correlation observed in this study, shear stress remains an 
important physiological stimulus for vasodilation during the assessment of FMD. In 
addition, shear stress has been shown to mediate vascular structural and functional 
adaptations, specifically in response to exercise (Green et al., 2017). Previous efforts 
have been made to examine the impact of different shear rate patterns (i.e. different 
levels of antegrade and retrograde shear) with various exercise modalities. Nonetheless 
these interventions importantly caused changes in mean shear stress, making it difficult 
to assess the isolated effects of antegrade versus retrograde shear. Therefore, the next 
chapter will explore the impact of increasing antegrade and retrograde shear through 











Chapter 6  
 
 
The Effect of Fluctuations in 
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Increased mean shear stress represents a key stimulus for vascular adaptation (Green 
et al., 2017; Tinken et al., 2010; Birk et al., 2012) and in vivo evidence has shown that 
elevation in mean shear rate mediates acute (Tinken et al., 2009; Greyling et al., 2015b) 
and chronic (Naylor et al., 2011a) improvement in FMD. In addition to levels of mean 
shear stress, the pattern of shear stress is important, since increasing the antegrade 
shear component was associated with improved FMD, whilst increasing retrograde and 
oscillatory shear is associated with impaired FMD (Thijssen et al., 2009c; Schreuder et 
al., 2015).  
 
As outlined in Chapter 2 (Section 2.6.2), Sundby et al. (2016b) showed that exposure to 
intermittent negative pressure causes fluctuations in patterns of blood flow and shear rate, 
whilst this method also improved wound healing in patients with lower limb ischaemia 
and ulcers (Sundby et al., 2016a; Sundby et al., 2018b; Sundby et al., 2018a). These 
clinical effects suggest that fluctuations in blood flow and shear stress patterns may 
impact vascular health in humans. Nonetheless, since these studies did not control for 
potential increases in mean shear levels, it remains unclear whether these observations 
are linked to repetitive exposure to fluctuations in shear, or increases in mean shear 
stress levels. 
 
No previous study in animals or humans has directly examined whether fluctuations in 
blood flow and shear stress patterns, in the presence of unaltered mean blood flow and 
shear rate, impacts upon endothelial function. Therefore, the aim of this study was to 
assess the effect of 30-minute exposure to intermittent negative pressure, which 
mediates fluctuations in blood flow and shear rate patterns through the brachial artery, 




shear stress patterns would induce improvement in brachial artery FMD. Since 
fluctuations in mean shear stress are relevant to many activities of daily living, this study 
was planned to provide insight into the potential clinical relevance of fluctuations in shear 




Fifteen healthy males (age 27.3±5.0 years) were recruited for the study. All participants 
were non-smokers, not taking medication and/or supplements known to influence the 
cardiovascular system and free from cardiovascular/metabolic disease risk factors. 
Based on a pre-screening health questionnaire, participants were excluded if they had 
poor circulation (including diagnosis of peripheral vascular disease or Reynaud’s 
disease). Each participant provided written informed consent before taking part in the 
experimental procedure. The research study was ethically approved by the Liverpool 
John Moores School of Sport and Exercise Science Research Ethics Committee and 
adhered to the Declaration of Helsinki. 
 
6.2.2 Experimental Design 
Participants completed two conditions (control and intervention; control condition data 
not shown) on separate days. After 15 minutes of supine resting, bilateral brachial artery 
FMD was assessed, followed by a 10-minute rest period to allow blood flow and diameter 
to return to baseline levels. Subsequently, following a 1-minute recording of baseline 
diameter and blood flow velocity, subjects underwent a 30-minute intervention involving 
intermittent negative pressure (i.e. left arm), whilst the right arm served as a control arm. 






Prior to the laboratory visit, all participants were instructed to refrain from strenuous 
exercise for at least 24 hours, alcohol for 12 hours, avoid all caffeinated products for 8 
hours and food products high in polyphenols for 24 hours.  Participants reported to the 
quiet, temperature-controlled laboratory after fasting for at least 6 hours. Stature and 
body mass were recorded to the nearest 0.1 unit using a stadiometer and digital scales, 
respectively. BMI was calculated as body mass in kilograms divided by stature in metres 
squared (kg/m2).  
 
6.2.4 Brachial Artery FMD 
Brachial artery FMD was measured in accordance with contemporary expert-consensus 
guidelines ((Thijssen et al., 2011a); see Chapter 3). Following 15 minutes of supine rest, 
left and right brachial artery FMD were assessed simultaneously via high-resolution 
duplex ultrasound (Terason u-smart 3300, Teratech, Burlington, MA) with a 10-12 MHz 
linear array probe. All measurements were taken by the same experienced operators 
within participants. Bilateral FMD was repeated following the 30-minute intervention 
period. 
 
6.2.5 Brachial Artery Diameter and Shear Rate  
High-resolution ultrasound was used to examine brachial artery diameter and shear rate 
as described above. Following the pre-intervention FMD, the participant’s skin was 
marked to ensure a consistent ultrasound probe position and therefore artery segment 
during the visit. Furthermore, the ultrasound machine settings remained constant (i.e. 
depth and Doppler cursor position) in order to assume the same probe angle whilst 
imaging.  Bilateral artery diameter and shear rate were recorded for 1-minute baseline, 




6.2.6 Intervention  
During the laboratory visit, participants rested in the supine position with both arms 
extended away from their body to approximately 80°, with their palms facing upwards for 
optimal ultrasound imaging of the brachial artery. During the 10-minute rest period 
following the pre-intervention FMD, the left arm was placed inside a rigid plastic cylinder 
(8.5x40cm) connected to a pressure control box (FlowOxTM, Otivio AS, Oslo, Norway; 
Figure 6.1). The cylinder was sealed around the forearm with a thermoplastic elastomer 
(TPS-SEBS). The arm was exposed to repeated bouts of negative pressure (-40 mmHg; 
10 seconds negative pressure, 7 seconds atmospheric pressure) for 30 minutes (~105 
full cycles of negative pressure). 
Figure 6.1: Photo of the experimental set-up.  
 
6.2.6.1 Blood Pressure  
Blood pressure and heart rate were recorded continuously during the protocol from the 
right (control) arm index/middle finger using a Portapres (Finapres Medical Systems BV, 
Amsterdam, The Netherlands). This data were displayed, recorded and exported using 
PowerLab software (ADInstruments, Australia). The difference in blood pressure and 
heart rate was calculated from a 1-minute recording before the intervention period started, 




6.2.7 Data Analysis  
All FMD data analysis was performed blinded by the same observer using BloodFlow 
Analysis software, and in line with protocol guidelines (see Chapter 3). Brachial artery 
diameter and shear rate (during the intervention) were analysed using the same software. 
The region of interest location (selected by the operator) remained consistent for each 
1-minute recording within participants. Using markers placed by the operator, the 
software calculated the average artery diameter and shear rate across the minute 
recordings. The fluctuations in shear stress were analysed as an average during the 
application of negative pressure (10secs; On), atmospheric pressure (7secs; Off), and 
the full cycle, then repeated for the 3 full cycles captured during each 1-minute recording. 
These processes were repeated for each time point during the intervention (i.e. every 5 
minutes). Mean (± standard error) shear rate data at baseline and during 3 cycles of 
intermittent negative pressure are presented in Figure 6.2. 
 
6.2.8 Statistical Analysis  
Statistical analysis was conducted using IBM SPSS version 25 (SPSS Inc., Chicago, IL). 
Allometric scaling was performed on FMD data to control for differences in baseline 
diameter (Atkinson & Batterham, 2013a; Atkinson et al., 2013). A linear mixed model 
with covariate control for SRAUC and scaled baseline diameter determined the main 
effect for time (pre-post) and arm. A general linear model assessed the changes in blood 
pressure and heart rate across the intervention period. Paired T-tests determined the 
difference in antegrade and retrograde shear during intermittent negative pressure 
compared to baseline in both arms. Statistical significance was recognised when a P 







Subject characteristics are presented in Table 1.  
Figure 6.2: Shear rate data in the intervention arm (A) and control arm (B), calculated 
as 1-s averages at rest, followed by 3 cycles of intermittent negative pressure (grey bars: 
negative pressure). Values are mean ± standard error. Mean shear rate is presented as 















6.3.1 Brachial Artery Blood Flow and Shear Rate  
There were no significant changes across the 30-minute intervention in heart rate (mean 
52bpm ± SD 7 bpm versus 54±8 bpm, P=0.47) or in systolic (129±9 mmHg versus 
135±12 mmHg, P=0.16), diastolic (55±8 mmHg versus 59±9 mmHg, P=0.36) or mean 
arterial blood pressure (80±8 mmHg versus 84±9 mmHg, P=0.23). Negative pressure 
was associated with a significant increase in mean shear rate, whilst pressure release 
was followed by a significant decrease in mean shear rate, to levels below baseline 
(“pressure on”: ∆+34.2s-1, “pressure off”: ∆-26.5s-1; both P<0.001; Figure 6.3A). 
Consequently, mean shear rate across the intervention period was not different from 
baseline (“pressure on/off cycle”: ∆+3.8s-1; P=0.458). In the control arm, negative 
pressure did not change mean shear from baseline levels (“pressure on”: ∆+1.6 P=0.805, 
“pressure off”: ∆+3.5s-1 P=0.613). Therefore, mean shear rate remained unchanged 
throughout the intervention period compared to baseline (“pressure on/off cycle”: ∆+2.5s-
1 P=0.702; Figure 6.3B).  
Parameter Mean±SD 
Age (years) 27.3±5.0 
Stature (m) 1.75±0.06 
Body mass (kg) 75.1±7.5 
Body mass index (kg/m2) 24.4±2.0 
Systolic blood pressure (mmHg) 115±3 
Diastolic blood pressure (mmHg) 62±7 
Mean arterial pressure (mmHg) 80±5 




Figure 6.3: Average levels of antegrade (white bars), retrograde (black bars) and mean 
(grey bars) shear rate at baseline and during the intermittent negative pressure 
intervention in the intervention arm (A) and control arm (B). Data during the intermittent 
negative pressure were presented during negative pressure (‘on’), during pressure 
release (‘off’) and as the average across the entire 30-minute intervention (‘mean’). Error 
bars represent standard error. Paired T-tests determined differences in shear rate 
compared to baseline. *Significantly different from baseline at P<0.05. 
 
When examining shear patterns, negative pressure increased antegrade shear rate 
(P<0.001) and decreased retrograde shear rate (P=0.006; Figure 6.3A). Upon pressure 
release, compared to baseline levels, a decrease in antegrade shear rate and increase 
in retrograde shear rate was found (P=0.003 and P<0.001, respectively). As a result, 




not different from baseline (P=0.504 and 0.777, respectively). Antegrade and retrograde 
shear rate remained unaltered from baseline in the control arm during “pressure on” 
(antegrade: ∆+2.5s-1, P=0.730; retrograde: ∆-1.9s-1, P=0.190) and “pressure off” 
(antegrade: ∆+1.9s-1, P=0.779; retrograde: ∆-2.0s-1, P=0.164; Figure 6.3B). Therefore, 
mean antegrade and retrograde shear rate was not different from baseline across the 
intervention (antegrade: ∆+2.2s-1, P=0.750; retrograde: ∆-1.9s-1, P=0.173). 
 
6.3.2 Brachial Artery FMD  
Linear mixed model analysis revealed a significant main effect for time (P=0.029; F-
ratio=5.146), whilst no effect was observed for arm (P=0.619; F-ratio=0.251) or 
interaction effect (P=0.096; F-ratio=2.906). Post-hoc exploratory analysis (LSD) revealed 
a significant increase in FMD in the intervention arm (∆+2.0%, P=0.008), whilst no 
change was observed in the control arm (∆+0.5%, P=0.664). Individual FMD responses 
are presented in Figure 6.4 and all associated parameters (mean and 95% confidence 







Figure 6.4: Individual brachial artery FMD responses to 30-minutes intermittent negative 
pressure in the intervention and control arms of healthy young individuals (n=15). Black 
dotted line represents mean change in FMD. Error bars represent standard error. A linear 
mixed model determined the main effect for time and arm. 
 
 











Table 6.2: Brachial artery FMD for the intervention and control arms before and after 30-minute exposure to unilateral intermittent negative 
pressure. P-values refer to a linear mixed model to examine the main effect of ‘time’ (pre- versus post-intervention), ‘arm’ (intervention-arm versus 








FMD – flow-mediated dilation; SRAUC – shear rate area-under-the-curve. 
 
 Intervention arm Control arm    
 Pre Post Pre Post ‘time’ ‘arm’ ‘time*arm’ 








0.671 0.002 0.957 








0.797 0.001 0.603 








0.029 0.619 0.096 








0.762 0.428 0.572 













This study showed that application of intermittent negative pressure to the forearm 
increases antegrade blood flow and shear rate, whilst pressure release mediates 
increased retrograde blood flow and shear rate measured at the brachial artery, relative 
to baseline and the contralateral control arm. Despite these marked fluctuations in blood 
flow and shear rate patterns throughout the 30-minute intervention, mean blood flow and 
shear rate was not different from baseline. Therefore average resting levels of flow and 
shear rate were successfully preserved, despite inducing fluctuations of these variables. 
Although exploratory in nature, brachial artery FMD improved as a result of these 
fluctuations in blood flow and shear rate, an effect that was not apparent in the 
contralateral control limb. Taken together, these findings suggest that fluctuations in 
shear rate, independent of mean blood flow and shear rate, may impact acute vascular 
function in healthy young individuals. Whilst further research is required, this contributes 
to improving understanding of shear stress as an important hemodynamic stimulus in the 
adaptation of vascular health in humans in vivo.  
 
These findings regarding the impact of cyclical negative pressure are in line with a 
previous study in the lower limbs (Sundby et al., 2016b). Importantly, the current study 
adds the novel knowledge that these fluctuations were associated with improvements in 
endothelial function, as measured with the brachial artery FMD. Blood pressure and 
heart rate remained unaltered during the intervention period, effectively excluding the 
possibility that systemic factors contributed to these observations. To further support this 
notion, no changes in brachial artery blood flow or shear rate were found in the 
contralateral arm. This strongly suggests that the mechanisms contributing to the 
increase in FMD in the intervention arm relate to local effects (i.e. fluctuations in shear 




These novel results may be somewhat surprising, in that the fluctuations in shear rate 
were not accompanied by changes in mean shear rate, but still caused an increase in 
FMD. In previous work, supported by studies in animals (Pohl et al., 1986; Woodman et 
al., 2005), it has been consistently reported that changes in mean shear rate are 
essential to change FMD (Thijssen et al., 2009c; Tinken et al., 2009). More specifically, 
selective increases in antegrade shear rate (and therefore mean shear rate) were related 
to improved FMD (Tinken et al., 2009; Greyling et al., 2015b), whilst an isolated increase 
in retrograde shear rate (i.e. lower mean shear rate) was associated with a dose-
dependent decrease in brachial and femoral artery FMD (Thijssen et al., 2009c; 
Schreuder et al., 2015). One potential explanation for the increase in FMD is the relative 
larger importance of increases in antegrade shear rate compared to changes in 
retrograde shear rate. To support this idea, moderate-intensity cycling exercise acutely 
increases retrograde shear rate (Green et al., 2002; Thijssen et al., 2009b), followed by 
normalisation after ~15 minutes with a concomitant increase in antegrade shear rate 
(Simmons et al., 2011). Nonetheless, acute or chronic performance of cycling exercise 
(i.e. 30-/40-min bouts) leads to improvement in brachial artery FMD (Green et al., 2017; 
Birk et al., 2012). This evolving hypothesis that changes in antegrade shear rate may be 
relatively more important than changes in retrograde shear rate has been discussed 
further in Section 7.3.2.2 and warrants further investigation 
 
Another explanation for these findings relates to the importance of fluctuations in shear 
rate patterns, rather than mean shear rate. In the microcirculation, previous work used 
mathematical simulation to support the concept that fluctuations of capillary blood flow, 
rather than steady-state conditions, improve oxygenation of tissue (Tsai & Intaglietta, 
1993a). Follow-up work in humans examining skin perfusion and oxygenation 
demonstrated that periodic fluctuations in vasomotion may be beneficial for local 




enhanced external counterpulsation increased shear rate fluctuations and FMD in the 
brachial artery (Braith et al., 2010; Gurovich & Braith, 2013). However, these changes 
were also accompanied by an overall increase in mean shear rate, making it impossible 
to isolate the impact of fluctuations per se (i.e. in the absence of changes in mean shear). 
Finally, indirect support for a potential clinically-relevant, beneficial effect on vascular 
health for these fluctuations is provided by the observation of improved wound healing 
upon repeated exposure to intermittent negative pressure (Sundby et al., 2016a; Sundby 
et al., 2018b). These observations may contribute to improved microcirculatory blood 
flow and therefore the delivery of oxygen and nutrients to promote wound healing 
(Sundby et al., 2018a; Sundby et al., 2016a). Although speculative, findings of the current 
study suggest that these benefits of intermittent negative pressure stimulus on wound 
healing (Sundby et al., 2016a; Sundby et al., 2018b) may be related to enhanced 
endothelial function.  
 
A final possible explanation for these findings relates to the impact of intermittent 
negative pressure on changes in the pressure gradient across the artery wall (Smyth, 
1969) and, therefore, transmural pressure (Pfitzner, 1976). Although changes in 
transmural pressure may affect vascular health (Green et al., 2017; Atkinson et al., 
2015b), it seems unlikely this can explain the present findings. First, negative pressure 
likely increases transmural pressure (due to the drop in external pressure), which is 
typically associated with impaired vascular health (Atkinson et al., 2015b). Secondly, 
vascular function was examined in the brachial artery, i.e. not directly exposed to the 
changes in transmural pressure, no significant systemic effects on blood pressure of 





6.4.1 Clinical Relevance  
The clinical relevance of  these findings is that fluctuations in blood flow or shear rate per 
se represent a hemodynamic stimulus capable of improving vascular health. Previous 
studies manipulating shear rate have increased mean shear rate to improve FMD. In 
contrast to these stimuli, mean shear rate was not changed, but still found improved FMD, 
most likely due to the fluctuations in shear and blood flow patterns. Furthermore, these 
fluctuations in blood flow and shear rate may be more ecologically valid compared to 
sustained increases in shear rate. More specifically, fluctuations in blood flow and shear 
rate are more related to activities of daily living, such as those associated with low-
intensity physical activity and changes in posture. Therefore, repetitive exposure to these 
stimuli may be efficient in improving vascular health. Indeed, recent work has 
demonstrated that regular exposure to mild physical activity stimuli, such as walking 
breaks (Carter et al., 2018; Thosar et al., 2015) or fidgeting (Morishima et al., 2016), 
prevents decline in cerebro- and cardiovascular health associated with prolonged sitting. 
Although speculative, activity-induced fluctuations in blood flow may be the underlying 
mediator contributing to the preserved vascular health. 
 
6.4.2 Strengths and Limitations  
The present study possesses several strengths, including strict adherence to 
contemporary expert-consensus guidelines for FMD (Thijssen et al., 2011a) and blinded 
data analysis using custom-designed edge-detection software to eliminate operator bias. 
There are some limitations to the study. Firstly, healthy recreationally active males were 
recruited, which makes it difficult to extrapolate these findings to other populations (e.g. 
females (Hashimoto et al., 1995; Williams et al., 2001; Brandão et al., 2014) or clinical 
groups). However, larger improvements in FMD may be observed in those with a priori 
endothelial dysfunction (Maiorana et al., 2003). A second limitation is that additional 




performed. In vitro studies in cultured endothelial cells and isolated arteries, reviewed 
elsewhere (Green et al., 2017), demonstrate the release of pro- and anti-atherogenic 
substances in response to exposure to oscillatory (or low) and laminar (or high) shear 
stress, respectively. Insight into the impact of fluctuations in shear stress (with preserved 
mean shear) would have contributed to further understanding the underlying 
mechanisms of the present findings. A final limitation relates to the relatively small 
sample size of this study. More specifically, 15 participants were selected based on 
previous studies in which the impact of shear stress manipulation was assessed and 
demonstrated significant changes in conduit artery diameter and FMD (Thijssen et al., 
2009c; Tinken et al., 2009; Tinken et al., 2010; Birk et al., 2012; Carter et al., 2013; 
Atkinson et al., 2015a; Atkinson et al., 2015b; Naylor et al., 2011a). Nonetheless, post-
hoc statistical power analysis using G*Power software (Faul et al., 2007) revealed a 
power of 0.77 to detect within-subject changes in FMD, but a power of 0.27 to find a 
significant interaction effect. Therefore, since more participants would be required for 
greater statistical power, these results should be interpreted with caution, and further 
work is required to better understand the potency of fluctuations in shear rate patterns 
on vascular function.  
 
6.5 Conclusion 
In conclusion, findings of the current study suggest that 30-minutes exposure to 
fluctuations in shear rate improves endothelial function, despite the absence of 
concomitant changes in mean shear rate compared to resting baseline levels. This work 
implies that fluctuations in blood flow or shear rate may represent a hemodynamic 
stimulus to potentially improve vascular health. Future research to examine the 















Chapter 7  
 
 





7.1 Aims and Objectives 
The research presented in this thesis aimed to examine age- and sex-specific differences 
in brachial artery FMD across the lifespan in healthy individuals. Importantly, through 
collating data obtained with strict adherence to expert-consensus guidelines, work in this 
thesis was able to, for the first time, estimate reference values for brachial artery FMD. 
Since shear stress is a key stimulus for vasodilation, this work also focussed on the role 
of shear stress in vascular function. More specifically, this thesis examined age- and sex-
specific differences in the relation between FMD and SRAUC, in addition to the relevance 
of shear patterns (i.e. fluctuations in shear rate) for vascular function.  
 
7.2 Major Findings 
7.2.1 Sex Differences in Brachial Artery FMD Across the Lifespan  
The age- and sex-specific brachial artery FMD reference intervals presented in Chapter 
4 revealed sex differences in the age-related decline in FMD in healthy individuals. Firstly, 
females demonstrated a consistently larger FMD but declined at a faster rate compared 
to males, and the pattern of change across the lifespan also differed between sexes. 
More specifically, females demonstrated a linear relation between FMD and age, 
compared to a curvilinear relation in males. Chapter 4 also demonstrated sex differences 
in age-related increases in baseline brachial artery diameter. These findings suggest that 
the sex-specific age-related decline in FMD is likely to be partially explained by age-
related increases in baseline artery diameter. Notably, since the healthy population were 
selected following strict inclusion criteria for CVD risk factors (including BMI, blood 
pressure and blood metabolites), the decline in FMD occurs as a result of healthy human 
ageing. Furthermore, whilst previous work has highlighted the detrimental effect of CVD 
risk factors on FMD, including hypertension (Ghiadoni et al., 2001) and diabetes 
(Hamilton & Watts, 2013), it remains unclear how CVD risk factors influence FMD in 




7.2.2 The Relation Between CVD Risk Factors and FMD and the Impact of Sex 
Chapter 4 demonstrated that diabetes and systolic blood pressure were significant 
determinants negatively associated with FMD (i.e. lower FMD compared to healthy 
individuals of the same age and sex) in both un-medicated males and females. In 
medicated individuals, diabetes and dyslipidaemia were negatively associated with FMD 
in males and females, whilst the relation between systolic blood pressure and FMD 
disappeared (i.e. not different from healthy). This implies that the use of medication 
targeting these risk factors effectively normalises FMD and therefore improves CVD risk.  
 
When examining sex differences in the relation between risk factors and medications 
with FMD, Chapter 4 revealed that systolic- and diastolic blood pressure were stronger 
determinants of FMD in un-medicated females compared to males. However, in 
medicated individuals, there were sex differences in the relation between BMI and 
dyslipidaemia with FMD. More specifically, FMD appeared to be supra-normalised in 
medicated males with dyslipidaemia (i.e. greater than the healthy population mean), 
whilst a significant negative relation remained in females. With the novel knowledge of 
age-, sex- and CVD risk factor-specific differences in FMD, other physiological 
determinants of FMD outcome must be considered. Specifically, potential age- and sex-
specific differences in the eliciting shear stress stimulus.  
 
 
7.2.3 Age and Sex Differences in the Relation Between FMD and SRAUC 
Data presented in Chapter 5 (published in Journal of the American Heart Association;  
doi: 10.1161/JAHA.118.010994) provided evidence for a stronger relation between FMD 
and the eliciting shear stress stimulus (i.e. SRAUC) in healthy young women compared 




female-specific analysis revealed no statistical differences in the relation between FMD 
and SRAUC in pre- versus post-menopausal women. These findings suggest that 
women may be more sensitive to increases in shear stress as a stimulus for vasodilation 
compared to men, but this sensitivity declines with age. Despite the weak relation 
between FMD and SRAUC, shear stress remains an important stimulus during FMD, and 
may also be relevant to change/improve FMD.  
 
7.2.4 Shear Stress as a Stimulus to Improve FMD 
The acute experimental study detailed in Chapter 6 (published in Journal of Applied 
Physiology; doi: 10.1152/japplphysiol.00009.2019) demonstrated that FMD can be 
improved through fluctuations in shear rate (induced by intermittent negative pressure 
with significant increases in both antegrade and retrograde shear rate) in healthy young 
men. Importantly, this localised improvement in FMD was observed in the absence of 
changes in mean shear rate compared to resting baseline levels. This novel data 
highlights the importance of shear stress as a hemodynamic stimulus for vascular health 
and function.  
 
 
7.3 General Discussion  
7.3.1 Sex Differences in Vascular Health and Function 
7.3.1.1 The Effect of Sex Hormones on FMD 
Key physiological differences between males and females relate to the presence and 
impact of sex hormones, including oestrogen, progesterone and testosterone. The 
actions of endogenous oestrogen provides protection against CVD and promotes 
vascular health in women (see Section 2.4.1.1), emphasised by the exponential increase 




in women has demonstrated a menopause-related decline in FMD (Celermajer et al., 
1994b; Taddei et al., 1996; Gavin et al., 2009; Moreau et al., 2012a; Moreau & Hildreth, 
2014). In contrast to these findings, the reference values data (Chapter 4) did not 
explicitly demonstrate a drop in FMD around menopause, however there was a large 
overlap of age between pre- and post-menopausal women. When women were grouped 
by menopausal status, there was no difference in the correlation between FMD and age 
(Fisher P=0.197; Figure 7.1), whilst FMD differed between groups (pre-menopause 
7.7±3.5%, post-menopause 5.9±2.8%; P<0.001, Table 7.1). Since menopause generally 
occurs between ages 40-60 years, additional analysis within this age range showed no 
difference in FMD between pre- and post-menopausal women (6.5±2.8% and 6.1±2.6%, 











Figure 7.1: Correlation between FMD and age in healthy female adults, organised by 
hormonal status (pre-menopause [n=303; closed diamonds] and post-menopause [n=92; 
open diamonds]). 
 
Potential explanations for these discrepancies in comparison with previous literature may 
relate to the presence of CVD risk factors. More specifically, compared to the female 
participants included in the reference values dataset, some of the post-menopausal 
participants assessed by others demonstrate higher BMI (Moreau et al., 2012a; Gavin et 
al., 2009), waist circumference, and cholesterol (Moreau et al., 2012a). Other CVD risk 
factors potentially affecting these findings relates to physical activity and fitness. 
However, these data were not included in the database, and there is inconsistent 
evidence surrounding the vascular effects of physical activity in old women (Seals et al., 
2019; Gliemann & Hellsten, 2019). Taken together, it is plausible to suggest that the 
menopause-related drop in FMD observed by others (Celermajer et al., 1994b; Taddei 




effect of oestrogen and CVD risk factors associated with the menopause rather than the 
loss of oestrogen alone.  
 
Another important factor to consider is ageing, since menopause occurs at a different 
age between individuals. Given that FMD declines with age (Chapter 4), the age-related 
differences may also explain the decline in FMD observed across the menopause 
transition. Hence, one may question the relative contribution of ageing versus 
menopause in the decline in vascular function in women. In order to control for age-
related differences in FMD and (attempt to) isolate the effect of the loss of oestrogen, 
additional sub-analysis (T-Test) was completed to compare FMD in 11 pairs of age-
matched pre- and post-menopausal women, who were also closely matched for BMI and 
blood pressure to control for CVD risk factors (Table 7.1). A potentially clinically 
meaningful difference in FMD was observed (pre-menopause 6.97±3.22% versus post-
menopause 4.95±1.82%; P=0.096, Table 7.1). However, given the small sample size, 
this data must be interpreted with caution. Also, the time spent post-menopause is 
unknown, which has been shown to negatively affect FMD (Vitale et al., 2008), and the 
youngest post-menopausal woman was 42 years, immediately presenting greater CVD 
risk compared to post-menopausal women >45 years (Gong et al., 2016; Muka et al., 
2016). Furthermore, a recent study by (Brislane et al., 2019) found no difference in 
brachial artery FMD between healthy, active late pre-menopausal (~46years) and early 
post-menopausal (~50years; <5years post-menopause) women. Therefore, the true 
effect of the menopause on vascular function is likely multi-factorial, but further 
investigation is warranted to untangle the isolated effects of age versus hormonal status 





Similar to the menopause, puberty occurs at a different age between individuals. 
Importantly, the large dataset in Chapter 4 reported brachial artery FMD across the 
lifespan (4-84 years), whereas previous work has explicitly focussed on 
children/adolescents (Hopkins et al., 2015) or adults (Juonala et al., 2008). Separate FP 
regression analyses in adults revealed a negative linear relation between FMD and age 
in both sexes (Figure 7.2). However, when children were included, this relation became 
curvilinear in males, but remained linear in females (Chapter 4, Figure 4.1). Specifically, 
FMD in males dropped sharply during childhood and adolescence, followed by a gradual 
decline across adulthood. The large variation in FMD observed in children may be related 
to differences in growth and/or maturation, supported by sex-specific differences in artery 
diameter during childhood (Chapter 4, Figure 4.1), where male children exhibited a 
steeper rate of change in artery diameter compared to females. This may be explained 
by sex hormones; i.e. testosterone promotes muscle and bodily growth (Rogol, 2002), 
which in turn may influence vascular structure. As outlined in Section 2.4.2, specific 
underlying mechanisms of puberty and endothelial function remain unclear, and may be 
related to changes in CVD risk factors such as body composition and blood pressure 
(Moran et al., 2008). Hopkins et al. (2015) reported significant associations between 
artery diameter and body size in children, implying that artery size may be mediated by 
growth/maturation. However, since sex hormone data in addition to Tanner stage was 
not collected in these studies, it remains unclear how increases in sex hormones versus 
growth, in addition to a reduction in sex hormones (i.e. menopause), directly impacts 





















BMI – body mass index; BP – blood pressure; MAP – mean arterial pressure; LDL – low density lipoprotein; HDL – high density lipoprotein; FMD – flow-mediated 
dilation.
 All women Age 40-60 years Age-matched 
Pre Post P value Pre Post P value Pre Post P value 
n 303 92  43 71  11 11  
Age (years) 30±7 57±8 <0.001 43±3 53±4 <0.001 46±4 46±4 1.000 
BMI (kg/m2) 21.7±2.1 22.1±1.8 0.123 22.5±1.5 22.1±1.8 0.224 22.1±1.4 22.8±1.5 0.265 
Systolic BP (mmHg) 112±10 123±11 <0.001 120±10 123±10 0.169 118±8 119±11 0.851 
Diastolic BP (mmHg) 69±9 75±8 <0.001 76±9 76±8 0.868 74±7 74±10 0.818 
MAP (mmHg) 83±9 91±8 <0.001 91±9 92±8 0.663 89±8 89±10 0.925 
Total cholesterol (mmol/L) 4.3±0.4 4.4±0.4 0.233 4.3±0.4 4.4±0.4 0.625 4.1±0.5 4.3±0.4 0.415 
LDL cholesterol (mmol/L) 2.3±0.4 2.4±0.4 0.252 2.2±0.5 2.4±0.4 0.215 1.9±0.6 2.3±0.4 0.280 
HDL cholesterol (mmol/L) 1.7±0.3 1.7±0.2 0.832 1.8±0.4 1.7±0.2 0.298 1.7±0.3 1.7±0.3 0.857 
Total-HDL ratio (unit) 2.6±0.4 2.7±0.4 0.355 2.5±0.4 2.7±0.4 0.229 2.5±0.5 2.6±0.6 0.761 
Triglycerides (mmol/L) 0.8±0.3 0.8±0.3 0.687 0.7±0.3 0.8±0.3 0.670 0.8±0.4 0.7±0.3 0.744 
Plasma glucose (mmol/L) 4.6±0.5 4.7±0.6 0.469 4.6±0.4 4.7±0.6 0.693 4.6±0.5 4.5±0.3 0.716 
Baseline diameter (mm) 3.35±0.58 3.69±0.65 <0.001 3.44±0.54 3.64±0.65 0.092 3.36±0.53 3.68±0.58 0.205 
Peak diameter (mm) 3.60±0.59 3.90±0.67 <0.001 3.66±0.57 3.86±0.67 0.109 3.60±0.57 3.86±0.59 0.317 




Figure 7.2: Age-specific percentiles of brachial artery FMD in adult females (A; n=395) 
and males (B; n=598). 
 
7.3.1.2 Sex Differences in Artery Size 
Another important sex difference relates to artery size, which may explain some part of 
the differences in FMD. Chapter 4 demonstrated a larger baseline brachial artery 
diameter in males compared to females, supported by Adams et al. (1996), which also 




related changes in arterial stiffness and vascular tone (Bossuyt et al., 2015; Engelen et 
al., 2015). A curvilinear relation between artery diameter and age was observed in both 
sexes, however the rate of change during childhood and adolescence was greater in 
males compared to females. As discussed above, this may represent different 
growth/maturation rates between boys and girls. Interestingly, the pattern of change in 
baseline artery diameter mirrored the curvilinear relation between FMD and age in males, 
but not in females. Additional correlational analyses revealed a weak relationship with 
no sex differences between observed FMD and baseline artery diameter (Chapter 4, 
Figure 4.2). However, a very strong relation was observed between estimated FMD and 
baseline artery diameter (calculated from the equations derived in Chapter 4) in males, 
whilst females demonstrated a weaker relation (Figure 7.3). This data suggests that the 
age-related increases in baseline artery diameter may play a larger role in the age-
related decline in FMD in males compared to females.  
 
The age-related changes in baseline brachial artery diameter may be associated with 
structural changes within the artery wall, i.e. IMT (Nishiyama et al., 2008), stimulating 
outward remodelling to preserve lumen diameter. It was proposed by Folkow et al. (1958) 
that vascular responsiveness was determined by the wall-to-lumen ratio (i.e. the relative 
artery wall thickness for a given lumen diameter). This concept suggested that smaller 
arteries (with a greater wall-to-lumen ratio) were “hyper-responsive” to vasoactive stimuli. 
Accordingly, in support of this hypothesis, a significant correlation was observed between 
wall-to-lumen ratio and both FMD and GTN responses (Thijssen et al., 2011d). 
Nonetheless, since wall-to-lumen ratio is generally not measured/reported in FMD 
literature and was not considered in the reference values dataset, this concept to support 




Figure 7.3: Correlation between estimated FMD and baseline artery diameter in females 
(A; n=579) and males (B; n=796). 
 
Despite the relevance of baseline artery diameter in FMD, previous work has suggested 
that peak artery diameter may represent a better marker of conduit artery structure 
compared to baseline diameter (Naylor et al., 2005b). The authors proposed that it may 
be more physiologically relevant to assess maximal dilation, since resting (baseline) 
diameter is influenced by competing vasodilators and constrictors. Interestingly though, 
when FP analyses were conducted for peak artery diameter (Figure 7.4), the pattern of 
change was similar to the age-related increase in baseline artery diameter (Figure 4.1). 
Unsurprisingly, sex-specific differences were evident in peak artery diameter (i.e., larger 
in males compared to females, and differences in the pattern or change). Although it is 
likely that the data presented in Figure 7.4 does not represent maximal dilation 
(compared to GTN and/or ischaemic exercise (Naylor et al., 2005b)), the similarities in 
the age-related changes in baseline and peak artery diameter highlight the importance 









Figure 7.4: Age-specific percentiles of peak artery diameter in healthy males (A, n=790) 









7.3.1.3 Eliciting Shear Stress Stimulus 
The total shear stress stimulus (i.e. SRAUC) following cuff release determines the 
magnitude of vasodilation during the FMD test (Pyke & Tschakovsky, 2007). Chapter 5 
suggested that the sensitivity of the endothelium to shear stress is greater in women 
compared to men, and declines with age in both sexes. Interestingly, a main effect for 
sex was observed, where women showed higher SRAUC compared to men. Whilst this 
may be unsurprising given the smaller artery diameter in women and inclusion of 
diameter in the calculation of shear rate, no main effect was observed for age (Table 
5.1). Moreover, despite significant differences in baseline diameter and FMD, there was 
no difference in SRAUC between pre- and post-menopausal women (Table 5.2). 
Therefore, our data shows that pre-menopausal women demonstrated a larger 
vasodilation response to a given shear stress stimulus, supporting previous work in 
animals (Huang et al., 1998). Underlying mechanisms have been discussed in Chapter 
2 (Section 2.4.1.1), nonetheless these findings support the concept of oestrogen 
improving the sensitivity of the endothelium to shear stress.  
 
These findings may translate to beneficial vascular adaptations to exercise training. More 
specifically, functional and structural adaptation induced by repetitive exercise-induced 
increases in shear stress (Tinken et al., 2010; Green et al., 2017). Nonetheless, whilst 
the current literature reports favourable vascular effects of regular exercise in ageing 
men (Seals et al., 2019; Pierce et al., 2011; Tanaka et al., 2000; DeSouza et al., 2000), 
consensus has not been reached in women (Seals et al., 2019; Witkowski & Serviente, 
2018). Some studies have reported no change in FMD in healthy post-menopausal 
women following an aerobic exercise training intervention (Pierce et al., 2011; Swift et 
al., 2014; Moreau et al., 2013; Nyberg et al., 2014), whilst others have reported improved 
FMD only in women with increased CVD risk (Swift et al., 2012). Furthermore, FMD was 




(Black et al., 2009), suggesting a protective effect of exercise and/or cardiorespiratory 
fitness on vascular function with age. Interestingly, previous work in animals (Tarhouni 
et al., 2016) and humans (Moreau et al., 2013) suggests that the presence of oestrogen 
mediates the vascular adaptations to exercise in women. It is thought that oestrogen and 
exercise-induced shear stress share common signalling pathways to facilitate NO 
production through the activation of eNOS (Traub & Berk, 1998; Kim et al., 2008; 
Chambliss & Shaul, 2002; Zhang et al., 2009; Chen et al., 1999). In vitro studies have 
shown that oestrogen augments the vasodilation response to a given shear stress 
stimulus (Huang et al., 1998; Huang et al., 2000), which appears to be mediated by 
oestrogen receptors (Huang et al., 2000). Since oestrogen concentration determines 
receptor expression (Gavin et al., 2009), the lack of effect of exercise observed in post-
menopausal women may be related to the reduced expression of oestrogen receptors 
and eNOS activation. Therefore, it is possible that this explains the attenuated relation 
between FMD and SRAUC in post-menopausal women observed in Chapter 5. 
Nonetheless, evidence surrounding the true vascular effects and underlying 
mechanisms of exercise in post-menopausal women remains inconclusive and warrants 
further investigation.  
 
7.3.2 The Role of Shear Stress in Vascular Health and Disease 
The vascular tree is comprised of a network of macro- and microvessels, including 
arteries, arterioles, veins, venules and capillaries. Importantly, these blood vessels are 
lined with a thin layer of endothelial cells, which are sensitive to hemodynamic forces 
exerted by flowing blood, i.e., blood pressure and shear stress (Cahill & Redmond, 2016). 
Given the pivotal roles of the endothelium and shear stress in the development and 
progression of atherosclerosis (McLenachan et al., 1991; Cecchi et al., 2011), the FMD 
test is a widely-used research tool to evaluate macrovascular (i.e. conduit artery) 




reactive hyperaemic response following distal limb ischaemia to restore blood flow and 
oxygen delivery. This is quantified as SRAUC as the eliciting stimulus for vasodilation 
(Pyke & Tschakovsky, 2007), and largely reflects dilation of resistance vessels by 
ischaemia-induced production of vasodilators including NO (Meredith et al., 1996). Some 
studies have implied that reactive hyperaemia, measured as forearm blood flow via laser 
Doppler flowmetry, may represent microvascular function (Higashi et al., 2001), which is 
attenuated with CVD risk (Binggeli et al., 2003; Rossi et al., 2011; Huang et al., 2007). 
However, whilst there appears to be a weak relation between forearm blood flow and 
FMD (Ibrahimi et al., 2018), there is no strong evidence to confirm whether SRAUC 
measured during the FMD is correlated with microvascular function. Furthermore, 
microvascular dysfunction often precedes macrovascular dysfunction (Krentz et al., 2007; 
Sena et al., 2013), and is associated with CVD and diabetes (Jaap et al., 1994; Jaap et 
al., 1997; Sprague & Ellsworth, 2010). Since Chapter 4 demonstrated that the presence 
of diabetes was the strongest determinant negatively affecting FMD, future research 
should explore the potential to combine macro- and microvascular function to determine 
endothelial function across different vascular beds. 
 
When examining the relation between FMD and SRAUC, Chapter 5 demonstrated that 
this relation is attenuated with age in healthy men and women. Interestingly, there was 
a significant main effect for age for blood pressure and BMI (Table 5.1).  Despite this, 
blood pressure and BMI for the participants were well within the normal range for “healthy” 
(i.e. <140/90mmHg and <30kg/m2, respectively). Additional regression analysis revealed 
that FMD is influenced by systolic blood pressure, but not diastolic blood pressure or 
BMI. Repeated correlation analysis in a subgroup with blood pressure <130/80mmHg 
(n=505) confirmed the age- and sex-specific differences in the FMD-SRAUC relationship. 
Therefore, it is unlikely that CVD risk factors explained the age-specific attenuation in 




the FMD-SRAUC with age may be attributable to age-related changes in artery structure 
(Dinenno et al., 2000; Engelen et al., 2013), NO bioavailability (Taddei et al., 2001; Al-
Shaer et al., 2006), and shear patterns (Credeur et al., 2009; Young et al., 2010; Padilla 
et al., 2011; Casey et al., 2012). 
 
7.3.2.2 Shear Patterns or Fluctuations: What is More Important for Vascular Function?  
Experimental research manipulating shear stress through exercise or heating has 
demonstrated improvements in FMD (Tinken et al., 2009; Greyling et al., 2015a; Naylor 
et al., 2011a; Brunt et al., 2016; Carter et al., 2014). However, these interventions 
resulted in increased mean shear rate, whilst the intermittent negative pressure-induced 
fluctuations in shear rate (Chapter 6) without altering mean shear rate compared to 
resting baseline levels. When examining shear patterns, the application of negative 
pressure (-40mmHg) caused significant increases and decreases in antegrade- and 
retrograde shear rate, respectively, compared to baseline. Then the release of negative 
pressure (i.e. back to atmospheric pressure) caused increased and decreased 
retrograde- and antegrade shear rate, respectively. Despite these fluctuations, average 
antegrade- and retrograde shear rate during the intervention was not different compared 
to resting baseline levels (Figure 6.3). Furthermore, regardless of the ‘clamped’ average 
shear rate, brachial artery FMD improved in the arm exposed to the intervention. This 
may be somewhat surprising, especially since increased antegrade- and retrograde 
shear rate induce opposing effects on FMD (Thijssen et al., 2009c; Schreuder et al., 
2015; Johnson et al., 2012; Tinken et al., 2009) and evidence suggests that the 
endothelium may be responsive to changes in mean shear rate (Pyke et al., 2008; 
Tremblay et al., 2019). This raises the question related to the importance of each 
component of blood flow and shear rate (i.e. antegrade versus retrograde). FMD has 
been shown to improve following exercise/heating, consisting of different shear patterns 




antegrade shear rate was attenuated (Tinken et al., 2009). During the intermittent 
negative pressure intervention, the relative change for antegrade shear rate was ~20% 
(absolute change = 25s-1), whilst retrograde shear rate increased by ~60% (absolute 
change = 8s-1) compared to baseline. Since FMD improved despite the larger relative 
increase in retrograde shear rate, this data suggests that concomitant increases in 
antegrade shear rate may override the negative vascular effects associated with 
retrograde shear rate. It is also plausible that these findings were attributed to the 
absolute change in shear rate during the application of negative pressure (i.e. larger 
absolute change in antegrade compared to retrograde shear rate). Nonetheless, the 
findings presented in Chapter 6 propose that increases in mean shear rate may not be 
necessary to improve endothelial function; rather, antegrade shear rate may be of 
greater importance.  
 
Fluctuations in blood flow and shear rate may be related to engaging in regular low-
intensity physical activity, particularly as a strategy to break up sedentary behaviour. An 
acute experiment by Thosar et al. (2014) found a decline in femoral artery FMD, but not 
brachial artery FMD following uninterrupted sitting, implying a local negative effect of 
sitting. Recent work has demonstrated that the prolonged sitting-induced decline in blood 
flow and shear stress, and subsequent vascular function can be prevented by breaking 
up sitting with physical activity breaks (Carter et al., 2018; Thosar et al., 2015) or even 
fidgeting (Morishima et al., 2016). In addition, intermittent negative pressure-induced 
fluctuations in blood flow and shear rate was shown to improve wound healing in patients 
with foot ulcers and disturbed blood flow (Sundby et al., 2016a; Sundby et al., 2017; 
Sundby et al., 2018b). These observations were largely stimulated by increased 
microvascular (skin) blood flow during the application of negative pressure (Sundby et 
al., 2016b), therefore improving oxygen/nutrient delivery to the wound (Tsai & Intaglietta, 




enhanced prostacyclin and NO release in response to pulsatile shear stress (Frangos et 
al., 1985; Nakano et al., 2000). Whilst greater abundance/availability of vasodilators may 
have explained the improvement in FMD observed in Chapter 6, these positive effects 
may be even further augmented in clinical populations. Given the observed effectiveness 
and tolerability of intermittent negative pressure from the above studies, further research 
is warranted into the feasibility of use as a treatment method, particularly in disabled/bed-
bound individuals where physical activity is not a viable option. Taken together, in 
addition to the data presented in Chapter 6, these findings support the benefits of 
fluctuations in blood flow and shear rate, which also appears to positively affect multiple 
vascular beds.  
 
7.3.3 Implications for the Performance of FMD 
The large dataset presented in Chapter 4 originated from FMD studies completed across 
six laboratories worldwide, with different investigators/sonographers, ultrasound 
machines and analysis software. Specific to the analysis software, five out of six 
laboratories used the same edge-detection and wall-tracking analysis software 
(BloodFlow Analysis), whilst one laboratory used FMD Studio (Quipu, SRL). To 
statistically account for this, multiple linear regression analysis revealed an insignificant 
regression coefficient of β=0.166%, which was used as a calibration factor to rescale 
individual FMD values obtained using FMD Studio. Importantly, all FMD data included in 
the large dataset were collected with strict adherence to expert-consensus guidelines 
(Corretti et al., 2002; Thijssen et al., 2011a) and the minimal calibration factor applied 
further reinforces that variability between FMD outcome is low when protocol guidelines 
are adhered to (Greyling et al., 2016a). Moreover, updated FMD guidelines (see Chapter 
3; published in European Heart Journal; doi: 10.1093/eurheartj/ehz350) recommend 
research groups worldwide to adhere to protocol (and analysis) guidelines, in order to 




this, future FMD research should only be published if the guidelines have been met (and 
this should be monitored at the peer review stage), thereby maintaining the credibility of 
the FMD technique. Ultimately, estimation of reference values for brachial artery FMD 
enables improved interpretation of FMD outcome in addition to comparability between 
populations in a research setting. 
 
7.4 Methodological Considerations: Strengths and Limitations 
Key strengths specifically relate to the FMD methodology presented in this thesis. Firstly, 
despite the worldwide use of the FMD technique since the initial work by Celermajer et 
al. (1992), work presented in this thesis is the first study to construct reference values 
for brachial FMD in a large number of strictly healthy individuals. Importantly, all FMD 
data presented in Chapters 4, 5 and 6 was obtained following strict adherence to expert-
consensus guidelines for the performance and analysis of the FMD (Corretti et al., 2002; 
Thijssen et al., 2011a). Furthermore, as described above, Chapter 4 demonstrated that 
despite different investigators and technology, variability in FMD outcome was low.  
 
Despite this, the nature of the data collection for Chapters 4 and 5 (i.e. retrospective 
design) provides a number of limitations to this thesis. Only a small number of studies 
included in the dataset collected data on physical activity and cardiorespiratory fitness, 
whilst no studies examined sex hormones or endothelial markers. Therefore, this 
information could not be included in the database. Furthermore, whilst multiple 
imputation was used to “fill in” missing data (e.g., blood pressure, BMI, baseline artery 
diameter), some datasets were missing critical (and easily obtainable) information 
related to CVD risk. More specifically, due to low availability, a sub-analysis was required 
to examine the relation of smoker status with FMD. Additionally, ethnicity was not 




specific sub-analysis). Therefore, it is imperative for researchers to collect (and report) 
more comprehensive participant information related to all CVD risk factors affecting FMD. 
For example, questionnaires can be used to assess physical activity, ethnicity and 
smoker status (plus number of cigarettes per day), whilst more experience (and funds) 
are required to assess blood markers and hormone levels. Nonetheless, these data 
would have complemented the data presented in this thesis to provide some mechanistic 
insight underlying our major findings. 
 
7.5 Future Directions 
Currently, the FMD technique is limited to use in a research setting, due to its non-
invasive nature and susceptibility to respond to stimuli such as exercise and/or 
pharmacological interventions. As a result of Chapter 4 of this thesis, the estimation of 
reference values for brachial artery FMD has provided greater clinical/prognostic 
meaning to the FMD. Therefore, with the new estimation of what is “normal” for healthy 
individuals, and given the association with atherosclerosis and CVD risk, the FMD 
technique may be ready for use in a clinical setting. Nonetheless, potential barriers to 
clinical use relates to qualified sonographers in addition to time constraints (i.e. 15mins 
rest, 9mins FMD protocol [1min baseline, 5mins cuff inflation, 3mins post]), and subject 
preparation (i.e. fasted state, avoid exercise and alcohol etc.).  
 
Findings presented in this thesis have provided a stepping stone for future research 
within the field of cardiovascular physiology and contributed to the “hot topic” of sex 
differences. Females are largely underrepresented in human and animal physiological 
research (Beery & Zucker, 2011), which is also demonstrated by the difference in the 
number of females compared to males in the datasets presented in Chapters 4 and 5. 




data may not always translate to females, in the same way that an experiment in healthy 
participants may not apply to clinical populations. Potential explanations for the scarce 
physiological research in females may relate to the lack of knowledge and/or 
understanding of the impact of female-specific hormones; not only during a normal 28-
day menstrual cycle, but also with the use of different hormone-based contraception 
methods and replacement therapy. Specific to the FMD (and other cardiovascular health 
markers), females are assessed during the first 7 days of the menstrual cycle when 
oestrogen is lowest, whilst those on hormone-based contraception or replacement 
therapy are generally excluded from cardiovascular studies. This immediately reduces 
the pool of eligible female subjects, therefore further highlighting the need for future 
research to improve understanding around the impact of sex hormones on 
cardiovascular health and function.  
 
Another emerging theme from this thesis relates to novel findings presented in Chapter 
6, highlighting the importance of fluctuations in shear rate for endothelial function. Given 
that the study was statistically underpowered, further work is warranted to better 
understand the potency of fluctuations in shear rate patterns on vascular function. More 
specifically, future research should endeavour to explore the underlying mediating 
mechanisms, in addition to the chronic effect of fluctuations in shear rate on vascular 
function in health and disease.  
 
7.6 Conclusion 
In summary, FMD data obtained with strict adherence to expert-consensus guidelines 
(Corretti et al., 2002; Thijssen et al., 2011a) allowed for the estimation of reference 
values for brachial artery FMD. These data demonstrated sex differences in the age-




higher and declines at a faster rate. For the first time, Chapter 4 has provided predictive 
equations for the estimation of brachial artery FMD in healthy individuals, and explored 
the relation with CVD risk factors. When exploring the role of total shear stress as the 
eliciting stimulus for FMD (i.e. SRAUC (Pyke & Tschakovsky, 2007)), the relation 
between FMD and SRAUC was stronger in women compared to men, and also declines 
with age (Chapter 5). Finally, the novel data presented in Chapter 6 provided insight into 
the relevance of shear rate, specifically fluctuations in shear rate, as a stimulus for 
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Endothelial dysfunction is involved in the development of atherosclerosis, which precedes asymptomatic structural vascular alterations as
well as clinical manifestations of cardiovascular disease (CVD). Endothelial function can be assessed non-invasively using the flow-mediated
dilation (FMD) technique. Flow-mediated dilation represents an endothelium-dependent, largely nitric oxide (NO)-mediated dilatation of
conduit arteries in response to an imposed increase in blood flow and shear stress. Flow-mediated dilation is affected by cardiovascular
(CV) risk factors, relates to coronary artery endothelial function, and independently predicts CVD outcome. Accordingly, FMD is a tool
for examining the pathophysiology of CVD and possibly identifying subjects at increased risk for future CV events. Moreover, it has merit
in examining the acute and long-term impact of physiological and pharmacological interventions in humans. Despite concerns about its re-
producibility, the available evidence shows that highly reliable FMD measurements can be achieved when specialized laboratories follow
standardized protocols. For this purpose, updated expert consensus guidelines for the performance of FMD are presented, which are
based on critical appraisal of novel technical approaches, development of analysis software, and studies exploring the physiological princi-
ples underlying the technique. Uniformity in FMD performance will (i) improve comparability between studies, (ii) contribute to construc-
tion of reference values, and (iii) offer an easy accessible and early marker of atherosclerosis that could complement clinical symptoms of
structural arterial disease and facilitate early diagnosis and prediction of CVD outcomes.
...................................................................................................................................................................................................
Keywords Flow-mediated dilation • Methodology • Cardiovascular disease • Brachial artery • Vascular function
Introduction
Cardiovascular disease (CVD) remains the world’s leading cause of
morbidity and mortality.1,2 Development of CVD starts in early child-
hood and progresses silently for many years,3 ultimately resulting in
angina, myocardial infarction, or ischaemic stroke. The endothelium
plays a central role in the process of atherosclerosis from the first to
the advanced stages. Due to its strategic anatomical position, it is
highly responsive to detect various haemodynamic stimuli (e.g. shear
stress, circumferential wall strain)4 and regulates vascular tone,
growth, adhesion, and coagulation in a endocrine-paracrine manner.5
Not surprisingly, impairment of endothelial function precedes devel-
opment of atherosclerosis, evident by thickening of the arterial wall
and plaque formation.6–9 Endothelial dysfunction is also linked to in-
flammatory changes within atherosclerotic plaques, leading to plaque
vulnerability and, subsequently, increased risk for clinical events.3,10
The intrinsic link between inflammation and endothelial dysfunction
is well-established.11,12
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Several (non-)invasive tools to examine endothelial function have
been developed. These techniques provide insight into the patho-
physiology of atherosclerosis and CVD, but may also predict cardio-
vascular (CV) events. The present article discusses flow-mediated
dilation (FMD), which represents a popular and widely used non-
invasive tool for examining peripheral artery endothelium-dependent
dilation, originally introduced in 1992.13 Briefly, this technique adopts
ultrasound to examine changes in brachial artery diameter in response
to ischaemia (typically 5 min), induced by inflating a blood pressure
cuff distal from the imaged artery around the forearm to supra-
systolic level. Importantly, substantial variation in performing the FMD
is present, which impairs its reproducibility and comparison between
studies. First, we will briefly discuss techniques utilized to assess endo-
thelial (dys)function, and specifically focus on the clinical value of FMD.
Subsequently, we will provide updated expert consensus guidelines
for the performance of FMD, which are based on critical appraisal of
novel technical advances, development of analysis software, and stud-
ies exploring physiological principles underlying the technique.
Vascular reactivity tests
Endothelial dysfunction, which is characterized by reduced nitric
oxide (NO) availability,14 was originally demonstrated by infusing
acetylcholine in atherosclerotic coronary arteries.15 Since this tech-
nique is invasive and not widely applicable, less invasive studies in the
peripheral circulation have been then introduced (Supplementary
material online, Table). A technique with methodological similarities
to intra-coronary infusion involves venous plethysmography, typically
of the forearm. After arterial cannulation, forearm blood flow
changes after infusion of vasoactive substances modulating NO-
release are measured. Alternatively, non-invasive techniques include
peripheral arterial tonometry (PAT) and FMD, both measuring vaso-
dilator responses after transient ischaemia. Whereas FMD examines
macrovascular endothelial function of the brachial artery, PAT may
represent a measure of finger microvascular function. Techniques
have their specific advantages and disadvantages (Supplementary ma-
terial online, Table), as extensively reviewed elsewhere.14
Importantly, non-invasive techniques have been validated against cor-
onary endothelial function, providing the pathophysiological basis for
the predictive value of these tests for CVD.16,17
Clinical value of flow-mediated
dilation
Association with cardiovascular disease
prognosis
Impaired FMD has been associated with conditions predisposing to
atherosclerosis and CVD, representing an early step in developing
subclinical target organ damage and late clinical events.18 Brachial
FMD is associated with carotid intima-media thickness progression in
a population free of CVD7 and in hypertensive, postmenopausal
women.19 In a 3-year follow-up study in hypertensive patients, FMD-
predicted target organ damage progression (including carotid intima-
media thickness, pulse wave velocity, albuminuria, and left ventricular
hypertrophy), even after adjustment for known risk factors.20
Furthermore, impaired FMD represents an independent predictor of
in-stent stenosis after single-vessel coronary interventions.21
Several studies have demonstrated the prognostic value of brachial
artery FMD for CV events (Table 1).22–25 Meta-analyses indicate a sig-
nificant 8–13% lower risk of CV events per percent point increase in
brachial artery FMD (e.g. from 5% to 6% dilation, Figure 1). This re-
duction was relevant both in high- and low-risk populations,22,25
though appeared larger in patients with established CVD.23,24 Except
for one meta-analysis,24 the overall estimated study quality did not
significantly influence FMD predictive value.22,23,25
One meta-analysis of 14 studies assessed the influence of the site
of the cuff position, which was either placed distal (i.e. forearm) or
proximal (i.e. arm) from the imaged artery (Table 1).26 This study
found that the predictive capacity of the FMD using distal cuff pos-
ition did not differ from using FMD with proximal cuff positioning.
This was confirmed in a later meta-analysis that included a larger
number of studies.24
Incremental value of flow-mediated
dilation over traditional cardiovascular
risk factors
Flow-mediated dilation has failed to demonstrate an added value to
classical CV risk factors in terms of discrimination and net reclassifica-
tion.27 In the Multi-Ethnic Study of Atherosclerosis (MESA) cohort of
intermediate-risk individuals, FMD did not increase discriminative
power or net reclassification index of risk compared to the
Framingham Risk Score.28 However, the low reproducibility of the
FMD in the MESA study, in which the intra-class correlation coeffi-
cient was 0.5428 (worse than other studies in healthy volunteers29,30
and CVD patients30,31), may have contributed to these negative find-
ings. Alternatively, FMD may simply reflect compound risk burden
that impacts upon vessel function and hence may not provide incre-
mental risk prediction. A recent position paper by the European
Society of Cardiology Working Group on Peripheral Circulation32 con-
cluded that FMD is principally a valuable research tool. Moreover,
authors stated that, partly because poor standardization between
laboratories and lack of guideline adherence, FMD is currently not
recommended for the assessment of CV risk, with evidence grading
remaining at III, in accordance with other guidelines.33,34
Clinical value of long-term changes in
flow-mediated dilation
Longer-term improvement in FMD may have a prognostic implica-
tion.35 Therefore, assessment of FMD in interventional trials could
represent a surrogate endpoint, especially since FMD responds rapid-
ly to therapies, allowing identification and selection of new drugs or
bioactive substances.36 The lack of improvement in FMD might iden-
tify ‘non-responder’ patients, who might be suitable for more inten-
sive or new therapeutic approaches. For example, improvement in
FMD following 6 months of antihypertensive therapy was associated
with a more favourable prognosis for CV events in hypertensive
postmenopausal women.37 Furthermore, persistent impairment in
FMD after optimized risk reduction therapy represents an independ-
ent predictor of CV events in patients with coronary artery disease.38
Finally, a persistently impaired FMD, after optimized therapy in heart
failure, independently predicted cardiac events.39 These studies



































































support the potential use of repeated assessment of FMD, rather
than a single measure, to predict future CV events.
Potential value of short-term changes in
flow-mediated dilation
Many studies have examined short-term changes in FMD, ranging
from a few hours, to several days, and up to months. In these
randomized trials, FMD was selected as the primary outcome meas-
ure to investigate the potential protective impact of (non-)pharmaco-
logical therapies.36,40–42 Increase in FMD in response to (non-
)pharmacological substances may translate to long-term improve-
ments in endothelial function and protection against atherosclerosis
and/or CVD. The relative simplicity of the design and the ability to
perform reproducible, repeated measurements explain the popular-
ity of examining changes in FMD in these studies.14
In summary, a biomarker is only useful for CV risk prediction when
it adds incremental information to traditional CV risk factors, being
independently associated with outcomes, and also improving discrim-
ination, calibration and net reclassification of risk, especially in those
at intermediate risk.43 Current evidence on these issues pertaining to
FMD is incomplete. In part, this seems related to the diversity be-
tween studies in adherence to expert consensus guidelines.
Moreover, reference values are yet to be established and are neces-
sary for widespread applicability. Nonetheless, FMD has proven
beneficial when examining (short-term) changes to evaluate the




Diameter and velocity assessment
Flow-mediated dilation is typically examined in the brachial artery
(diameter 3–5 mm). Longitudinal images of the brachial artery are
taken using high-resolution B-mode ultrasound, usually with an ultra-
sound probe of 7.5–12 MHz. Studies have also examined smaller (e.g.
radial artery: diameter 1.5–3 mm) or larger sized arteries (e.g.
superficial femoral artery: diameter 5–7 mm, popliteal artery: diam-
eter 4–6 mm). Changes in resolution may be required to optimize B-
mode images in arteries that lie at differing depths. A key challenge
with B-mode imaging is to identify clear vascular boundaries, i.e. the
double lines of Pignoli (Figure 2).44–46 A reasonable approach involves
obtaining an image characterized by a single echogenic layer, repre-
senting the brachial artery wall-lumen interface. Since diameter is a
key determinant of FMD, the modality of measurement applied may
influence results and, under all circumstances, should be kept the
same throughout the experiment. Special attention should be paid to
perform adequate scanning of the baseline diameter. More specifical-
ly, tangential scanning is a common error and results in underestima-
tion of the true brachial artery diameter. Recent technological
advances, which adopt an H-shaped probe capturing two short-axis
and one long-axis for automatic probe position correction, may over-
come this crucial limitation.47
Simultaneous live acquisition of the pulsed-wave Doppler velocity
is recommended, given the importance of shear stress as the eliciting
stimulus for dilation.48–50 An important limitation of this approach is
that the same transducer is employed to detect Doppler velocity and
arterial diameter, which have competing requirements for optimal
data acquisition. B-mode echoes are of greater intensity with perpen-
dicular insonation of the ultrasound beam (90), whereas optimal
pulse-waved Doppler signals require parallel incidence with the dir-
ection of blood flow (ideally 0, Figure 2).51–53 Therefore, a com-
promise must be reached to uphold fundamental principles and
assumptions for both modalities.53 The error linked to incorrect esti-
mation of insonation angle increases exponentially with angles
greater than 60 .51–53 Therefore, we recommend an insonation angle
of <60–70 (which is the best achievable angle with standard ultra-
sound machines), which should be kept constant and reported in the
manuscript.
Finally, the sample volume used for pulsed-wave Doppler should
be considered. Since measurements settings of the width of the sam-
ple volume vary between laboratories and impact upon the analysis
of the velocity signal (see Analysis of the Velocity Signal section), we
recommend to maintain consistency in methods within studies, and
in particular for repeated tests within subjects.
....................................................................................................................................................................................................................
Table 1 Summary of meta-analyses that included studies on predictive value of flow-mediated dilation on cardiovas-
cular disease prognosis











Inaba et al.22 15 (9/4) 5547 51–78 6–93 0.87; 0.83–0.91
Green, et al.26 14 (9/5) 8318 51–79 6–93 0.83; 0.78–0.88b
0.91; 0.87–0.69c
Ras et al.23 23 (15/8) 14753 46–79 12–96 0.92; 0.88–0.95
Xu et al.25 32 (19/13) 15191 47–73 6–115 0.90; 0.88–0.92
Matsuzawa et al.24 35 (22/13) 17280 46–79 6–115 0.88; 0.84–0.91
CI, confidence interval; CVD, cardiovascular disease; FMD, flow-mediated dilation; RR, relative risk.
aPer 1% higher FMD.
bDistal cuff occlusion.
cProximal cuff occlusion.




















..Analysis of the velocity signal
Duplex ultrasound-derived velocity and diameter data are both
required for calculating shear stress, the eliciting stimulus for artery
dilation during FMD. Although the increase in shear stress is the
physiological stimulus for dilation, most studies present shear rate, as
it is assumed that blood viscosity does not differ between participants
and/or groups.50,54,55 Since no uniformity exists in the calculation of
shear rate,56 calculations must be described in the manuscript. Two
different formulas have been suggested, according to the sample vol-
ume size and placement:
a. Shear rate = 8  mean blood velocity/internal diameter; for large,
centred sample volume;
b. Shear rate = 4  mean blood velocity/internal diameter; for small,
centred sample volume.
Figure 1 (A) Schematic presentation of diameter and shear stress (or rate) responses before and after a 5-min ischaemic stimulus applied distally
to the forearm. (B) Representative diameter (upper panel) and velocity (lower panel) data from a healthy person before and after the 5-min ischaemic
stimulus. (C) Representative diameter (upper panel) and velocity (lower panel) data from a person with endothelial dysfunction before and after the
5-min ischaemic stimulus.















































A clear description must also be provided for the calculation of
velocity. Mean velocity can be estimated by taking half of the peak vel-
ocity (i.e. fastest moving blood cells in the centre of the vessel) or the
intensity weighted mean velocity (i.e. mean velocity from all Doppler
shifts across the vessel).52 Although both methods seem valid, they
cannot be used interchangeably.57
Maintaining the optimal image: probe-
holder vs. hand-held
Another common mistake is inconsistency in scanning the same por-
tion of the artery during repeated measurements, or throughout a
single FMD. Therefore, anatomical landmarks should be identified
and recorded and/or the distance between the elbow crease and
ultrasound probe should be recorded (or photographed). The pos-
ition of the subject (related to the arm and hand), but also cuff size
and position (see Protocol: Cuff Position section) should be also
recorded and standardized.58
To further ensure optimal image throughout the FMD-procedure,
a probe-holding device can be useful.29,58,59 A stereotactic adjustable
probe-holding device allows adjustment of probe position during the
test, ensuring that the same scan is maintained throughout the
study.18 Subject movement can also be compensated for when the
probe hand-held, assuming an experienced sonographer. In a recent
systematic review of studies that examined the reproducibility of the
FMD, the use of a probe-holding device was associated with a higher
FMD reproducibility.60 However, another recent study pooling
repeated measurements from different centres found that reproduci-
bility is not affected by a probe-holder device, when experienced lab-
oratories perform FMD following strict guidelines.30 It cannot be
excluded that other differences between laboratories may explain
these findings. Nevertheless, a probe-holding device is a cheap, easily
obtainable tool. Because it may facilitate FMD testing for inexperi-
enced operators and increase accuracy, a probe-holder device is rec-
ommended, especially for less experienced laboratories.
Practical considerations, study
protocol, and data analysis
Subject preparation and environmental
influences
Subject preparation is important in the valid and reproducible as-
sessment of the FMD, with many studies failing to control for these
factors and/or failing to report on their procedures in sufficient de-
tail (Take home figure). Several subject-related factors can influence
FMD, including food, alcohol, smoking, supplements, drugs, physical
activity, and mental stress.61–64 While some factors directly impact
stimulated NO-release, others, such as acute physical exercise,62
modify baseline vasomotor tone (and therefore baseline diam-
eter).4 To minimize their effect, it is strongly recommended that
Figure 2 Experimental set up for the performance of the brachial artery flow-mediated dilation. (A) Position of the cuff and ultrasound probe
placed on the upper arm. (B) Screen shot of a representative B-mode image of the diameter and Doppler blood flow velocity. (C) Wall tracking soft-
ware to perform (semi)automated analysis. (D) Output generated by the analysis software to enable calculation of the flow-mediated dilation.












































..prior to FMD examination, subjects are fasted (>6 h), avoid exer-
cise (>24 h), and refrain from caffeine, vitamin C, polyphenols, alco-
hol, and supplements known to affect the CV system for a
consistent period of time (typically >12 h) (Table 2). Smokers must
refrain from smoking for a standardized period (preferably >6 h).
When examining patient groups taking drugs, we recommend wait-
ing 4 times the half-life of the drug. If drug intake cannot be avoided,
examination should be performed after a consistent and standar-
dized time.59 Since mental stress affects FMD,64,66 testing must be
performed in a quiet, temperature-controlled room after a standar-
dized period of supine rest of >10–15 min. Acute intense mental
stress can cause prolonged (up to 90 min) impairment in FMD,67
but its confounding effect can be hardly controlled or eliminated.
Premenopausal women should be examined in a standardized
phase of the menstrual cycle, since hormonal changes can affect
FMD.68 Vascular function in humans, including that assessed by
FMD,69 demonstrates a diurnal variation. This implies that the time
of the day of FMD should be standardized and reported, especially
when performing repeated measures. Other environmental factors
that may affect FMD are outdoor temperature,70 seasonality,71 and
air pollution.72 However, because of practical reasons, these fac-




Placement of the occlusion cuff importantly alters the magnitude,73 dur-
ation,73,74 nature,75 and possibly the clinical relevance26 of the dilator re-
sponse. Originally, Celermajer et al.13 examined brachial artery FMD
with the occlusion cuff placed around the forearm, distal to the ultra-
sound probe (Take home figure). Standardizing cuff position is of crucial
importance for valid comparisons between studies, since occlusion of a
smaller volume (i.e. placement towards the wrist) or larger volume of
tissue (i.e. cuff occlusion around the upper arm) leads to either a mark-
edly attenuated diameter58 or an enhanced73,76 shear stress response.
Some have supported the placement of the occlusion cuff above the
imaged artery,74 with the main argument that the larger dilator re-
sponse77 achieved by occluding a larger area may improve FMD dis-
criminative power. One analysis found no significant differences in
prognostic value between studies that adopted distal vs. proximal cuff
position.26 Furthermore, some limitations of proximal cuff inflation
must be considered. First, scanning the brachial artery during this pro-
cedure is challenging, since the artery can collapse and/or tissue move-
ments can worsen image quality. Secondly, the dilator response with
proximal cuff position is largely mediated through vasoactive substances
other than NO.61 A meta-analysis75 found that the dilation in response
to distal cuff occlusion is 70% NO-mediated, whereas proximal cuff
Take home figure Pictorial summary of the main recommendations for FMD evaluation in humans.


























..placement is only 30% NO-mediated. These differences between
studies are confirmed by direct comparisons of distal vs. proximal cuff
position in the same individual.74 This is mechanistically important, be-
cause several studies specifically aim to study the NO-dependent path-
way, given its established importance in the process of atherosclerosis.
Thus, strict standardization of distal cuff occlusion (i.e. below the imaged
artery) is recommended to ensure maximal dependence of the dilator
response on endothelium-derived NO.
Protocol: baseline diameter
The FMD-response is typically expressed as the relative change in
post-hyperaemia diameter from baseline. As a direct consequence
and limitation, the FMD is a function of the degree of responsiveness
to stimuli, but also of baseline vasomotor tone and structural remod-
elling. Correct assessment of baseline diameter is therefore of crucial
importance and implies the removal of potential factors influencing
both baseline diameter and vasomotor tone (see Subject Preparation
and Environmental Influences section), but also practical (Diameter
and Velocity Assessment section þ this section) and statistical pro-
cedures (Shear Stimulus: Normalization for flow-mediated dilation
Stimulus sectionþ this section) linked to baseline diameter.
Most studies use the pre-inflation diameter to calculate the FMD,
in line with the classic approach13 and previous FMD-guide-
lines.58,59,61 It is recommended that pre-inflation diameter should be
....................................................................................................................................................................................................................
Table 2 Recommendations for flow-mediated dilation assessment to examine a largely nitric oxide-mediated, endo-
thelium-dependent vasodilation of a conduit artery
Methodological and technical guidelines Required
Subject preparation
Rest in a quiet, preferably darkened room for a period of 10–15 min prior to assessment. 1
Supine posture (i.e. the imaged artery should be around heart level). 1
Testing times must be standardized to avoid diurnal variation, and for multiple tests, all are to be conducted at a similar time of day 1
Subjects must be fasted for >_6 h 2
Avoid exercise for >_24 h, alcohol or food/drinks that contain caffeine or are rich in polyphenols for >_12 h 2
No smoking or any tobacco consumption prior to measurement (>6 h) 2
Careful history should be taken regarding the use/timing of any drugs. Drug withdrawal may be required, but this depends on the
protocol and is not always feasible (in patients) or required
2
Premenopausal women should be assessed in standardized part of the menstrual cycle (especially when performing repeated
measures) or menstrual phase should be annotated.
2
Protocol
Baseline diameter must be examined before cuff inflation for a period of >30 s 1
Present absolute baseline diameter in Results section 1
Cuff must be placed distal to the imaged artery, with cuff pressure exceeding systolic pressure with >50 mmHg and inflated for 5 min 1
Post-deflation diameter should be monitored continuously from deflation for >_3 min 1
Endothelium-independent vasodilation should be tested and GTN dose should be reported 1
Sublingual administration of 25 lg is suggested 3
Technique
Continuous measurement of velocity and diameter using simultaneous live duplex ultrasound 1
B-mode images with a linear probe of >_7.5 MHz should be used (and report probe details). The highest MHz available should be used,
given tissue depth considerations
1
Blood velocity assessed using an insonation equal to 60–70 or less 1
Use the same angle for blood flow velocity within a study and study group (and report angle) 1
Analysis
Use continuous edge-detection and wall tracking software 1
Automated mathematical algorithms should be used to calculate the peak diameter 1
Present the baseline diameter 1
Present the FMD-response in absolute (in mm) and relative (in %) change 1
Present the relevant shear rate stimulus (area-under-the-curve or peak shear) 2
Off-line analysis is performed by a blinded observer 3
Operator-dependent factors
Sufficient training of sonographer (recommended levels of reproducibility: <2% coefficient of variation for diameter, <15%
coefficient of variation for FMD in consecutive scans)
1
Maintain sonographer experience 1
A stereotactic probe-holder is recommended for less experienced laboratories 2
Based on previous work,65 the right column indicates the level of requirement for specific recommendation: mandatory (1), highly recommended (2), and recommended when
possible (3).
































































































recorded for 1 min, with a minimum of 30 s.61 The end-of-ischaemia
diameter has been also proposed as the baseline diameter for FMD
calculation. However, ‘low-flow’ state during distal cuff occlusion
may lead to artery constriction, though this phenomenon appears to
be evident mostly in the radial78–80 rather than in the brachial ar-
tery.49,81–83 Conversely, one study showed that brachial artery diam-
eter during cuff inflation was significantly larger than that assessed
pre-inflation, leading to a lower FMD, an effect not present in older
groups.83 Based on these between-group differences, we recom-
mend using pre-occlusion diameters as the baseline value so that the
differential impacts of cuff occlusion on the baseline artery diameter
are avoided.
Because FMD is defined as increase in diameter after occlusion,
baseline diameter is strongly and inversely related with FMD.13,84,85
This relation has several important implications for comparing groups
that differ in baseline diameter (e.g. age, CVD),86,87 and for interpret-
ation of studies with interventions that may affect resting diameter
(e.g. exercise training).4 Atkinson et al.88 found that the FMD% does
not accurately scale for inter-individual differences in baseline diam-
eter but overestimated endothelial function for low baseline diame-
ters and vice versa, thus proposed to adopt allometric scaling, a
statistical method to account for the relationship between baseline
and peak diameter.84 The use of allometric scaling, however, is lim-
ited by its inability to adjust FMD values at an individual level.
Protocol: duration and magnitude of cuff occlusion
The original 5-min duration of cuff occlusion remains the most fre-
quently used protocol. Shorter periods lead to negligible dilation,89
whilst longer periods lead to larger blood flow and diameter
responses, but may be less tolerable for volunteers.73 Since the na-
ture of dilation changes with longer periods of occlusion,76 we rec-
ommend using a 5-min occlusion period.
Whilst a majority of studies use a pre-defined cuff occlusion pres-
sure (typically between 200 and 300 mmHg), it is important that cuff
pressure should exceed >50 mmHg above systolic pressure to pre-
vent arterial inflow. In our experience, the procedure is generally
well tolerated and drop-out due to discomfort is unusual, though no
studies are available in literature specifically dealing with this aspect.
A common-sense recommendation to minimize subject discomfort
is to use a smaller-sized (5 cm), paediatric cuff instead of a standard
(12 cm) cuff. In addition, providing clear information about the study
protocol and FMD-procedure is essential.
Protocol: post-deflation measurements
In the first studies using the FMD approach, peak diameter was exam-
ined using static frames at or around 60-s post-deflation.13 During
the past decade, several studies found that this approach (or using
pre-determined time-windows) can significantly underestimate the
true peak dilation.90 More importantly, the timing of the peak dilation
may differ between groups90 or after interventions.90–93 Therefore,
to ensure successful capture of the true peak brachial artery diam-
eter, guidelines support continuous examination up to 180-s post-
deflation.
Endothelial function is increasingly examined in conduit arteries
other than the brachial artery. However, the nature of the diameter
responses in other arteries may differ from that in the brachial artery.
For example, the content of endothelial NO synthase is
heterogeneous throughout the arterial tree.94 This may impact upon
the relative contribution of NO to the dilator response. In addition,
lower limb arteries show a significantly delayed peak dilation com-
pared to those in the arms.95 This means that the 3-min post-
deflation time window may not be long enough for all arteries. These
potential differences must be considered when performing and inter-
preting the FMD in other conduit arteries.
Identification of the peak diameter
Early studies applied electrocardiogram (ECG)-based-gated analysis
to identify peak diameter.59 This approach assesses the diameter at
the onset of R-waves (i.e. end-diastole), which limits the influence of
arterial compliance on the assessment of the diameter. In the past
decade, driven by the technical possibility and recognition of its rele-
vance, studies typically adopted continuous data analysis of the diam-
eter across the cardiac cycle. Continuous data analysis shows good
agreement with ECG-gated analysis96,97 and is more time-efficient.97
The accuracy and availability of this procedure makes ECG-gating no
longer mandatory for determining peak artery diameter.
Shear stimulus
Shear stimulus: importance for flow-mediated dilation
Although the terminology of FMD suggests that dilation is flow medi-
ated, physiological work demonstrates that it is rather mediated
through the post-deflation increase in shear stress.48 Studies that
adopted within-subject manipulation of the post-deflation shear
stress stimulus revealed that the relation between shear stress and
dilation is dose-dependent.48,49,98,99 This fits with landmark stud-
ies100,101 demonstrating the importance of shear stress in mediating
endothelium-dependent dilation. Pyke and Tschakovsky49 suggested
that the total, rather than peak shear stress, is more important in
mediating conduit artery dilation.49 This finding was later confirmed
by others.50 These studies show physiological and mechanistic basis
for the continuous recording of both conduit artery diameter and
velocity (Figure 1).
Shear stimulus: normalization for flow-mediated dilation
stimulus
Based on the importance of shear stress as the eliciting stimulus, and
also the assumption that within-/between-subject variation in FMD-
responses relate to the magnitude of reactive hyperaemia, studies
have used different approaches to account for the shear stress stimu-
lus. An early approach involved ‘simple’ ratio normalization by divid-
ing FMD by shear rate stimulus.50,82,102 However, this approach
tends to violate important statistical assumptions, being (i) the rela-
tionship between both parameters is linear, (ii) the intercept for the
regression slope of this relationship is zero, (iii) data (including resid-
uals) are normally distributed, (iv) variances are similar between
groups, and (v) the ratio does not lead to spurious correlations with
other variables.103 Whilst acceptable-to-good relation between the
shear rate stimulus and FMD is present within subjects,48–50,89,99,104
studies examining this relation between subjects found a weak95 or
absent105 relation. Whilst this does not invalidate the role of shear
stress as the dilator stimulus, it indicates that FMD variability cannot
be simply controlled for by ratio normalization.103
































































































Studies have also explored other strategies to statistically correct
the FMD-response for the shear stress stimulus, such as including
shear rate as a covariate in an analysis of covariance.103,106,107
Covariate in an analysis of covariance results, however, could be mis-
leading if the covariate (i.e. shear rate), is related to the independent
and/or outcome variable (e.g. age, sex, baseline diameter, and FMD).
However, since calculation of shear rate importantly depends on
baseline diameter, shear rate normalization may not be needed if the
FMD is scaled properly to baseline diameter using the previously
mentioned allometric scaling.108
Taken together, it is currently not clear which statistical strategy is
preferred to account for the eliciting shear rate stimulus in the FMD
response. Ratio-normalization seems statistically flawed, whilst too
many questions remain present around validity, practicality and po-
tential clinical importance of statistical correction for the shear rate
stimulus. It is recommended to report the relevant shear rate stimu-
lus, i.e. shear area-under-the-curve up to the peak diameter.
Reporting the shear stress stimulus may also be clinically relevant be-
cause the post-occlusion hyperaemia is strongly related to CV risk,
and may have prognostic value for future CV events.109–112
Analysis: Blinding, edge-detection, and
wall-tracking
Early FMD research relied on a manual approach to assess diameter
change through visual inspection and calipers placement.13,113 This
method is highly operator-dependent, carries risk of observer error
and is time-consuming.45,114–117 Recent years, software systems for
automatic diameter measurement have been developed. This repre-
sents a time-efficient approach and has limited operator-related
errors and bias. More importantly, intra-observer variation is signifi-
cantly lower with automated analysis compared to the classic manual
technique.45,46,114,116–118
Automatic wall tracking algorithms belong to two main categories
according to the input signal: radiofrequency (RF) backscattering or
grey scale speckle pixel intensities. In general, RF-based algorithms
are mono-dimensional, with raw data processed in a single vertical
line of view, while speckle tracking is applied on large bi-dimensional
regions of interest. Previously, the RF-system was considered more
accurate due to higher axial spatial resolution, but this comes at the
cost of assessing a single arterial diameter site (analogous to the use
of a single caliper dimension). Pixel density systems allow for multiple
diameter assessments within a given frame, whilst recent speckle
tracking systems have also overcome the spatial resolution
limitation.119
Adoption of automatic software overcomes methodological issues
linked to the use of manual calipers. Since maximal brachial vasodila-
tion is 0.1–0.4 mm and the typical resolving power of manual calipers
of 0.1 mm, the manual approach is likely to introduce significant with-
in- and between-observer error. Manual measurements also have a
low number of samples per time-frame, whilst a more detailed time-
course of changes in diameter is desirable, especially to identify the
true peak diameter.90 Among potential advantages offered by auto-
matic systems, real-time analysis allows for instantaneous feedback
on scan quality and rapid adjustments in response to patient/probe
movements. This real-time feedback may help the sonographer to
optimize image quality. Another potential advantage is to immediately
identify technical failure of the measurement, with the possibility to
repeat the FMD after an adequate resting time.
An additional advantage of automated systems is their ability to
use both ECG-gated and non-gated ultrasound images without affect-
ing the FMD results.96 This can help to keep the experimental setup
as simple as possible, for example, by adopting a cheaper entry-level
ultrasound device without ECG synchronization capability. Software
systems for automatic FMD evaluation should be usable and user-
friendly, but also should provide options to view and record different
parameters (i.e. shear rate). Furthermore, the high throughput of
data, ease of use and other technical features (e.g. real-time feedback,
overlay of edge detector output with B-Mode) may help adequate
training of the operator. Finally, any new automatic system must be
validated in appropriate populations before introducing its use in
laboratories.45,120
Summary and future directions
In conclusion, strong evidence supports the following methodologies:
placement of a lower cuff occlusion and use of continuous diameter
monitoring by automatic edge-detections systems. Furthermore, the
general study protocol, subject preparation and lab requirements are
well defined. It remains uncertain whether and how to correct FMD
for the shear stimulus and/or baseline diameter. The pathophysio-
logical significance and clinical relevance of additional parameters,
such as flow-mediated constriction and reactive hyperaemia as a




Several studies have examined FMD reproducibility. However, these
have been performed with widely varying adherence to FMD-
guidelines. After pooling the results of seven centres that strictly fol-
lowed FMD-guidelines, including optimal training of operators and
monitoring, Ghiadoni et al.29 found that FMD in healthy volunteers is
highly reproducible among centres (coefficient of variation 11.6–
16.1%). Data from the dal-VESSEL trial also showed reproducible
results in 19 laboratories after standardized training in patients with
CVD (coefficient of variation 15.8–17.5%).31 More recently, Greyling
et al.121 designed a tool to evaluate adherence to FMD expert con-
sensus guidelines. Subsequently, a meta-analysis was performed to as-
sess the relation between degree of adherence and reproducibility of
the FMD.60 Not surprisingly, stricter adherence to guidelines was
related with markedly less measurement error in brachial artery
FMD. This work highlights that strictly following contemporary guide-
lines leads to highly reproducible results.
Factors influencing reproducibility: group
and methodology differences
Guidelines for FMD measurement cannot cover and eliminate all
sources of measurement variations and error. Understanding of
these factors is important for designing studies on FMD (e.g. sample
size calculations). van Mil et al.30 recently performed analysis of 672
repeated FMD measurements that were collected after strictly fol-
lowing contemporary guidelines. High reproducibility was found in
































































































healthy subjects (9.3%), whilst regression models several factors that
contributed to variations in reproducibility (see below).
Subject characteristics
Subjects with older age, hypertension, or dyslipidaemia show a larger
variability in FMD.29–31 This supports earlier findings in that CV risk
factors impair FMD reproducibility.65 An explanation for the larger
variation in high-risk subjects may relate to the lower baseline FMD%
typically observed in these populations.58,122,123 Indeed, van Mil et
al.65 demonstrated that a lower FMD% explained part of the higher
variability in FMD with older age and dyslipidaemia. Differences in
vascular structure and compliance may also contribute to this higher
variability124 and finally, not all subjects may be equally susceptible to
the effects of CV risk factors at the endothelial level.
Methodological characteristics (time between
measurements)
Longer time periods between subsequent FMD measurements leads
to larger variation.29,30 Nonetheless, when strictly following guide-
lines and controlling for potential physiological factors,29 it is possible
to detect FMD changes, induced by interventions, over time with a
relatively low sample size. Current data on within- and between-
subject variability justify the use of FMD as an outcome measure in
short-to-medium-term studies to evaluate (non)pharmacological
interventions in humans.
Methodological factors (lab experience)
Possibly the most important methodological source of variability in
the FMD is proper operator training. Guidance and training by expert
colleagues seems crucial, since lower variability is present in more
experienced laboratories.30 Although the need of experience in scan-
ning is mentioned by previous guidelines, 58,59,61 it is difficult to quan-
tify ‘proper training’. No study specifically aimed at quantifying the
appropriate duration of the training, like what was done for carotid
intima-media thickness.125 Corretti et al.59 suggested that >100
scans/year are required to maintain competency. However, there
was no mention of the training required before performing FMD
measurements. Two independent consortia adopted a formal train-
ing for sonographers: sonographers were qualified for measurements
when the CV for repeated scans were <2% for brachial artery diam-
eter and <15% for FMD.29,31 Since FMD variability seems larger in
individuals with CV risk,29,31 operator training might be longer de-
pending on the study population enrolled. Both aforementioned
studies showed excellent reproducibility among centres, suggesting
that specialized training is feasible and successful. We therefore rec-
ommend that all studies on FMD should report details on prepar-
ation and training of the sonographers, along with the observed
variability in their FMD measurements.
Endothelium-independent dilation
Pathophysiology and clinical relevance
The degree of FMD can also be influenced by the functionality of vas-
cular smooth muscle (VSM) cells.126 Any functional defect in VSM
cells reduces their capacity to respond to NO, whilst a compensatory
increased VSM response may be present in endothelial dysfunc-
tion.127,128 In any case, it is recommended that the studies on
endothelium-dependent vasodilation also determine the extent of
any coexistent endothelium-independent dysfunction. Although this
recommendation was already present in previous FMD-guidelines,59
a standardized protocol has not been clearly defined yet.
Clinical determinants of VSM function are not fully understood. In a
large Japanese cohort, brachial artery dilation to sublingual glyceryl tri-
nitrate (GTN) was correlated with most classical CV risk factors and
represented an independent determinant of FMD.129 Conversely, a
meta-analysis reported micro-, but not macrovascular, impairment of
VSM in Type 2 diabetic patients.130 Since the brachial artery was
studied in only 12 out of the 31 studies, this subgroup analysis is likely
underpowered. Furthermore, some studies found a relation between
brachial artery GTN-responses and lack of nocturnal blood pressure
fall,131 coronary artery calcium,132 and microalbuminuria.133 Although
GTN-responses show a relationship with Framingham Risk score,129
only few prospective studies investigated the relation between this re-
sponse and CVD events.134,135 Thus, the prognostic value of the GTN-
response remains mostly inconclusive.134,135 Finally, the doses typically
used in these studies induce near-maximal dilation,73 hence the GTN-
responses may be a structural index rather than a functional one.
Dose, technique, and administration of
exogenous nitrates
Many research centres use sublingual GTN 400lg, the lowest mar-
keted dose in many countries. Administration of GTN via a sublingual
spray leads to a larger and faster response than by tablet administra-
tion.136 Lower dosages (25 lg) of GTN were later introduced137 and
recommended in the 2005 ESH-statement.138 The rationale for
lower dosages is the induction of less extreme dilatation, a faster re-
turn to baseline diameter (20 min), and lower risk of side effects. In
healthy volunteers, 8–35 lg GTN is estimated to induce a 4–10%
dilation, without changes in blood pressure and heart rate.129,139
Furthermore, 25-lg GTN did not cause any significant increase in
sympathetic signalling directed to muscle vasculature, evaluated by
microneurography.140 It has been suggested that higher GTN doses
might be useful to assess maximum vasodilating capacity, thus provid-
ing information about structural alterations. However, maximal vaso-
dilation cannot conceivably be obtained in these conditions because
of counter-regulatory sympathetic vasoconstriction induced by the
high doses of GTN. Although a low-dose GTN is recommended, this
approach may not always be feasible, since low-dose GTN for oral
use is not commercially available for most countries.
Glyceryl trinitrate should be administered >10 min after FMD test-
ing to ensure return to baseline diameter. Furthermore, continuous
diameter monitoring is recommended, because the timing of peak
dilatation varies between subjects.141 The peak vasodilation response
to GTN usually occurs between 4 and 5 min, both with high-141,142
and low-GTN doses.137 Therefore, monitoring should be performed
>5 min after GTN administration.
Conclusions
Flow-mediated dilation provides valuable and independent prognos-
tic information. Unfortunately, different methodological approaches
































































































importantly limit its validity, comparability, and its potential use as a
clinical and physiological research tool. Indeed, adherence to guide-
lines and appropriate operator training improve FMD variability.
Therefore, performing and reporting FMD according to state-of-the-
art guidelines (see Table 2) is crucial to ensure valid conclusions and
clinical evaluation. The application of state-of-the art methodology
allows examining whether the FMD correctly reclassifies individuals,
adding incremental information to traditional CV risk factors. Finally,
strict adherence to guidelines will also contribute to reference values,
which will further improve the clinical applicability of FMD.
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